ETHIOPIAN

MEDICAL

JOURNAL

 

 

JANUARY 2022 VOLUME 60 NUMBER 1

ISSN0014-1755

 

 

EDITORIAL

Addressing the root causes: social determinants of health and disease

ORIGINAL ARTICLES

Tuberculosis case notification rate mapping in Amhara Regional State, Ethiopia: Four years retrospective study

Seroprevalence of syphilis among female commercial sex workers in Hawassa, Ethiopia: a cross sectional study

Patterns of cardiovascular diseases among cardiac disease suspected patients in Bahir Dar City, Ethiopia

Prevalence and etiology of amblyopia among primary school children in Welliso Town: South West Shewa Zone,

Ethiopia.

Caregiver reported incidence of status epilepticus in persons with epilepsy in Enugu, Southeast Nigeria

Gastrointestinal anastomotic leaks and risk factors in four University Hospitals, Addis Ababa

Assessment of level of Job Satisfaction of radiologists practicing in Ethiopia

Dyspepsia and prevalence of clinically significant endoscopic findings and alarm symptoms of dyspepsia in a GI refer- ral clinic in Ethiopia

Magnitude and associated factors of undiagnosed diabetes mellitus among mid-adulthood urban residents of west

Ethiopia

CASE REPORT

A rare case of intestinal obstruction secondary to metastasis dermatofibrosarcoma protuberans

Persistent hiccups in men with Covid 19-two cases from Nigeria

BRIF COMMUNICATION

E-learning in Surgical Education: Experience from the Department of Surgery, Addis Ababa University

ETHIOPIAN MEDICAL ASSOCIATION

P.O. Box 3472, Addis Ababa, Ethiopia

Tel. No. 251-15533742 Fax: 251-1-5533742

www.emjema.org

The Ethiopian Medical Journal is the official quarterly publication of the Ethiopian Medical As- sociation. It is devoted to the advancement and dissemination of knowledge pertaining to medi- cine in Ethiopia and other developing countries.

EDITORIAL BOARD

Editor-in-Chief

Mirkuzie Woldie

Associate Editors-in-Chief

Yeshigeta Gelaw

Editors

Eyasu Makonnen

Abebe Bekele

Markos Tesfaye

Alemayehu Worku

Workeabeba Abebe

Tekalign Deressa

Wondwossen Amogne

Wendemagegn Enbiale

Esayas Kebede

Genet Gebremedhin

Fasika Amdeselasie

Fiker Bekele

Corresponding Editors

Sileshi Lulseged

Kassa Darge

Charles Larson

Frances Lester

Paulos Quana’a

Solomon Tesfaye

Carmela G. Abate

Henry Blumberg

Russell Kempker

Journal Manager

Betelhem Kassie

Senior Researcher

Mohammed Feyisso Shaka

The Ethiopian Medical Journal would like to dedicate this issue to all health workers that have lost their lives on the line of COVID care

Thank you for your service above self !

ETHIOPIAN MEDICAL JOURNAL

January 2022

EDITORIAL

Addressing the root causes: social determinants of health and disease

1

Mirkuzie Woldie

 

ORIGINAL ARTICLES

Tuberculosis case notification rate mapping in Amhara Regional State, Ethiopia:

3

Four years retrospective study

 

Daniel Mekonnen, Abaineh Munshae, Endalkachew Nibret, Awoke Derbie,

 

Andargachew Abeje, Berhanu Elfu Feleke, Yohannes Zenebe, Mengstie Taye,

 

Dessie Kiber, Birhanu Taye Amogne, Taye Zeru, Endalamaw Gadisa, Kidist Bobosha,

 

Adane Mihret, Liya Wassie, Yonas Kassahun, Abraham Aseffa.

 

Seroprevalence of syphilis among female commercial sex workers in Hawassa, Ethiopia:

13

A cross sectional study

 

Getahun Hilameskel Alemu, Deresse Daka Gidebo, Musa Mohammed Ali

 

Patterns of cardiovascular diseases among cardiac disease suspected patients in Bahir Dar City, Ethiopia

19

Habtamu Bayih Engida, Meseret Adugna Mamuye , Yohannes Tekleab Yehun ,

 

Abel Girma Guadie , Yinager Agidie Dagnew , Tesfaye Taye Gelaw , Gizachew Tadesse Wassie ,

 

Zelalem Alamrew Anteneh

 

Prevalence and etiology of amblyopia among primary school children in Welliso Town:

27

South West Shewa Zone, Ethiopia.

 

Sadik Taju Sherief , Mihret Deyesa

 

Caregiver reported incidence of status epilepticus in persons with epilepsy in Enugu, Southeast Nigeria

33

Ezeala-Adikaibe Birinus A, Onodugo Obinna D, Oti Bibiana, Ekochin Fintan, Nwazor Ernest,

 

Okoye Innocent, Mbadiwe Nkeiruka C, Orah-Chidimma Okpala, Onodugo Pascaline

 

Gastrointestinal anastomotic leaks and risk factors in four university hospitals, Addis Ababa

41

Alem Mekete, Birhanu Kotisso, Tessema Ersumo

 

Assessment of level of job satisfaction of Radiologists practicing in Ethiopia

51

Tesfaye Kebede, Daniel Zewdineh , Assefa Getachew, Kumlachew Abate .

 

Dyspepsia and prevalence of clinically significant endoscopic findings and alarm symptoms of

57

dyspepsia in a GI referral clinic in Ethiopia

 

Syibrah Khuzaimah Zahid, Wan Muhamad Mokhzani, Ahmad Fardi Sulaiman,

 

Wan Zainira Wan Zain, Siti Zarqah Omar.

 

Magnitude and associated factors of undiagnosed diabetes mellitus among mid-adulthood

63

urban residents of west Ethiopia

 

Alemu Adeba, Dessalegn Tamiru ,Tefera Belachew

 

CASE REPORT

 

A rare case of intestinal obstruction secondary to metastasis dermatofibrosarcoma protuberans

69

Syibrah Khuzaimah Zahid, Wan Muhamad Mokhzani, Ahmad Fardi Sulaiman,

 

Wan Zainira Wan Zain, Siti Zarqah Omar.

 

Persistent hiccups in men with Covid 19-two cases from Nigeria

73

Ajayi Aal , Babalola Oe

 

BRIEF COMMUNICATION

 

E-learning in surgical education: Experience from the Department of Surgery, Addis Ababa University

75

Yonas Ademe, Abebe Bekele

 

EDITORIAL POLICY

79

GUIDELINES FOR AUTHORS

85

ACKNOWLEDGMENT

90

SUBSCRIPTION

91

NOTICE TO MEMBERS OF THE ETHIOPIAN MEDICAL ASSOCIATION

91

1

Mirkuzie Woldie , Ethiop Med J, 2022, Vol. 60, No. 1

EDITORIAL

ADDRESSING THE ROOT CAUSES: SOCIAL DETERMINANTS OF HEALTH AND

DISEASE

Mirkuzie Woldie 1M.D., M.P.H

The definition of health has heavily been contested in the literature. The medical view of defining health as the absence of illness has been challenged long time ago. The criticisms mainly relate to the fact that this definition limits determinants of health to the individual level (1). However, health of individuals is shaped by a multitude of factors including social, economic, and political events prevailing in the environment of the individual citizens of a country (1, 2). Health status of individuals in a population cannot be separated from the resources and potential available for them to lead healthy life styles.

The World Health Organization’s (WHO) definition of health has been preferred by global health actors despite the popular reservations about its over ambitious intent. Recent publications by global health scholars have also reaf- firmed the importance of such a broad approach to defining health. McCartney and colleagues suggested a similar approach when they defined health as “a structural, functional and emotional state that is compatible with effective life as an individual and as a member of society (2).”

Use of such a broadly oriented definition of health has several public health and health care related benefits. First- ly, such an approach will back-up focus on social determinants of health for health policy and systems develop- ment. This will enable addressing the root causes of ill-health related with the life style, living and working condi- tions, economic status, educational status and many other conditions impacting the health of individuals and popu- lations. Consequently, the WHO’s Commission on the Social Determinants of Health has defined social determi- nants of health as “the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks (3).”

Secondly, such an orientation will make it clear that the development and effective delivery of medical care alone will not do the job of population health development adequately (4). While this is not to mean medical care does not influence population health status, it implies that the concerted effort of other essential sectors outside of the health care system are needed to attain optimal population health development. That is why population health de- velopment should be an integral part of policies crafted and implemented in sectors such as education, housing, and transportation.

Finally, a broad definition of health to address social determinants of health will also influence the design and de- livery of health and medical sciences education in a manner that fits this notion (5). The proper orientation of the health workforce about the role of social determinants of health will enable proper execution of public health inter- ventions by aligning the specific actions at points of health care and upstream actions at the level of policy design.

All of these will sum-up to addressing the root causes of ill-health, not just the manifestations of a wider social issue.

REFERENCES

1.Bircher J, Kuruvilla S. Defining health by addressing individual, social, and environmental determinants: new opportunities for health care and public health. J Public Health Policy. 2014;35(3):363-86.

2.McCartney G, Popham F, McMaster R, Cumbers A. Defining health and health inequalities. Public Health. 2019;172:22-30.

3.World Health Organization, Commission on Social Determinants of Health. Geneva: WHO; 2008. Closing the

gap in a generation: health equity through action on the social determinants of health. CSDH final report.

4.Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Pub- lic Health Rep. 2014;129 Suppl 2(Suppl 2):19-31.

5.Williams SD, Hansen K, Smithey M, Burnley J, Koplitz M, Koyama K, et al. Using social determinants of health to link health workforce diversity, care quality and access, and health disparities to achieve health equi- ty in nursing. Public Health Rep. 2014;129 Suppl 2(Suppl 2):32– 6

Senior Research Advisor, Ministry of Health , Addis Ababa, Ethiopia

Email: [email protected]

3

Daniel Mekonnen, Abaineh Munshae, Endalkachew Nibret, Awoke Derbie, Andargachew Abeje, Berhanu Elfu Feleke, Yohan- nes Zenebe, Mengstie Taye, Dessie Kiber, Birhanu Taye Amogne, Taye Zeru, Endalamaw Gadisa, Kidist Bobosha, Adane Mih- ret, Liya Wassie, Yonas Kassahun, Abraham Aseffa. Ethiop Med J, 2022, Vol. 60 No. 1

TUBERCULOSIS CASE NOTIFICATION RATE MAPPING IN AMHARA REGION-

AL STATE, ETHIOPIA: FOUR YEARS RETROSPECTIVE STUDY

Daniel Mekonnen1,2, Abaineh Munshae2,3, Endalkachew Nibret2,3, Awoke Derbie1,4, Andargachew Abeje5, Berhanu Elfu Feleke6, Yohannes Zenebe1,2, Mengstie Taye7, Dessie Kiber8, Birhanu Taye Amogne8, Taye Zeru9, Endalamaw Gadisa10, Kidist Bobosha10, Adane Mihret10,11, Liya Wassie10, Yonas Kassahun10, Abraham Aseffa10

ABSTRACT

Introduction: Determining the tuberculosis (TB) case notification rate (CNR) at Zonal and Woreda level admin- istration is very important for programmatic management.

Methods: Routine case notifications data archived between 1 July 2014 and 30 June 2018 were extracted from the regional health management information system (HMIS) database. The CNR of all forms of TB was calculated by dividing notified cases by the total population. The proportion of extra-pulmonary TB (EPTB) and TB/HIV co- infection were calculated by dividing the number of EPTB and TB/HIV against the total notified TB cases, respec- tively. The regional and zonal CNR of all forms of TB, TB types and TB/HIV co-infection were plotted using line and bar graphs. The Woreda TB, EPTB, and TB/HIV co-infection rate were mapped using ArcGIS 10.3.

Results: During the four-year period, 90,248 TB cases were registered in the database. The regional annual TB CNR was 113/100,000 population. Among the total notified cases, 47.5% were EPTB which have West-East belt characteristics. Proportionally, EPTB is higher among females than males; and in rural Woreda than urban Wore- da. The proportion of regional TB/HIV co-infection rate was 8%. However, it was much higher in big towns such as Dessie (21%), Gondar (20%) and Bahir Dar (16%). Many Woredas found to be hotspots of TB and TB/HIV co- infection across the study period.

Conclusion: TB and TB/HIV co-infection showed heterogeneous variation among Zones and Woredas. To better understand driving factors for TB in Amhara Region, hotspot versus cold spot ecological study is desirable.

Key words: Tuberculosis, case notification rate, mapping, Amhara Regional State, Ethiopia.

INTRODUCTION

Tuberculosis (TB) is an ancient disease that afflicted humankind for thousands of years(1). Based on 2019 world health organization (WHO) ann ual TB report, Ethiopia ranked 10th among the 20 high burden countries (HBC) and one of the top three in Africa with 114, 233 TB cases at a rate of 151/ 100,000 population (2). Over the last several years, 32 %, 30% and 38% of TB cases were extrapulmonary tu berculosis (EPTB), smear negative pulmonary TB (PT B‑) and smear positive pulmonary (PTB+), respective- ly (3).

Enclosed in 2019 WHO global TB report to Ethiopia, TB/HIV co-infection rate was 5% (2). However, based on two systematic reviews conducted in 2018, much higher rates of TB/HIV coinfection, 22% (4) and 25.6% (5) were reported. Specifically, the TB/HIV co- infection rate was reached to plateau, 26.7% in Amha- ra Regional State (ARS) (5). Taken together, Ethiopia is one among the 14 TB, MDR-TB and TB/HIV co- infection HBC (6).

Tuberculosis in Ethiopia showed spatial clustering and heterogeneity at region, zone and district level (7, 8). It also showed temporal variation, with the highest

CNR observed during April-June (the end of the dry season) and the lowest notification rate during October-December (the beginning of the dry sea- son) (9, 10). The high rate of Mycobacterium tu- berculosis (Mtb) transmission during the winter months might be due to indoor activities, seasonal change in immune function, delays in the diagnosis and treatment of TB and community food security

(9). Additionally, several religious and cultural festivities are held during month of October- December which might lead to population gather- ing and hence TB transmission. This period is also considered as the vacation season for farmers in Ethiopia and is noted for increased health seeking behavior of farmers which may lead to detection of more TB cases.

Tuberculosis CNR mapping and delineation of areas in to TB hot and cold spots is documented by a few studies in Ethiopia (7, 9-11) and globally (12). However, any similar observations from a specific location are always of interest. Moreover, there are new insights in this study not addressed by previous studies. For instance, previous studies failed to address EPTB spatial distribution.

1Department of Medical Microbiology, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. 2Biotechnology Research Institute, Bahir Dar University, Bahir Dar, Ethiopia. 3 Department of Biology, Bahir Dar University, Bahir Dar, Ethiopia

4The Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethio- pia.5Geospatial data and Technology center, Bahir Dar University, Bahir Dar Ethiopia. 6Department of Biostatistics and Epidemiology, School of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. 7Department of Animal Science, Col- lege of Agriculture and Environmental Sciences, Bahir Dar University, Bahir Dar, Ethiopia. 8Amhara Regional Health Bureau, Bahir Dar, Ethi- opia. 9Amhara Public Health Institute, Bahir Dar, Ethiopia. 10Armauer Hansen Research Institute, Addis Ababa, Ethiopia. 11Department of Medical Microbiology, Immunology and Parasitology, College of Medicine and Health Sciences, Addis Ababa University, Addis Ababa, Ethio- pia.

*Corresponding Author E-mail: [email protected], Tel: +251912990288, P, Box:1383, Bahir Dar, Ethiopia

Moreover, our finding described the correlation of EPTB with HIV and their urban-rural disparity. Thus, the aim of this study was to determine the CNR of all forms of TB, TB types (PTB and EPTB) and TB/HIV co-infection at regional and lower administrative lev- els (Zones and Woredas). Of these, Woreda level TB, EPTB and TB/HIV co-infection CNR mapping were done.

METHODS

Study design and period

The study was conducted using data collected and archived between

4

July 2014 and June 2018 in Amhara Regional State (ARS).

Amhara National Regional State of Ethiopia was di- vided in to 13 Zones and 181 Woredas (Figure 1). The Republic of Ethiopia has five tier administrative structures.

These are Federal Government, regional govern- ments, zones (intermediary or oversight bodies), dis- trict (commonly known as Woreda) and kebele (non- budgeted smallest administrative unit) (13).

Figure 1: Study area map, Amhara Regional State divided in to Woredas, 2020

Participants and variables

All registered TB and TB/HIV co-infected cases be- tween July 2014 and June 2018 were included in this study. TB patients were classified as PTB+, PTB- and EPTB. The PTB+ cases refer to a patient from whom at least one biological specimen is positive for Mtb by WHO recommended diagnostic technology. Clinical- ly diagnosed TB (PTB-) case refers to a patient who does not fulfill the criteria for PTB+ case but has been diagnosed with active TB by an experienced clinician (14). EPTB refers to TB involving organs other than the lungs. Diagnosis of EPTB is based on bacteriolog- ical, histological or clinical evidences (14).

Data sources and measurement

The health management information system (HMIS) databases were the secondary source of the data and that of the TB unit register at Directly Observed Treat- ment, Short-Course (DOTs) clinic were the primary sources (14).

The absolute number of regional, zonal and Woreda TB (all forms of TB, PTB+, PTB-, and EPTB) and TB/HIV co-infection were documented across the four years. The CNR of all forms of TB was calculated by dividing all cases of TB by Woreda or zonal popula- tion and then reported as per 100,000 populations. By this calculation, the trends of all forms of TB were assessed over the four-year period. The proportion of EPTB and TB/HIV co-infection was computed by dividing the number of EPTB and TB/HIV co-infected cases by all forms of TB and then multiplied by

100.The total TB data were disaggregated by age and gender. The regional TB/HIV co-infection CNR was also determined.

All forms of TB and TB/HIV co-infection rates were assessed and compared among the included zones and Woredas over the four years to identify the most prev- alent types of conditions.

Using the WHO annual TB report data of the 30 HBC (3), we roughly classified TBCNR of Woredas into: low (≤50 TB /105 population), moderate (50.1-114 TB /105 population), high (114.1-221 TB /105 popula- tion) and extremely high (>221 TB /105populations). Woreda EPTB proportions were classified as low (0- 15%, globally acceptable range), moderate (15.1-31%, nationally acceptable range), high (31.1-48%, higher than national average) and extremely high (>48 %) (3, 15). In the same fashion, the proportion of TB/HIV co -infection was classified as extremely high (>20%), high (12.1-20%), moderate (7.1-12 %) and low (<7%).

Statistical Analysis

Using the excel spread sheet, the regional and zonal TB, TB types and TB/HIV co-infection data were summarized using frequency, percentage, mean, medi- an and range. Regional and zonal TB CNRs were dis- played using line graphs. The CNR of EPTB and TB/ HIV co-infection were graphed using bar graphs. The Woreda TB, EPTB and TB/HIV co-infection CNR mapping were done using ArcGIS 10.3 (ArcGIS Desktop, ESRI 2011. Redlands, Canada).

5

The spatial data used for the maps were taken from Map library which is a public domain that can be accessed at www.maplibrary.org.

RESULTS

During the four-year period of 2014 to 2018, a total of 90,248 TB cases were notified and of these, 42, 911 (47.5%) were EPTB. Amhara regional state contributed for around 18.8% of annual na- tional TB CNR. The identified TB cases were dis- aggregated by age and gender. As such, TBCNR was reached plateaus at 25-34 years of age fol- lowed by 15-24 years of age. Not only the highest TBCNR but also the most infectious cases were also documented in these age groups. The propor- tion of EPTB appears to be higher below 15 years of age and particularly among children under 5 years of age. Smear negative TB is proportionally more frequent than other forms in the age groups above 45 years. Smear positive TB appears to be proportionally higher in frequency than other forms among young adults (15-44 years of age) (Figure 2).

Figure 2: The TBCNR across age groups in Amhara Regional State, 2014-2018

TBCNR: Tuberculosis case notification rate, PTB+: Smear positive pulmonary tuberculosis, PTB-: Smear negative

pulmonary tuberculosis; EPTB: Extra pulmonary tuberculosis

Of the total 90,248 new TB cases, 55% and 45% were males and females, respectively. Conversely, when we took female and male separately and disaggregated by types of TB, EPTB is much higher among females (51%) than males (45%).

Of the 13 zones in the region, North Gondar (recently divided in three administrative zones) was the highest

6

TB reporting zone accounting for 16.64% of the cas- es across the four fiscal years followed by West Gojam 12.85% and South Wello 12.66% zones. It was evident that the absolute numbers of TB types) were related with the total population size. Extra- pulmonary TB was the highest notified clinical phe- notype in all zones except in North Shewa Zone (Figure 3).

Figure 3: The CNR of TB types in 13 zones of ARS between 2014 and 2018

CNR: Case notification rate, ARN: Amhara Regional State, PTB+: Smear positive pulmonary tuberculosis, PTB-: Smear

negative pulmonary tuberculosis; EPTB: Extra pulmonary tuberculosis

It was a good achievement that, 99% of the new TB cases have been screened for HIV. Of those screened, 8% of TB cases were co-infected with HIV.

Proportionally highest TB/HIV co-infection CNR was reported from big towns such as Dessie, Gondar, and Bahir Dar; 21%, 20% and 16%, respectively (Figure 4).

Figure 4: The CNR of TB/HIV co-infection in 13 zones ARS between 2014-2018

CNR: case notification rate, TB/HIV: Tuberculosis/Human Immune Deficiency Virus, ARN: Amhara Regional State,

Figure 5 below depicts the pattern of TBCNR over the four years period among106 Woredas. The TBCNR was >221/100000 population per year in Metema, Bahir Dar town and Dessie over the years. Kombolcha, Ankasha, Gondar, Kobo and Sanja were also among the highest TB reporting woredas (Figure 5). Surprisingly, high TBCNR was reported from urban woreda than corresponding rural woredas signaling the phenomena of hotspot and cold spot di- chotomy.

7

For instance, Gendawuha, Kobo Town, Burie Town, Bati Town were hotspots for Metema, Raya Kobo, Burie Zuria and Bati Zuria Woredas, respectively. Taken together, Metema, Sanja, Bahir Dar, Gondar, Dessie, Chagni, Kemissie town, Kobo town, Bati, Woreta, Shewarobit, Dangla town, Jawi, Kombol- cha, Injibara town, and Woldia were considered TB hotspot woredas across the study period (Figure 5).

Figure 5: The TBCNR/100,000 populations in ARS between 2014- 2018

Low (green): ≤50 TB /105 population; Moderate (lime): 50.1-114 TB /105 population; High (Yellow): 114.1-221 TB /105

population; extremely high (Red): >221 TB /105populations. TBCNR: tuberculosis case notification rate; ANS: Amhara Re- gional State

Figure 6: The proportion of EPTB (A) and TB/HIV co-infection (B) in ARS between 2014- 2018

Contrary to the CNR of all forms of TB, the propor- tion of EPTB was higher in majority of rural Woredas compared to urban Woredas. The EPTB CNR ranged between 49% and 66% in 63 Woredas. Most of these Woredas were from western Amhara but also extend- ing to eastern Amhara, forming an “EPTB belt of Am- hara” or “EPTB hand of Amhara” (Figure 6A, Sup- plementary Material 1).

Closer look at figure 6b shows that the proportion of TB/HIV co-infection was ≥15% in 18 Woredas. Some of these include Lalibela (26%), Debre Markos (22%), Dessie (21%), Enemay, Gondar and Bati each (20%), Kobo town, Shewarobit and Tehuledere each 19% (Figure 6B).

EPTB proportions (Figure 6A): Low (Green): 0-15%

(globally acceptable range); Moderate (Lime): 15.1-31%

(nationally acceptable range); High (Yellow): 31.1-48%

(higher than national average); Extremely high (Red): >48 %). The proportion of TB/HIV co-infection (Figure 6B): Low (Green): <7%; Moderate (Lime): 7.1-12 %; High (Yellow):12.1-20%; Extremely high (Red): >20%. EPTB: Extra pulmonary tuberculosis; ARN: Amhara Regional State, TB/HIV: Tuberculosis/Human Immune Deficiency Virus

Collectively, it can be concluded that, the CNR of TB was population dependent, higher in urban than rural Woredas. Moreover, the declining rate of TB is prom- ising but very stagnant for infectious form of TB. In ARS, TB and TB/HIV co-infection CNR exhibited heterogeneous spatial pattern. Additionally, the pro- portion of EPTB is relatively higher in rural than ur- ban Woredas but the reverse is true in case of TB/HIV co-infection rate.

DISCUSSION

A total of 92,379.00 TB cases including relapse were notified during the four-year period with a mean annu- al CNR of 23, 095 TB cases. The annual TB CNR in ARS was 113/100,000 which was lower than the 2019 annual WHO TB report of Ethiopia, 151/100000 (2). The TBCNR reached plateau at 25-34 years of age followed by 15-24 years of age. Not only the highest CNR of TB but also the most infectious cases were also documented at these similar age groups (Table 1, Figure 2). Why TBCNR is high at these age ranges is not well understood. It is known that, age range of 15- 34 is the economically productive age group. On the other hand, poverty and TB are linked via malnutri- tion, immunity, poor housing and crowded housing

(16, 17). Hence, crippling of these age range by M. tuberculosis might have long term evolutionary

8

advantage for the bacteria. Overall, age range of 15 -44 is the most socially and physically interactive periods which might give the fitness advantage for the bacteria to transmit.

Furthermore, TBCNR is population size depend- ent; the high number of population at these age ranges might be another possible explanation. The high CNR of HIV at these age range might also be additional evolutionary pressure for progression to active TB.

The regional TB/HIV co-infection rate was gauged at 8% which was in line with the national estimate of 7% (3). Among zones, regional big towns such as Dessie, Gondar, and Bahir Dar were the highest TB/HIV co-infection reservoirs. Similar with our report, a study by Datiko et al (2008) found high TB/HIV co-infection CNR in urban than rural (18). This study concluded that, TB/HIV co-infection follows the HIV epidemiology rather than TB epi- demiology.

For the first time, this study deciphers the direction and CNR map of EPTB in ANRS. Figure 6a shows EPTB West-East belting directions which have a wider (palm like) geographic coverage in the west- ern Amhara and radiating towards Eastern Amha- ra. The high CNR of EPTB in Ethiopia and in par- ticular, ANRS was the subject of intense research (19, 20). Kodaman et al asserted that, severe dis- ease like EPTB is the outcome of a coevolutionary mismatch (21). Multiple reports support the higher prevalence of EPTB among females than males (22-24).

A study by Ganchua et al (2018) explained the role of lymph node (LN) as ecological niche for Mtb (25). This study determined that LNs are generally poor at killing Mtb compared with lung granulo- ma. This is because, granulomas that form in LNs lack B cell-rich tertiary lymphoid structures. With this, LNs are not only sites of antigen presentation and immune activation during infection, but also can serve as predator free niche for Mtb (25).

In general, a high rate of Mtb niche shift from pul- monary to LN in ARS, Ethiopia is the subject of further discussion. The high CNR of EPTB in rural than urban Woredas call for further study but might be related with delayed diagnosis (9, 26, 27) among other factors.

Our assessment identified high burden TB, EPTB and TB/HIV co-infection Woredas (Figs 5-6). Ad- ditionally, Figures 5-6 shows the presence of heter- ogeneous spatial distribution of all forms of TB (Figure5), EPTB (Figure 6a) and TB/HIV

co-infection (Figure 6b). Heterogeneous spatial distri- bution of all forms of TB was in line with Alene et al 2019. Based on spatial autocorrelation using Moran's I statistic, local indicators of spatial association (LISA) analysis and Bayesian models, a high-high cluster of CNR was found in northwest Ethiopia (7, 10). It showed that the incidence of notified TB was signifi- cantly associated with poor health care access and good knowledge about TB (7).

Rural/urban TBCNR dissimilarity might be due to population density, social mixing, delay in diagnosis, poverty, and access to health facility (28). In such dissimilarity and hot and cold spot scenario, transmis- sion dynamic models suggested hotspot targeted screening and intervention is more effective at lower- ing community-wide TB incidence when TB spills over transmission is expected from hotspots towards TB cold spot area [29]. However, it should be certain that the difference is true and free from detection and other bias [29].

The current high TB and TB/HIV prevalent areas (hotspots) are characterized by high population move- ment, social mixing, congregation, urban type, and commercial corridors. Thus, hotspots might not be driven by local transmission event alone rather migra- tion or aggregation of vulnerable hosts [29] might have significant share. Migration plays an important role not only to ignite the epidemic in areas previously cases free, but over the course of the entire epidemic [30].

In general, this study has several implication on policy related issues. For instance, the mapping is used for identification of predictors of diseases patterns and visualized the magnitude of TB across Zones and Woredas. Moreover, this TB CNR mapping study might be a footsstep for designing a model for coevo- lutionary study. This study pinpoints the most TB, EPTB and TB/HIV affected Woredas and Towns and this information would be an input on debate regard- ing alternative intervention measures. These current TB maps can also be used as baseline from which interventions success or failure can be monitored [31, 32].

This study described the correlation of EPTB with HIV and their urban-rural disparity. However, due to the retrospective nature of the study, spatial covariates were not considered in the analysis and only notifica- tion rate mapping was done. TB and TB/HIV co- infection CNR might depend on availability of nearby health service and socioeconomic status. Thus, this CNR might not mirror the true incidence and preva- lence of the diseases in the respective administrative units.

9

CONCLUSION

The detailed information comprehended and envel- oped in this study is the first in terms of giving a detail evaluation of TB and EPTB epidemiology in ANRS. In the four-year TBCNR study, 90,248 TB cases were notified and registered in regional HMIS database. Amhara Region contributed for around 18.8% of annual national TB CNR. Of the total notified cases, 47.5% were EPTB. The pro- portion of EPTB among notified cases was be- tween 49% and 66% in 63 Woredas. Most of these Woredas are from western Amhara but also ex- tending to eastern Amhara; ‘EPTB belt of Amha- ra”. Contrary to the CNR of all forms of TB, the proportion of notified EPTB cases were higher in rural Woredas compared to urban Woredas.

The TB/HIV co-infection CNR was 8%. Proportionally highest TB/HIV co-infection rate was reported from regionally big towns such as Dessie, Gondar and Bahir Dar; 21%, 20% and 16%, respectively. Hence, TB/HIV co-infection CNR depended on the HIV epidemiology rather than TB. Hence, TB case finding can be best inte- grated with HIV programmatic management.

In General, like other chronic diseases (eg. Diabtes Mellitus), the epidemiology TB in Amhara region is somehow exceptional compared with other re- gion/country. Hence, pathogen, host and environ- mental factor must be integrated to better under- stand TB in the region and in Ethiopia at large. Additionally, to better understand the driving fac- tors for TB in Amhara Region, hotspot versus cold spot ecological study is desirable.

ABBREVIATIONS

ANRS: Amhara National Regional State; BCG:

Bacillus Calmette–Guérin; CNR: Case notification

rate; DOTs: Directly Observed Treatment, Short-

Course ; EPTB: Extrapulmonary tuberculosis;

HBC: High burden countries; HIV: Human

immunedeficency virus; HMIS: Health Infor-

mation Management System; LISA: local indica-

tors of spatial association; LN: Lymph node; MDR

-TB: Multidrug resistance TB;; Mtb: M. tuber-

culosis; MTBC: Mycobacterium tuberculosis

complex; PTB+: smear positive pulmonary PTB;

RR:Rifanmpicine resistance; TB: Tuberculo- sis; TBCNR:TB case notification rate; WHO: World Health Organization.

DECLARATIONS

Ethics approval and consent to participate

The study was approved by Amhara Regional Ethical Review Committee (RERC). The HMIS archived da- tabase contains institutional level data and did not contain any patient identifier. The data were kept con- fidentially and used for the purpose of the study only.

Consent for publication

Not applicable

Availability of data and material

The datasets supporting the conclusions of this article are included within the article and its additional files. Any additional material can be obtained upon reasona- ble request.

10

Competing interests

The authors declare that they have no competing interests.

Funding

This research received no specific grant from any funding agency.

Acknowledgements

Authors express deep appreciation to Amhara Na- tional Regional Health Bureau Research Direc- torate for approving the proposal. Moreover, we also thank the Amhara Regional state the HMIS department for their kind cooperation during data extraction.

Supplementary Material

Table S1: Full Woreda TB, EPTB and TB/HIV data used for mapping figure 5 and 6

REFERENCES

1.Palomino, JC., Leao, SC., & Ritacco, V. (2007). Tuberculosis 2007; from basic science to patient care.

2.World Health Organization. Global Tuberculosis Report 2019. World Health Organization. Geneva, Swit- zerland; 2019.

3.World Health Organization. Global Tuberculosis Report 2018. World Health Organization, Geneva, Swit- zerland:; 2018.

4.Teweldemedhin M, Asres N, Gebreyesus H, Asgedom SW. Tuberculosis-Human Immunodeficiency Vi- rus (HIV) co-infection in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2018;18 (1):676.

5.Tesfaye B, Alebel A, Gebrie A, Zegeye A, Tesema C, Kassie B. The twin epidemics: Prevalence of TB/ HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysis. PLoS ONE. 2018;13(10):e0203986.

6.World Health Organization. Use of high burden country lists for TB by WHO in the post-2015 era. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epi. Geneva: World Health Organization; 2015.

7.Alene KA, Clements AC. Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study. PLoS ONE. 2019;14(8).

8.Alene KA, Viney K, McBryde ES, Clements AC. Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia. PLoS ONE. 2017;12(2).

9.Gashu Z, Jerene D, Datiko D, Hiruy N, Negash S, Melkieneh K, et al. Seasonal patterns of tuberculosis case notification in the tropics of Africa: A six-year trend analysis in Ethiopia. PLoS ONE. 2018;13(11).

10.Alene KA, Viney K, McBryde ES, Clements AC. Spatiotemporal transmission and socio-climatic factors related to paediatric tuberculosis in north-western Ethiopia. Geospatial health. 2017.

11.Dangisso MH, Datiko DG, Lindtjørn B. Spatio-temporal analysis of smear-positive tuberculosis in the Sidama Zone, southern Ethiopia. PLoS ONE. 2015;10(6).

12.Shaweno D, Karmakar M, Alene KA, Ragonnet R, Clements AC, Trauer JM, et al. Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review. BMC Med 2018;16(1):193.

13.V YSaV. Local government discretion and accountability in Ethiopia. Gorgia State University, Andrew young school of policy studies. USA 2008.

14.Federal Democratic Republic of Ethiopia MoH. Guidelines for clinical and programmatic management of TB, TB/HIV and Leprosy in Ethiopia. Addis Ababa: FMOH; 2016.

15.World Health Organization. Global Tuberculosis Report 2017. World Health Organization. Geneva, Swit- zerland; 2017. .

16.Marais B, Hesseling A, Cotton M. Poverty and tuberculosis: is it truly a simple inverse linear correlation? Eur Respir J. 2009;33(4):943-4.

17.Oxlade O, Murray M. Tuberculosis and poverty: why are the poor at greater risk in India? PLoS ONE. 2012;7(11):e47533.

11

18.Oxlade O, Murray M. Tuberculosis and poverty: why are the poor at greater risk in India? PLoS ONE. 2012;7(11):e47533.

19.Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjorn B. The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health. 2008;8:266.

20.Berg S, Schelling E, Hailu E, Firdessa R, Gumi B, Erenso G, et al. Investigation of the high rates of ex- trapulmonary tuberculosis in Ethiopia reveals no single driving factor and minimal evidence for zoonotic transmission of Mycobacterium bovis infection. BMC Infect Dis. 2015;15(1).

21.Iwnetu R, van den Hombergh J, Woldeamanuel Y, Asfaw M, Gebrekirstos C, Negussie Y, et al. Is tuber- culous lymphadenitis over-diagnosed in Ethiopia? Comparative performance of diagnostic tests for myco- bacterial lymphadenitis in a high-burden country. Scand J Infect Dis. 2009;41(6-7):462-8.

22.Kodaman N, Sobota RS, Mera R, Schneider BG, Williams SM. Disrupted human–pathogen co-evolution: a model for disease. Front. Genet. 2014;5:290.

23.Ohene S-A, Bakker MI, Ojo J, Toonstra A, Awudi D, Klatser P. Extra-pulmonary tuberculosis: A retro- spective study of patients in Accra, Ghana. PLoS ONE. 2019;14(1):e0209650.

24.Mekonnen D DA, Abeje A,Shumet A,Nibret E, Biadglegne F, Munshae A, Bobosha K, Wassie L,Berg S, Aseffa A. Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysis. PLoS ONE. 2019;14(4):20.

25.Katsnelson A. Beyond the breath: Exploring sex differences in tuberculosis outside the lungs. Nat Med. 2017;23:4.

26.Ganchua SKC, Cadena AM, Maiello P, Gideon HP, Myers AJ, Junecko BF, et al. Lymph nodes are sites of prolonged bacterial persistence during Mycobacterium tuberculosis infection in macaques. PLoS Pathog. 2018;14(11):e1007337.

27.Jørstad MD, Aẞmus J, Marijani M, Sviland L, Mustafa T. Diagnostic delay in extrapulmonary tuberculo- sis and impact on patient morbidity: A study from Zanzibar. PLoS ONE. 2018;13(9):e0203593.

27.Asres A, Jerene D, Deressa W. Delays to anti-tuberculosis treatment intiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study. BMC Infect Dis. 2019;19(1):481.

28.Dangisso MH, Datiko DG, Lindtjørn BJGha. Accessibility to tuberculosis control services and tuberculo- sis programme performance in southern Ethiopia. Glob Health Action 2015;8(1):29443.

29.Cudahy PG, Andrews JR, Bilinski A, Dowdy DW, Mathema B, Menzies NA, et al. Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings. Lancet Infect Dis . 2018; 19(3), pp.e89-e95

30.Kraemer M, Golding N, Bisanzio D, Bhatt S, Pigott D, Ray S, et al. Utilizing general human movement models to predict the spread of emerging infectious diseases in resource poor settings. Sci Rep. 2019;9 (1):5151.

31.Hay SI, Battle KE, Pigott DM, Smith DL, Moyes CL, Bhatt S, et al. Global mapping of infectious disease. Philos Trans R Soc London B Biol Sci 2013; 368 (1614):20120250.

32.Linard C, Tatem AJ. Large-scale spatial population databases in infectious disease research. Int J Health Geogr 2012;11(1):7.

13

Getahun Hilameskel Alemu, Deresse Daka Gidebo, Musa Mohammed Ali, Ethiop Med J, 2022, Vol. 60 No. 1

ORIGINAL ARTICLE

SEROPREVALENCE OF SYPHILIS AMONG FEMALE COMMERCIAL SEX WORK-

ERS IN HAWASSA, ETHIOPIA: A CROSSECTIONAL STUDY

Getahun Hilameskel Alemu 1Deresse Daka Gidebo 2, Musa Mohammed Ali2*,

ABSTRACT

Introduction: Syphilis is an important public health problem worldwide. Female commercial sex workers are disproportionately affected by syphilis. There is scarce data on the prevalence of syphilis among female sex work- ers in Ethiopia. The objective of this study was to identify the seroprevalence of syphilis and associated factors among female commercial sex workers.

Methods: Institution-based cross-sectional study was conducted in Hawassa city among 381 female Commercial sex workers from July 5 to November 25, 2018. Background data were collected using a structured questionnaire. Blood samples were collected from participants; plasma was prepared and tested for the antibody produced against T. pallidum using the syphilis test strip. Data were analyzed using SPSS version 21. A logistic regression model was used to assess factors associated with seroprevalence of syphilis.

Results: Most of the participants belong to the age group 20‒24 years; most of them were single and reside in an

urban area, Seroprevalence of syphilis among female commercial sex workers was 4.2% ( 95% CI: 2.4-6.3). None of the factors assessed were significantly associated with the seroprevalence of syphilis.

Conclusions: Relatively low seroprevalence of syphilis was found in the present study requiring large-scale study to identify whether the low rate is a reflection of the global trend or program-related success involving this marginalized segment of society.

Keywords: Syphilis, Female commercial Sex workers, Seroprevalence Ethiopia

INTRODUCTION

Syphilis, caused by spirochete Treponema pallidum, is an important public health problem worldwide. Syphi- lis is transmitted through close contact such as sexual contact and from a mother to fetus during pregnancy or birth and result in stillbirth and infant death in about 40% of cases [1]. Syphilis causes significant morbidity and mortality among adults, infants, and young children. The infection is usually asymptomatic but can cause ulceration in the genital area that could enhance the transmission of sexually transmitted dis- eases [2].

Even though the burden of syphilis is declining, the prevalence of syphilis remains high in most African countries with an estimated prevalence of 3.24 [3]. The prevalence of syphilis varies based on the study period, study population, and across different coun- tries. Most importantly, all segments of society are not equally affected by syphilis. Some groups such as female commercial sex workers (FCSW), pregnant women, and Human Immuno Deficiency Virus/ Acquired Immuno Deficiency Syndrome (HIV/AIDS) patients are disproportionately affected by syphilis as compared to the general population [4, 5].

According to the report of the World Health Or- ganization (WHO), the prevalence of syphilis among FCSWs was >5% in ten countries [6]. Whereas, countries such as Somaliland (3.1%) [7] and Kenya (3.3%) [8] reported a prevalence of less than 10%. A high prevalence of syphilis among FSWs from Uganda (21%) [9] and Addis Ababa, Ethiopia (52.4 [10] was reposted.

In Ethiopia, antenatal-based surveillance of HIV and syphilis is carried out by Ethiopian Public Health Institute (EPHI). EPHI reported incon- sistent prevalence of syphilis over different years: the prevalence of syphilis was 2.7% and 2.3% in 2007 and 2009 respectively [11]. The prevalence increased from 1% in 2012 to 1.2% in 2014 [12]. The participants of the survey were only pregnant women who visited the antenatal care clinics.

There are several studies that attempted to meas- ure the prevalence of syphilis among blood do- nors [13, 14] and pregnant women in Ethiopia [15, 16]. According to Kebede et al. (17), syphilis is considered as one of the public health im- portant diseases in Ethiopia; however, there are few published data indicating the burden of syph- ilis among FCSWs in Ethiopia [10].

Getahun Hilameskel Alemu 1, Musa Mohammed Ali2*, Deresse Daka Gidebo 2 1Hawassa University Comprehensive Specialized Hospital

2Hawassa University, College of Medicine and Health Sciences, School of Medical Laboratory Science

Corresponding author e-mails of Authors: GHA: [email protected], MMA: [email protected], DDG: [email protected]

As to the Authors knowledge, there is no study that addressed this issue in the Southern parts of Ethiopia. Having data on the prevalence of syphilis among FCSWs will help to strengthen existing prevention methods or design other suitable mechanisms to pre- vent and control the dissemination of syphilis. The aim of this study was to investigate the seroprevalence of syphilis and associated factors among FCSWs in Hawassa City, Ethiopia.

METHODS

Study design and period

An Institution-based cross-sectional study was con- ducted from July 5 to November 25, 2018.

Study area

This study was conducted in Hawassa City, Ethiopia at an integrated service on health and development organization (ISHDO) private clinic. Hawassa is found 275 Km from Addis Ababa, the capital of Ethi- opia. The total population of the city is 328,283. ISH- DO is one of the non-governmental clinics which is dedicated in providing health-related services for FCSWs residing in Hawassa area.

Variables of the study

Dependent variable: T. pallidum antibody test result.

Independent Variables: Marital status, educational status, place of residence, use of condom, frequency of condom use, use of stimulant, history of genital ulcer, place of sex.

Study population

Female Commercial sex workers who work in Hawas- sa area and obtain health and social-related services from the ISHDO clinic.

Operational definition

Female sex worker: Women who receive money or goods in exchange for sexual services.

Sample size determination and sampling technique The sample size was determined using single propor- tion formula by considering 50% prevalence of syphi- lis, with a 95% confidence interval, 5% margin of error, and using correction formula (since the number of FSWs was less than 10,000). Based on the above assumptions, the total sample size was 381. To recruit participants, a systematic random sampling technique was used. Assuming a five-month study period, a total of 620 FCSWs were expected to visit ISHDO clinic according to the clinic plan and the past five month’s performance report. To determine the sample interval, the estimated value (n=640) was divided by the sample size (n=381), which would be 1.7 (K~2). The first participant was selected by using lottery methods. Then onwards, every second participant was included until the sample size is reached. The partici- pants were approached at the ISHDO clinic.

14

The blood sample was collected and transported to the Microbiology laboratory of Hawassa University Comprehensive Specialized Hospital.

Eligibility criteria

Female Commercial Sex Workers aged greater than 16yrs and who were willing to participate were in- cluded in the study. FCSWs that were not voluntary were excluded from the study.

Data collection

Before data collection, study participants were in- formed about the study: procedures to be carried out, benefits, risks, rights, and confidentiality. The background data were collected from FSWs after obtaining written informed consent using a struc- tured questionnaire. From all study participants, 5 ml of blood was collected in test tubes with an anti- coagulant. The whole blood was centrifuged at 5000 revolutions/minute for 10 minutes to prepare plas- ma. Antibodies to T. pallidum were confirmed by using a syphilis test strip (Gaungzhou wondfo bio- tech China). The sensitivity and specificity of the test strip were 100% and 98% respectively. In brief, three drops of plasma were added to the sample pad of the strip; the result was read and recorded after 10 minutes. The distinct red line on the control and test regions indicated a positive test result.

As part of quality control, the questionnaire was translated from English to Amharic and then trans- lated back to English to check the consistency. The questionnaire was pretested on 5% of the total sam- ple size. During the study, data were checked daily for completeness. For laboratory work, the manu- facturer’s manual was followed carefully. The test kit was checked by using known positive and nega- tive controls before using for the study.

Data analysis

SPSS version 21 software was used for data analy- sis; results were summarized and presented in tables and text. The logistic regression model was used to determine predictors of syphilis infection. A p-value of less than 0.05 was considered statistically signifi- cant.

Ethics approval and consent to participate

Ethical clearance was obtained from Hawassa Uni- versity College of Medicine and Health Sciences institutional review board (IRB) with the reference number IRB026/10. Permission was requested and obtained from the study site (ISHDO clinics). Study participants were recruited after informed written consent was obtained. They were informed not to participate or might leave the study at any time. Confidentiality was kept by using codes instead of names that could relate to the participants

15

Results

In this study, 381 FSWs participated with a 100% response rate. Most of the participants were single, reside in an urban area, use condoms, and have no history of a genital ulcer (Table 1 & 2). The mean age and SD of participants was 22.6 + 3 years.

Table 1. Sociodemographic and behavioral characteristic of Female Sex worker at Hawassa, Ethiopia, July 5 to November 25, 2018 (N=381).

Variables

 

Frequency, n (%)

 

 

 

 

Age in year

15-19

91

(23.9)

 

20-24

174 (45.6)

 

25-29

90

(23.6)

 

30-34

17

(4.5)

 

35-40

9 (2.4)

Marital status

Married

11

(2.9)

 

Single

289 (75.9)

 

Widowed

37

(9.7)

 

Divorce

44

(11.5)

Educational status

No formal education

75

(19.7)

 

Formal education

306 (80.3)

Residence

Rural

139 (36.5)

 

Urban

242 (63.5)

 

 

 

 

Table 2. Sexual behaviors and clinical features of Female Sex worker at Hawassa,

Ethiopia, July 5 to November 25, 2018 (N=381).

Variables

 

Frequency, n (%)

 

 

 

 

Condom use during sex

Yes

367

(96.3)

 

No

14

(3.7)

Frequency of condom use

Always

303

(82.6)

 

Sometimes

53

(14.4)

 

Rarely

11

(2.9)

Reason for not using condom

Satisfy customer

4

(28.6)

 

To get more money

8

(57.1)

 

Negligence

2

(14.3)

History of genital ulcer

Yes

99

(26.0)

 

No

282

(74.0)

Steady partner

Yes

103

(27.0)

 

No

278

(73.0)

Place of work( sex)

Hotel

172

(45.1)

 

Street

160

(42’0)

 

Home

48

(12.6)

 

Any place

1

(0.3)

 

 

 

 

 

 

16

Seroprevalence of syphilis

Out of 381 FSWs tested, 16(4.2%) 95% CI: (2.4, 6.3) were positive for T. pallidum antibody. None of the factors assessed were significantly associated with of seroprevalence of syphilis (p>0.05) (Table 3).

Table 3. Factors associated with seroprevalence of syphilis among Female Sex Workers at Hawassa, Ethio-

pia,

July 5

 

 

 

 

 

 

 

 

to

 

 

T. pallidum anti-

 

 

No-

 

 

 

 

 

Variables

 

body test result

 

 

 

 

 

COR (95% CI)

p-value

 

 

 

Positive

Negative

 

 

 

n (%)

n (%)

 

 

 

 

 

 

 

 

 

 

 

 

 

Marital status

Married

1

(9.1)

10 (90.9)

1

1

 

 

 

Single

11 (3.8)

278

(96.2)

2.5(0.29-21.6)

0.39

 

 

 

Widowed

1

(2.7)

36 (97.3)

3.6(0.21-62.7)

0.38

 

 

 

Divorced

3

(6.8)

41 (93.2)

1.4(0.13-14.6)

0.79

 

 

Educational status

No formal

2

(2.7)

73 (97.3)

1.8(0.39-7.89)

0.47

 

 

 

education

 

 

 

 

 

 

 

 

 

Formal educa-

14 (4.6)

292

(95.4)

1

 

 

 

 

tion

 

 

 

 

 

 

 

 

Place of residence

Rural

6

(4.3)

133

(95.7)

0.9(0.34-2.7)

0.9

 

 

 

Urban

10 (4.1)

232

(95.9)

1

1

 

 

Do you use con-

Yes

15 (4.1)

352

(95.9)

1

1

 

 

dom

No

1

(7.1)

13 (92.9)

0.5(0.07-4.52)

0.51

 

 

 

 

 

How often do you

Always

12 (3.8)

303

(96.2)

1

1

 

 

use condom

Sometimes

3

(5.5)

52 (94.5)

0.69(0.19-2.52)

0.57

 

 

 

 

 

 

Rarely

1

(9.1)

10 (90.9)

0.39(0.05-3.35)

0.39

 

 

Reason for not

To satisfy cus-

2

(10.5)

17 (89.5)

 

 

 

 

using condom reg-

tomer

 

 

 

 

 

 

 

 

ularly

To get more

2

(4.8)

40 (95.2)

 

 

 

 

 

 

 

 

 

 

money

 

 

 

 

 

 

 

 

 

Negligence

-

 

8 (100)

 

 

 

 

Use of stimulant

Yes

11 (4.6)

230

(95.4)

1.24(0.42-3.66)

0.69

 

 

 

No

5

(3.7)

130

(96.3)

1

1

 

 

History of genital

Yes

5

(5.1)

94 (94.9)

1.3(0.44-3.87)

0.63

 

 

ulcer

No

11 (3.9)

271

(96.1)

1

1

 

 

 

 

 

Steady partner

Yes

5

(4.9)

98 (95.1)

1

1

 

 

 

No

11 (4)

267

(96)

0.81(0.27-2.38)

0.69

 

 

Place of sex

Hotel

9

(5.2)

163

(94.8)

 

 

 

 

 

Street

5

(3.1)

155

(96.9)

 

 

 

 

 

Home

2

(4.2)

46 (95.8)

 

 

 

 

 

Any place

-

 

1 (100)

 

 

 

 

 

 

 

 

 

 

 

 

 

DISCUSSION

Female Sex workers are prone to syphilis, one of the sexually transmitted diseases, as compared to the gen- eral population because of the nature of their work. The seroprevalence of syphilis among FSW identified in this study was 4.2% which is in line with a report from Burkina Faso (5.6%) [18]. In contrast to our study, high prevalence of syphilis among FSWs was reported from several countries such as Addis Ababa Ethiopia (52.4%) [10], Argentina (45.7%) [19], Rwan- da (51.1%) [20], Brazil (14%) [21], China (7.5-8.8%)

[22].The finding of the current study is higher than the study conducted in Togo (2.2%, 0.8%) [23, 24]. The difference observed could be due to the study design, laboratory methods used and period with an earlier study reporting higher prevalence than recent studies. [25]. The other reasons are laboratory meth- ods used and sample size used.

Relatively, the prevalence of syphilis is well studied among blood donors and pregnant women in Ethiopia. The prevalence of syphilis detected in this study is in line with the prevalence of syphilis reported among blood donors [13, 14] and HIV/AIDS patients [15, 16] reported from Ethiopia. Our finding is low compared to the previous reports of syphilis among FSWs from Ethiopia [10]; however, it is difficult to make a sub- stantial comment on the status of our finding whether it is high or low since there are no similar studies from Ethiopia. We noted the importance of addressing the magnitude of syphilis among FSWs at a large scale in Ethiopia. Even though none of the factors assessed were significantly associated with the prevalence of syphilis, the high prevalence was noted among those who place sexual activity was a hotel, those who had a genital ulcer, and those who did not use condoms. The absence of association could be due to a small sample or a limitation of quantitative study. Future qualitative studies will possibly identify the protective and/ or exposing risk factors to the high-risk popula- tion like FCSW to Syphilis.

17

Limitations of the study: There are limited studies to compare our findings with others. the study car- ries a risk to recall bias and some sensitive infor- mation may not be revealed by participants. the design of the study and. The low power of the study was additional limitation of the study.

Strength of the study: In this study, we tried to as- sess the magnitude of syphilis among segments of the population who are prone to sexually transmit- ted diseases

Conclusions

Syphilis is one of the public health important dis- eases in Ethiopia. In this study, a relatively low se- roprevalence of syphilis was found among FSWs in Hawassa. None of the factors were significantly associated with the seroprevalence of syphilis. Large-scale studies incorporating mixed methods will yield not only the prevalence but the determi- nants for the low prevalence in High- risk popula- tions.

Abbreviations

FSW: Female Sex Worker, HIV/AIDS: Human Im- muno Deficiency Virus/Acquired Immuno Defi- ciency Syndrome, WHO: World Health Organiza- tion, RPR: Rapid Plasma Reagin, ISHDO: integrat- ed service on health and development organization

Acknowledgment

We would like to acknowledge the staff of Integrat- ed Service on Health and Development Organiza- tion and Hawassa University Comprehensive Spe- cialized Hospital. We thank study participants for their participation.

Competing interests

The authors declare that this manuscript was ap- proved by all authors in its current form and that no competing interest exists.

REFERENCES

1.Ingraham NR. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Derm Venereol. 1951;31(Suppl 24):60–88.

2.Korenromp EL, Mahiané SG, Nagelkerke N, Taylor MM. Syphilis prevalence trends in adult women in 132 countries estimations using the Spectrum Sexually Transmitted Infections model. Scientific reports (2018) 8:11503.

3.Smolak A, Rowley J, Nagelkerke N, Kassebaum NJ, Chico RM, Korenromp EL, Abu-Raddad LJ. Trends and predictors of syphilis prevalence in the general population: Global pooled analyses of 1103 preva- lence measures including 136 million syphilis tests. Clin Infect Dis. 2017;66 (8):1184–91.

4.Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010;10(1):111.

5.Amsalu A, Ferede G, Assegu D. High seroprevalence of syphilis infection among pregnant women in Yiregalem hospital southern Ethiopia. BMC Infect Dis. 2018;18(1):109.

6.World Health Organization. Baseline report on global sexually transmitted infection surveillance 2018

18

7.Kriitmaa K, Testa A, Osman M, et al. HIV prevalence and characteristics of sex work among female sex workers in Hargeisa, Somaliland. Somalia. AIDS. 2010;24(suppl 2):S61–7.

8.Vandenhoudt HM, Langat L, Menten J, Odongo F, Oswago S, et al. Prevalence of HIV and Other Sexual- ly Transmitted Infections among Female Sex Workers in Kisumu, Western Kenya, 1997 and 2008. PLoSONE. 2013;8(1):e54953.

9.Vandepitte J, Bukenya J, Weiss HA, et al. HIV and Other Sexually Transmitted Infections in a Cohort of Women Involved in High-Risk Sexual Behavior in Kampala. Uganda. Sex Transm Dis. 2011;38(4):316– 23.

10.Aklilu M, Messele T, Tsegaye A, et al. Factors associated with HIV-1 infection among sex workers of Addis Ababa, Ethiopia. AIDS. 2001;15:87–96.

11.EHNRI. Report on the 2009 Round Antenatal Care Sentinel HIV Surveillance in Ethiopia; 2011; 1–59.

12.EPHI. Report on the 2014 Round Antenatal Care based Sentinel HIV Surveillance in Ethiopia; 2015;1–52

13.Birhaneselassie M. Prevalence of transfusion-transmissible infections in donors to an Ethiopian Blood Bank between 2009 and 2013 and donation factors that would improve the safety of the blood supply in underdeveloped countries. Lab Med. 2016;47(2):134–9.

14.Mohammed Y, Bekele A. Seroprevalence of transfusion transmitted infection among blood donors at Jiji- ga blood bank, Eastern Ethiopia: retrospective 4 years study. BMC Res Notes. 2016;9(1):129.

15.Amsalu A, Ferede G, Assegu D. High seroprevalence of syphilis infection among pregnant women in Yiregalem hospital southern Ethiopia. BMC Infect Dis. 2018;18(1):109.

16.Melku M, Kebede A, Addis Z. Magnitude of HIV and syphilis seroprevalence among pregnant women in gondar, northwest ethiopia: a cross-sectional study. HIV/AIDS (Auckland, NZ). 2015;7:175.

17.Kebede KM, Abateneh DD, Sayih Belay AS, Ayele Manaye GA. The epidemiology of syphilis in Ethio- pia: a protocol for systematic review and metaanalysis covering the last three decades. BMC Systematic Reviews, 2019; 8:2010.

18.Ouedraogo HG, Meda IB, Zongo I, Ky-Zerbo O, Grosso A et al., Syphilis among Female Sex Workers: Results of Point-of-Care Screening during a Cross-Sectional Behavioral Survey in Burkina Faso, West Africa. International Journal of Microbiology Volume 2018, Article ID 4790560, 10 pages

19.Pando MA, Berini C, Bibini M, Fernández M, Reinaga E, et al. Prevalence of HIV and other sexually transmitted infections among female commercial sex workers in Argentina. Am. J. Trop. Med. Hyg., 74 (2), 2006, pp. 233–238.

20.Mutagoma M, Nyirazinyoye L, Sebuhoro D, Riedel DL, Ntaganira J. Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda. BMC Infectious Diseases. 2017;17:525.

21.de Souza RL, Madeira LD, Pereira MS, Silva RM, Sales JB, Azevedo VN, Feitosa RN et a;. Prevalence of syphilis in female sex workers in three countryside cities of the state of Pará Brazilian Amazon. BMC Infectious Diseases. 2020; 20:129.

22.Wang HB, Smith K, Brown KS, Wang GX, Chang DF, et al. Prevalence, incidence, and persistence of syphilis infection in female sex workers in a Chinese province. Epidemiol Infect. 2011; 139, 1401–1409.

23.Halatoko WA, Landoh DE, Saka B, Akolly K, Layibo Y, et al. Prevalence of syphilis among female sex workers and their clients in Togo in 2011. BMC Public Health. 2017; 17:219

24.Ekouevi DK, Bitty-Anderson AM, Gbeasor-Komlanvi FA, Konu YR, Sewu EK, et al. Low prevalence of syphilis infection among key populations in Togo in 2017: a national cross-sectional survey. Archives of Public Health. 2019; 77:39.

25.García PJ, Bayer A, Cárcamo CP. The changing face of HIV in Latin America and the Caribbean. Current Hiv/Aids Reports. 2014 Jun 1;11(2):146-57.

19

Habtamu Bayih Engida, Meseret Adugna Mamuye , Yohannes Tekleab Yehun , Abel Girma Guadie , Yinager Agi- die Dagnew , Tesfaye Taye Gelaw , Gizachew Tadesse Wassie , Zelalem Alamrew Anteneh Ethiop Med J, 2022, Vol. 60 No. 1

PATTERNS OF CARDIOVASCULAR DISEASES AMONG CARDIAC DISEASE SUS-

PECTED PATIENTS IN BAHIR DAR CITY, ETHIOPIA

Habtamu Bayih Engida MD, Cardiologist1, Meseret Adugna Mamuye MD, Internist2, Yohannes Tekleab Yehun MD, Cardiologist1, Abel Girma Guadie MD, Internist2, Yinager Agidie Dagnew MD, Internist 2, Tesfaye Taye Gelaw MD, Cardiologist3, Gizachew Tadesse Wassie MPH4, Zelalem Alamrew Anteneh MSC*4

ABSTRACT

Background: Rheumatic heart disease (RHD) has remained a substantial public health challenge in low and mid- dle-income countries. We aimed to determine the prevalence and associated factors of RHD among patients who received echocardiographic examinations.

Methods: A total of 849 patients who underwent echocardiography examinations were included in the study. Descriptive statistics and logistic regression analysis were performed. The odds ratio with 95% confidence inter- val, and p-values were used to determine the presence of associations.

Results: A total of 849 cardiac disease suspected cases were included in the analysis, of which 406 (47.8%) had a definite cardiac disorder. RHD is responsible for 76(18.2%) of the total cardiovascular disorders. The preva- lence of RHD was 76(9.0%) among the total study population. The sex and age of the patients showed associa- tions with rheumatic heart disease. The odds of having RHD among females was nearly three times that of male counterparts (AOR= 2.9, 95%CI: 1.6-5.4). Besides, the odds of having RHD among younger than 24, and from 25 to 35 was seventeen times that of respondents older than 50 years of age (AOR=17.2, 95%CI: 7.2-41.5, & AOR= 17.1, 95%CI: 7.3-40.0) respectively.

Conclusions: One-half of the cardiac disease suspected individuals had a definite cardiac disease, and RHD ac- counted for 18.2% of the total cardiac diseases. Younger age and female in gender were associated with greater likelihood of having RHD. Therefore, interventions should be tailored to the magnitude of the problem; females and younger age groups should be the focus of concern.

Keywords: Cardiac disease, Rheumatic heart disease, Echocardiography, Ethiopia

INTRODUCTION

Cardiovascular diseases (CVDs) are a group of disor- ders of the heart and blood vessels. Rheumatic heart disease(RHD) is one of the CVDs that result in dam- age to the heart muscle and valves from rheumatic fever caused by streptococcal bacteria(1). Cardiovas- cular diseases (CVDs) are the leading cause of death globally; evidence shows that more people die annual- ly from CVDs than from any other cause. Nearly, 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Over three-quarters of CVD deaths take place in low- and middle-income countries (1, 2).

RHD remains an important public health challenge across the globe; it accounts for more than 15.6 mil- lion cases worldwide each year, however, low and middle-income countries are disproportionately affect- ed (3, 4). The disease persists in all countries of WHO regions, however, the African, South-East

Asia, and Western Pacific regions are the worst affected, accounting for 84% of all prevalent cases and 80% of all estimated deaths due to RHD(5).

According to health institution level studies con- ducted in Africa, RHD is the main cause of heart failure and is responsible for more than 34.0% of cardiovascular disease-related hospital admissions (6, 7). RHD mostly affects the population in low and middle-income countries, particularly; where poverty is widespread. RHD commonly affects chil- dren and can result in life-long disability or death. Effective early intervention can prevent premature mortality from RHD(4, 8).

A country like Ethiopia, whose economy is very weak, and the population living standard is very low, and more than 30% of the population living below the national poverty line bears the highest potential risk of communicable diseases including RHD (9). In addition, as RHD is more common in

1 Department of Internal Medicine Cardiac Unit, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia 2 Departments of Internal Medicine, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia 3Department of Pediatrics, School of Medicine, Bahir Dar University, Bahir Dar, Ethiopia

4 Departments of Epidemiology, School of Public Health, Bahir Dar University, Bahir Dar, Ethiopia Correspondent author email: Zelalem Alamrew Anteneh ([email protected])

young age, and Ethiopia is a country of young popula- tion with over 70 percent of the total population is below the age of 30, and about 45 percent of the popu- lation is below 15 years of age, as a consequence, the country pertains highest potential risk of RHD, and other cardiovascular diseases (10, 11). However, stud- ies conducted on cardiovascular disease including RHD are very scarce.

Therefore, this study aimed to determine the pattern of RHD among patients suspected of heart disease and who underwent echocardiography examinations. Fur- thermore, our study aims to produce hypotheses for future study directions and to have some insight into the contributing factors for RHD.

METHOD AND MATERIALS

Study design and setting: a cross-sectional study de- sign was used among patients visiting cardiac clinics from October 1, 2019 to October 1, 2020. The study was conducted in two hospitals (Felege Hiwot Refer- ral and Addinas General) hospitals. The hospitals are found in Bahir Dar City, located at 560 km distance from Addis Ababa, the capital city of Ethiopia. These hospitals are a few of the health institutions that pro- vide cardiovascular disease examinations and inter- ventions in the city. Patients suspected of a cardiac problem from different health institutions and nearby regions are commonly referred to these hospitals for diagnosis and intervention.

Echocardiographic examination was performed in the parasternal long axis, short axis, apical four chambers, and occasionally in the subcostal and suprasternal views using GE and Sonoscape echocardiography machines at Adinas & Felege Hiwot hospitals. Indices were analyzed and presented in the left ventricle sys- tolic diameter (LVIDS), left ventricle diastolic diame- ter (LVIDD), and the ejection fraction (EF). All the echocardiographic diagnoses were based the Ameri- can Society of Echocardiogram and World Heart Fed- eration guidelines (12, 13).

Study period: we included patients who received echocardiographic examinations from October 1, 2019, to October 1, 2020) and the data was collected from June 15, to May 10, 2021.

Sample size and sampling technique

All patients for whom echocardiography diagnostic tests were carried out in the two hospitals during the selected one-year period were included in this study. A total of 849 cardiac disease suspected patients were included in our final analysis. As eligibility criteria, our analysis considered only the first echocardio- graphic examination reports of each patient in the study.

Study variables

Both hospitals use cardiac disease examination tools consisting of age, the gender of the patients, and the echocardiographic diagnosis.

20

Rheumatic heart disease, is the outcome varia- ble of interest for this study, and age, and gender were independent factors available on the charts and used for this study.

Other cardiac disorders: ischemic heart disease, hypertensive heart disease, Pericardial Effusion, Dilated Cardiomyopathy (DCMP), Degenerative valvular heart diseases (DVHD), Cor-plumonale, pulmonary hypertension, etc

Operational definitions

RHD: According to the World Heart Federation (WHF) criteria for echocardiographic diagnosis of RHD as defined by the presence of any evidence of mitral or aortic regurgitation seen in two planes associated with at least two of the following mor- phologic abnormalities of the regurgitating valve: restricted leaflet motility, focal or generalized val- vular thickening, and abnormal sub-valvular thick- ening (13).

Ischemic heart disease: were documented by detec- tion of regional wall motion abnormality on a dif- ferent region of the heart (such as loss systolic thickening, hypokinesia, akinesia dyskinesia) and associated with LV systolic dysfunction(14).

Hypertensive heart disease: was diagnosed in the presence of any or combination of the following abnormalities: left ventricular diastolic dysfunction (e.g. altered E: A ratio), left ventricular hypertro- phy, left ventricular systolic dysfunction, and dilat- ed left atrium, a surrogate of impaired LV filling in the presence of hypertension(15).

Pericardial Effusion: This was diagnosed when there is echo-free space between the visceral and parietal pericardium(16).

Dilated Cardiomyopathy (DCMP),: was diagnosed when there are dilated heart chambers with normal or decreased wall chambers as well as impaired LV systolic function(17).

Cor-plumonale: was present when there is dilated and hypertrophied right ventricle (RV), evidence of increased RV systolic pressure D-shaped LV in diastole (diastolic flattening of the LV septum) (18).

Data management and analysis

The data received from the hospitals were entered into SPSS software version 26 for analysis. Data cleaning was performed to make it ready for analy- sis. Then after descriptive statistics such as fre- quency distributions, percentages for categorical variables, and median, and interquartile range for the continuous variable were performed. Logistic regression analysis between rheumatic heart dis- ease, and demographic factors (sex and age) were performed to see the crude effect of these factors on rheumatic heart disease. The results were pre- sented in tables, and figures for the descriptive study, and odds ratio with its 95% confidence level and p-values were used for the logistic regression analysis.

Ethical approval

Ethical clearance was obtained from the research and the ethical review committee of Bahir Dar University. Permissions were received from Felege Hiwot Refer- ral Hospital and Addinas General Hospital to use the echocardiography data from the cardiac unit. The data were anonymous; there are no names or any personal identifier in the data.

RESULTS

Demographic characteristics of patients visiting car- diac clinics in Bahir Dar city

This study analyzed a total of 849 patients suspected of having cardiac disorder for which echocardiog- raphy examinations were done. About 55% of the study participants were males, and 44% were younger than 49 years of age. The ages of the respondents were varied between 6 and 103 years, the median and inter- quartile range for the ages was 52, and 34.6 years re- spectively. This study was conducted in two hospitals, 490 (57.7%) of the cases were from Addinas hospital, and the remainings were from FelgeHiwot hospital

(table 1).

patients suspected of cardiac

 

 

 

 

 

Chi-square

20.6

85.6

 

0.2

Percent

44.4 55.6

13.3 16.1

14.7 55.8

57.7 42.3

frequency

 

 

 

 

Table 1: Demographic characteristics of disease in Bahir Dar city

377 472

113 137

125 474

490 359

Categories

Male Female

<24 25-35

36-49 >49

Addinas Felege Hiwot

Variable

Sex

Age in years

 

Hospital

 

 

 

 

 

Cardiac diseases distribution among patients under- went echocardiography examinations in Bahir Dar city

Out of 849 individuals with health problems that un- derwent echocardiography diagnosis 406 (47.2%) had a definite cardiac disease. The prevalence of RHD was 76 (9.0%); it accounts for 18.2% of the total cases of

21

revealed that the prevalence of hypertensive heart disease (HHD) was 80(9.4%), ischemic heart dis- ease (IHD) was 59(6.9%), degenerative valvular heart disease (DVHD) was 63(7.4%), and dilated cardiomyopathy (DCMP) was, 56(6.6%) (Table 2).

Table 2: Diagnostic classifications of cardiac patients using Transthoracic Echocardiography Examinations in Bahir Dar city

Cardiac diseases

Frequency

Percentage

 

 

 

Hypertensive Heart

 

 

Disease (HHD)

80

9.4

Yes

No

769

90.6

Rheumatic Heart

 

 

Disease (RHD)

76

9

Yes

NO

773

91

Degenerative Valvu-

 

 

lar Heart diseases

63

7.4

(DVHD)

Yes

786

92.6

No

 

 

Ischemic Heart Dis-

 

 

ease (IHD)

59

6.9

Yes

No

790

93.1

Dilated Cardiomyo-

 

 

pathy (DCMP)

56

6.6

Yes

No

793

93.4

Pericardial Effusion

 

 

(PE)

43

5.1

Yes

No

806

94.9

Co-pulumonale

36

4.2

Yes

No

813

95.8

Restrictive cardio-

 

 

myopathy (RCM)

14

98.4

Yes

No

835

1.6

Congenital heart

 

 

disease (CHD)

6

0.7

Yes

No

843

99.3

Overall Cardiac

 

 

disease

406

47.8

Yes

No

443

52.2

22

Echocardiographic diagnostic classifications by gender among cardiac patients in Bahir Dar city

Gender distributions of cardiac diseases indicated that rheumatic heart disease was much higher among females compared to males of the total confirmed cardiac cases (61 vs. 15) p-value (<0.001), ischemic heart disease is higher for males than females (36, vs. 23) p-value (<0.008), and similarly dilated cardiomyopathy was higher for males compared to females (33 vs. 23) p-value (0.02) (table 3).

Table 3: Echocardiographic diagnostic classifications by gender in cardiac patients in Bahir Dar City

Disease

Male, n

Female, n

Total (%)

Chi square

P-value

HHD

42

38

80(19.7)

2.3

0.12

RHD

15

61

76(18.7)

20.6

<0.001

DVHD

30

33

63(15.5)

0.7

0.4

IHD

36

23

59(14.5)

7.1

0.008

DCMP

33

23

56(13.8)

5.1

0.02

PE

22

21

43(10.6)

0.84

0.36

Co-pulumonale

13

23

36(8.9)

1.1

0.31

RCM

6

8

14(3.5)

0.01

0.9

CHD

1

5

6(1.5)

1.9

0.2

Any cardiac disease

183

223

406(47.8%)

0.5

0.7

Valvular lesions among RHD patients in Bahir Dar city

Our study showed that 58 (7.5%) and 199 (23.4%) of the study participants had mitral stenosis and regurgitations respectively. In addition, 29(3.4%) and 104(12.2%) of the study participants had aortic stenosis and regurgitations respectively. About 56(96.6%) of the total patients with mitral stenosis and 54(27.1%) of mitral regurgitations were positive for RHD. Besides, one out of four patients with aortic stenosis and one in three patients with aortic regurgitations were positive for RHD.

The findings of this study also indicated that some cardiac patients reported having more than one valvular lesion. More specifically, the distribution of RHD among cardiac patients with more than one lesion varies based on the kind of valvular lesion combined; 38(86.4%) cases with MS and MR, 7(35%) with AS and AR were positive for RHD (Table 4).

Table 5: The frequency distributions & percentages of Valvular lesions based on severity among patients

who underwent echocardiographic examinations in Bahir Dar city

Valvular lesions

 

Severity

 

RHD (N=76)

 

Mild

Moderate

Severe

 

Mitral stenosis (n=58)

17(26.6%)

11(17.2%)

30(56.3%)

58(76.3%)

Mitral regurgitation (n=199)

123(61.8%)

53(26.6%)

23(11.6%)

54(71.7%)

Aortic stenosis (n=29)

15(51.7%)

10(34.5%)

4(13.7%)

8(10.5%)

Aortic regurgitation (n=104)

79(75.2%)

21(20%)

4(3.8%)

34(44.7%)

Regression analysis of rheumatic heart disease by sex and age among patients underwent echocardi- ography examinations

This study is based on echocardiographic diagnostic tests in patients suspected of cardiac disease. Our data contain only sex and age as potential confound- ing factors that entered both in bivariate and multi- variate regression analysis. Both the sex and age of the patients showed associations with RHD. The study revealed that females were more likely to be positive for RHD, where the odds of having a posi- tive diagnosis for RHD among females was nearly three times that for male patients (AOR= 2.9, 95%CI: 1.6-5.4). Similarly,

23

the age of the respondents was showed strong as- sociations with RHD; the odds of disease were significantly higher among the young age group than older ones. The odds of RHD among respond- ents whose age was 35 years or younger was sev- enteen times that of respondents older than 50 years of age (table 6).

Table 6: Regression analysis of rheumatic heart disease for sex and age among patients who under- went echocardiography examinations in Bahir Dar city

Variable

 

Classifications

RHD

 

OR (95% CI for OR)

 

P-value

 

 

 

Yes

No

Crude

Adjusted

 

Sex

 

Male

15

362

1.00

1.00

0.001

 

 

Female

61

411

3.58(2.01-6.41

2.9(1.6-5.4)

 

 

 

 

 

 

 

 

Age

in

<24

24

89

18(7.5-43.0)

17.2(7.2-41.5)

<0.001

years

 

25-35

31

106

19.5(8.4-45.5)

17.1(7.3-40.0)

 

 

36-49

14

111

8.4(3.3-21.3)

7.5(3.0-19.2)

 

 

 

>49

7

467

1.00

1.00

 

 

 

 

 

 

 

 

 

Discussions

Current evidence shows that CVDs are the leading causes of death globally. Low and middle-income countries are disproportionately affected by the dis- ease, where over 80% of these deaths take place (2, 19). However, there is a limited number of studies available to show the burden, distribution, and deter- minant factors for CVDs including RHD in low- income countries. Therefore, this study was aimed to determine the prevalence and the associated factors of RHD among cardiac disease suspected patients.

Accordingly, 406 (47.8%) of patients who underwent echocardiographic examinations reported having a definite cardiac disease. Our finding is supported by a study conducted in Buea, South West Region of Cameroon, where 45.2% of patients who had under- gone echocardiographic tests had a definite CVS (20). In the current study, nearly one in ten patients (9.0%) of the study participants that received echo- cardiographic tests were positive for RHD. This find- ing is in accordance with a study conducted by Nige- rian savannah, where 9.8% of the study subjects with abnormal results had an echocardiographic diagnosis of RHD (21). However, the magnitude of RHD in the current study is much higher than other studies, where the proportion of RHD lies in the ranges of 3.1% to 6.5% (20, 22, 23). The difference may be attributed to several reasons such as

variations in socioeconomic status, gender ratio, and age composition in the study population. In addition, our study domain was patients suspected of cardiac disease and who visited cardiac treat- ment centers seeking interventions; this might in- crease the magnitude of RHD in our study popula- tion unlike similar studies conducted among appar- ently healthy individuals.

In this study, of the cardiac patients with mitral stenosis, 56(96.6%) were positive for RHD. This is supported by the evidence that most mitral stenosis cases among cardiac patients are caused by RHD (24). Likewise, studies conducted so far revealed that in most of the cases, cardiac patients with mi- tral stenosis were positive for RHD (25, 26). Our findings also showed that nearly, 30% of patients who reported having mitral regurgitations were positive for RHD. This finding is in line with simi- lar other study findings where the RHD manifests as congestive heart failure due to valvular involve- ment including mitral valve regurgitations (27, 28). In this study, the prevalence of RHD was signifi- cantly higher among females compared to males, 61(80%) vs. 15(20%) respectively. Furthermore, the odds of having RHD among the female was about three times more likely as compared to their male counterparts in patients suspected of cardiac diseases. This finding is supported by several

pieces of evidence, where the female sex is at higher risk of acquiring RHD compared to males. A review study conducted on the impacts of gender on RHD, all review articles included were showed that a female predominance for RHD (29).

Similarly, a study conducted in India showed that the prevalence of RHD was more than two-fold higher in females than males (71.4% vs. 29.6%) (30). Besides, several studies across the globe indicated that the risk of RHD varies for women and men (31-33).

The age of the respondents showed a strong associa- tion with RHD; the disease was significantly higher among the young age group than older ones. The odds of RHD among respondents younger than 35 years of age was more than seventeen times that of older than 50 years of age. Evidence showed that virtually any- one at any age can get RHD; however, the risk is highest among children and young adults (34-36). Our finding is supported by the evidence from other stud- ies that RHD is more prevalent among young age than older ones; a study conducted in Fiji Oceania among participants between the ages of 5 to 65 years, almost half of RHD cases occurred before age 40 years (37). Similarly, several studies conducted across the globe indicated that the risks of RHD inversely correlated with age, showing that as the age of study participants increases the risk of RHD decreases (8, 36, 38).

This study was conducted merely based on echocardi- ographic examinations done for cardiac disease sus- pected patients. The data was primarily collected for the purpose of diagnosis and intervention. Our study has drawbacks in terms of controlling confounding factors for RHD, because the data composed of only sex and age as confounding factors; the remaining data is all about clinical information such as sign, symptom, specific diagnosis of cardiac diseases, and intervention plan.

24

Conclusion

In this study, one in ten cardiac suspected cases were positive for RHD. Males and females with the cardiac disorder have different risk profiles for rheumatic heart disease that might have a substan- tial impact on the prognosis and treatment out- comes. The odds of RHD among the females is three times that of males. In addition, the odds of RHD inversely decreases with age, the young age groups were at a higher risk of getting the disease compared to older ones. In general, RHD is sub- stantially higher in this study compared to several studies available, indicating that it is an important public health challenge to our community. There- fore, interventions should be tailor the magnitude of the problem, and should also target females and young age groups.

Competing interests

The authors declare that they have no competing interests.

Authors’ contribution

HB and ZAA- conceptualized the study, designed the study, performed data analysis, interpreted the findings, and drafted the manuscript.

MA, YK, AG, YA…and GTW - critically re- viewed the report and manuscript.

All authors read and approved the final version of the manuscript.

ACKNOWLEDGMENT

We received the data from the Felege Hiwot Refer- ral Hospital and Addinas General Hospital. We like to thank the Felege Hiwot Referral Hospital and Addinas Hospital administration offices for grating us the data.

REFERENCES

1.Hopkins J. Rheumatic Heart Disease 2021 [cited 2021 11 Nov. 2021]. Available from: https:// www.hopkinsmedicine.org/health/conditions-and-diseases/rheumatic-heart-disease.

2.World Health Organization. Cardiovascular diseases (CVDs) 2017 [cited October 20,2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

3.Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. The Lancet Infectious diseases. 2005;5(11):685-94. Epub 2005/10/29. doi: 10.1016/s1473-3099(05)70267-x. Pub- Med PMID: 16253886.

4.S.R.A Dodu SB. Rheumatic heart fever and rheumatic heart disease in developing countries. World Health Forum. 1989.

5.Rheumatic fever and rheumatic heart disease [Internet]. WHO. 2018 [cited 15 October, 2020]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_25-en.pdf?ua=1.

6.Liesl Zühlke MM, Eloi Marijon. Congenital heart disease and rheumatic heart disease in Africa: recent ad- vances and current priorities. BMJ. 2013;99(21).

7.Nkoke C JA, Makoge C, Teuwafeu D, Nkouonlack C, Dzudie A. Epidemiology of cardiovascular diseases related admissions in a referral hospital in the South West region of Cameroon: A cross-sectional study in sub- Saharan Africa. PLoS ONE 2019;14(12).

25

8.AO M. Rheumatic heart disease in Africa: is there a role for genetic studies? Cardiovasc J Afr. 2015;26(2 Suppl 1):S21-6.

9. The World Bank. Ethiopia Poverty Assessment [cited 2020 10 october]. Available from: https:// www.worldbank.org/en/topic/poverty/publication/ethiopia-poverty-assessment.

10.Reviews WEn. EDUCATION SYSTEM PROFILES 2018 [cited 2020 12 October]. Available from: https:// wenr.wes.org/2018/11/education-in-ethiopia.

11.Assefa Admassie SN, Shelley Megquier. Harnessing the Demographic Dividend in Ethiopia 2017 [cited 2020 5 December]. Available from: https://www.prb.org/harnessing-the-demographic-dividend-in-ethiopia/.

12.Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the Ameri- can Society of Echocardiography. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2019;32(1):1-64. Epub 2018/10/05. doi: 10.1016/ j.echo.2018.06.004. PubMed PMID: 30282592.

13.Reményi B, Nigel Steer, Andrew Ferreira, et al. World Heart Federation criteria for echocardiographic diagno- sis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol. 2012;9(5):297-309. doi: 10.1038/nrcardio.2012.7. PubMed PMID: 22371105.

14.Paelinck BP. Ischemic Heart Disease, Ultrasound. In: Baert AL, editor. Encyclopedia of Diagnostic Imaging.

Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 1026-8.

15.Janardhanan RK, Christopher M. Imaging in hypertensive heart disease. Expert Rev Cardiovasc Ther. 2011;9 (2):199-209. doi: 10.1586/erc.10.190. PubMed PMID: 21453216.

16.Bernhard Maisch PMS, Arsen D. Ristic et al. Guidelines on the Diagnosis and Management of Pericardial Diseases. The European Society of Cardiology. 2004:1-28. doi: doi:10.1016/j.ehj.2004.02.001.

17.Thomas Mathew LW, Govardhan Navaratnam et al Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Birtish Society of Cardiography. 2017;4 (2):G1–G13.

18.Mandoli GE, Sciaccaluga C, Bandera F, Cameli P, Esposito R, D’Andrea A, et al. Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings. Heart Failure Reviews. 2020. doi: 10.1007/s10741-020-10014-4.

19.Gaziano TAB, Asaf Anand, Shuchi Abrahams-Gessel, Shafika. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72-115. doi: 10.1016/ j.cpcardiol.2009.10.002. PubMed PMID: 20109979.

20.Nkoke CM, C. Dzudie, A. Mfeukeu, L. K. Luchuo, E. B. Menanga, A. Kingue, S. A predominance of hyper- tensive heart disease among patients with cardiac disease in Buea, a semi-urban setting, South West Region of Cameroon. BMC Res Notes. 2017;10(1):684. Epub 2017/12/06. doi: 10.1186/s13104-017-3034-6. PubMed PMID: 29202813; PubMed Central PMCID: PMCPMC5715493.

21.Sani MUK, K. M. Borodo, M. M. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr. 2007;18(5):295-9. Epub 2007/10/25. PubMed PMID: 17957324; PubMed Central PMCID: PMCPMC3975544.

22.Gemechu TM, H. Parry, E. H. Phillips, D. I., acoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24(7):717-23. Epub 2017/01/11. doi: 10.1177/2047487316687104. PubMed PMID: 28071960.

23.Nkoke CD, A. Makoge, C. Luchuo, E. B. Jingi, A. M. Kingue, S. Rheumatic heart disease in the South West region of Cameroon: a hospital based echocardiographic study. BMC Res Notes. 2018;11(1):221. Epub 2018/04/05. doi: 10.1186/s13104-018-3341-6. PubMed PMID: 29615091; PubMed Central PMCID: PMCPMC5883525.

24.Korzan SJ, Evan Mutneja, Rahul Grover, Prashant. Mitral stenosis due to rheumatic heart disease - A rare cause of massive hemoptysis. Respir Med Case Rep. 2018;24:35-9. doi: 10.1016/j.rmcr.2018.03.007. PubMed PMID: 29977754.

25.Leal MTBC, Passos LSA, Guarçoni FV, Aguiar JMdS, Silva RBRd, Paula TMNd, et al. Rheumatic heart dis- ease in the modern era: recent developments and current challenges %J Revista da Sociedade Brasileira de Medicina Tropical. 2019;52.

26.Sticchi A. Mitral valve stenosis: epidemiology and causes in elderly patients. European Society of Cardiology. 2018;16(17).

27.Healio learn the heart. Rheumatic heart disease 2020 [cited 2020 29 December]. Available from: https:// www.healio.com/cardiology/learn-the-heart/cardiology-review/topic-reviews/rheumatic-heart-disease#.

28.Lembo NJ, Dell'Italia LJ, Crawford MH, Miller JF, Richards KL, O'Rourke RA. Mitral valve prolapse in pa- tients with prior rheumatic fever. Circulation. 1988;77(4):830-6. Epub 1988/04/01. doi: 10.1161/01.cir.77.4.830. PubMed PMID: 3349583.

29.Reuben K Mutagaywa A-MW, Apolinary Kamuhabwa et al. Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management. Eur J Clin Invest. 2020;50(12).

26

30.Prakash Chand Negi AK, Sanjeev Asotra et al. Gender differences in the epidemiology of Rheumatic Fever/ Rheumatic heart disease (RF/RHD) patient population of hill state of northern India; 9 years prospective hos- pital based, HP-RHD registry. Indian Heart Journal. 2020;72(6):552-6. doi: https://doi.org/10.1016/ j.ihj.2020.09.011.

31.Ibrahim-Khalil S, Elhag M, Ali E, Mahgoub F, Hakiem S, Omer N, et al. An epidemiological survey of rheu- matic fever and rheumatic heart disease in Sahafa Town, Sudan. Journal of epidemiology and community health. 1992;46(5):477-9. Epub 1992/10/01. doi: 10.1136/jech.46.5.477. PubMed PMID: 1479314; PubMed Central PMCID: PMCPMC1059635.

32.Manuel Martínez-Sellés MAG-F, MarMoreno, et al Influence of Gender on the Etiology of Mitral Regurgita- tion. Revista Española de Cardiología 2006;59(12):1335-8.

33.Nitsche C, Koschutnik M, Kammerlander A, Hengstenberg C, Mascherbauer J. Gender-specific differences in valvular heart disease. Wiener klinische Wochenschrift. 2020;132(3):61-8. doi: 10.1007/s00508-019-01603-x.

34.Centers for disease control and prevention. Rheumatic Fever: All You Need to Know 2020 [updated 2018;

cited 2020 24 December]. Available from: https://www.cdc.gov/groupastrep/diseases-public/rheumatic- fever.html.

35.World Health Organization. Rheumatic Heart Disease 2020 [cited 2020 10 October].

36.World Heart federation. Rheumatic Heart Disease Geneva Switzerland2020 [cited 2020 24 December]. Avail- able from: https://www.world-heart-federation.org/global-advocacy/rheumatic-heart-disease/.

37.Parks T, Kado J, Miller AE, Ward B, Heenan R, Colquhoun SM, et al. Rheumatic Heart Disease-Attributable Mortality at Ages 5-69 Years in Fiji: A Five-Year, National, Population-Based Record-Linkage Cohort Study. PLoS Negl Trop Dis. 2015;9(9):e0004033-e. doi: 10.1371/journal.pntd.0004033. PubMed PMID: 26371755.

38.Paar JA, Berrios NM, Rose JD, Cáceres M, Peña R, Pérez W, et al. Prevalence of rheumatic heart disease in children and young adults in Nicaragua. Am J Cardiol. 2010;105(12):1809-14. Epub 2010/04/27. doi: 10.1016/j.amjcard.2010.01.364. PubMed PMID: 20538135.

27

Sadik Taju Sherief , Mihret Deyesa . Ethiop Med J, 2022, Vol. 60 No. 1

PREVALENCE AND ETIOLOGY OF AMBLYOPIA AMONG PRIMARY SCHOOL CHILDREN IN WOLLISO TOWN: SOUTH WEST SHEWA ZONE, ETHIOPIA.

Sadik Taju Sherief MD1, Mihret Deyesa MD 1

ABSTRACT

Background: Amblyopia is a unilateral or bilateral condition which results in visual reduction whilst the eye seems to be healthy. The main purpose of this study was to determine the prevalence and etiology of amblyopia in school children.

Methods: A school based prospective cross-sectional study design was employed. A total of 1,226 school children aged between 7 and 15 years were screened. Best corrected visual acuity and detailed ophthalmic evaluation were performed in all participants. A diagnosis of amblyopia was based on a best-corrected visual acuity of 6/12 or less in one or both eyes, or a bilateral difference of at least two best- corrected visual acuity lines.

Results: Prevalence of amblyopia was 5.14 % (95% CI: 3.9%-6.4%) and the majority of them were from public schools (82.5%). There was statistical association between students from public school and amblyopia (p=0.003). A total of 44 (41.9%) children had severe amblyopia. Underlying amblyogenic causes were anisometropia (49.2%), isometropia (36.5%), sensory deprivation (11.1%) and strabismus (3.2%).

Conclusion: In this study, the prevalence of amblyopia among school children was 5.14%.

Refractive error is a major risk factor for amblyopia. We found significant statistical difference in amblyopia prevalence between public and private school children.

Key words: Amblyopia, cross-sectional study, prevalence, refractive error, school children

INTRODUCTION

Amblyopia is a unilateral or, less commonly, bilateral reduction in corrected visual acuity in the absence of visible organic abnormalities and is due to misdi- rected, blurred, or absent retinal images during devel- opment of the visual system (1). It is the second lead- ing cause of bilateral visual impairment in children after refractive errors, and has been reported as the leading cause of unilateral visual impairment in pedi- atric patients (2,3).

Anisometropia, constant unilateral strabismus, bilat- eral isoametropia, amblyogenic unilateral or bilateral astigmatism and ocular media opacities are causes of Amblyopia (4).

The overall prevalence of amblyopia varies between

1.6to 3.6% for preschool and school population and from 3.25% to 5.3% in clinical population in different regions of the world (5).

Amblyopia, being unilateral, commonly even severe cases may not be detected by parents or care givers

(6). And failure to detect and treat amblyopia at young age, when the prognosis for successful treatment is best, leads to permanent visual impairment, adverse effects on school performance, poor fine motor skills, weak social interactions, and self –image (7). An am- blyopic individual is at a significantly higher risk of becoming blind compared to an individual with nor- mal visual acuity and individuals with childhood- onset unilateral amblyopia have a greater lifetime risk of eventual bilateral visual impairment and age-related macular degeneration (8).

There are very few studies focused on amblyopia from sub-Saharan Africa countries. The preva- lence of amblyopia among school children in Gha- na and Nigeria were 9.9%, and 0.3% respectively. And anisometropia was the major amblyogenic factor in these studies (9, 10).

Understanding the prevalence, burden and pattern of Amblyopia is important for adequate healthcare planning in an effort to establish a routine school eye screening. In Ethiopia there is paucity of pub- lished data on prevalence and pattern of amblyo- pia. Hence, this study was conducted to estimate the prevalence and determine the causes of ambly- opia among children aged 7-15 years in Wolliso town, Southwest Ethiopia.

SUBJECTS AND METHODS

This school based cross- sectional study was car- ried out in May 2018 in Wolliso town, Southwest Ethiopia. For this research purpose public schools were defined as schools supported by either public or government funds and whereas private schools were defined as schools run and supported by pri- vate individuals or a corporation.

The department of Ophthalmology of Addis Ababa University’s Institutional Review Boards gave approval for the research and informed written consent was obtained from parents and/or legally authorized representatives of the study partici- pants.

Department of Ophthalmology, Addis Ababa University, Addis Ababa, Ethiopia. Corresponding Author Information:

Sadik Taju Sherief , MD Menelik II Hospital , Addis Ababa University Email: [email protected] or [email protected]

Requisition letters were sent to all the selected schools seeking permission from the respective school heads. All study procedures adhered to the principles out- lined in the Declaration of Helsinki for human subject research. Those children with visual impairment were referred to the nearby hospital and managed accord- ingly.

Using Leslie-Kish formula a sample size of 1226 was calculated (11) and 4 schools (2 publics and 2 private) were selected using a random cluster sampling meth- od. A multistage random sampling technique was used in recruiting the students, aged range from 7-15 years, in each grade level/class using the class registers as the sampling frame.

Pre –survey trainings were conducted to the research team to familiarize themselves with the standard oper- ating procedures involved in the study. The first step of the study was screening of the students within the school compound. A large room inside the school premises was selected for the screening program. Monocular distance visual acuity was tested using a logarithm of minimum angle of resolution (logMAR) chart. Step 2 was conducted at the nearby hospital. The parents/guardians of students whose Best Correct- ed Visual Acuity (BCVA) worse than or equal to 6/12 (or ≤ 6/12) in at least one eye, in absence of any or- ganic lesion according to Amblyopia Treatment Stud- ies (12), were requested to bring their children to the nearby, Saint Lukas hospital, for further evaluation. In the outpatient department, a detailed history about past and present ocular problems and treatments was obtained from the parents by the principal investigator of the study. Distance visual acuity was re-checked using the Snellen’s chart. Assessment of ocular align- ment, ocular motility and associated deviation, and slit lamp examination for the assessment of any anterior segment pathology was performed. A detailed fundus examination was done with 90D lens to rule out any posterior segment pathology.

Cycloplegic refraction by streak retinoscope was per- formed after pupillary dilation using 1% cyclopento- late eye drops.

Operational DefinitionFor the purpose of this study , amblyopia was defined as BCVA < 6/12 the affected eye without any underlying structural abnormality of the visual pathway, a 2-line difference between the two eyes, and the presence of an amblyogenic factor. The severity of amblyopia was further graded into mild (BCVA 6/12-6/18), moderate (BCVA 6/18–6/

36)and severe (BCVA <6/36) ( 12). Standard defini- tions for various types of amblyopia were used for diagnosis (12). Bilateral amblyopia was defined as best VA in both eyes ≤ 6/12.

Anisometropic amblyopia includes patients who had amblyopia in the presence of anisometropia that is 1.5 D or greater in spherical equivalent, or a 1.5 D or greater difference in astigmatism between the eyes in the absence of any measurable heterotropia at distance or near.

28

Strabismic amblyopia included that due to conflict- ing visual inputs between the eyes due to squint. Combined amblyopia includes either patients with a heterotropia at distance or near along with aniso- metropia of 1.5D or more in spherical equivalent or a 1.5 D or more difference in astigmatism in any meridian between the eyes. (5, 12)

Data generated were collected using a structured data collection form, and statistical analysis was done using SPSS 21.0 version (SAS Institute, Cary, NC 2010) software. Statistical association between categorical variables was computed using Fisher’s exact test and Pearson chi-square (χ2 ) test. P < 0. 05 was considered statistically signifi- cant.

RESULTS

In total, we screened 1,226 children of which 63 (5.14 %; 95% CI: 3.9%-6.4%) were found to have amblyopia. No student was reported to have been treated for amblyopia previously. The mean age of children with amblyopia was 10.45+ 2.09 years with age range between 7 to 15 years. Almost half amblyopic children 30 (47.6 %) were between 10- 12 years old (Table 1).

TABLES AND FIGURES

Table 1: Age at presentation and gender distri- bution of amblyopia among school children at Wolliso town, Southwest Ethiopia, May 2018.

 

 

 

Sex

 

 

 

 

 

 

 

 

Male

 

Female

Total N (%)

 

N (%)

 

N (%)

 

 

 

 

 

 

 

 

 

Age

5

(7.9)

 

9 (14.3)

14

(22.2)

7-9

 

10-12

11(17.5)

 

19 (30.1)

30

(47.6)

13-15

8

(12.7)

 

11(17.5)

19(30.2)

 

 

 

 

 

 

 

School

20 (31.7)

 

32 (50.8)

52

(82.5)

Public

 

Private

4

(6.4)

 

7 (11.1)

11

(17.5)

 

 

 

 

 

 

Total

24 (38.1)

 

39 (61.9)

63

(100%)

 

 

 

 

 

 

 

Thirty-nine of the subjects, 61.9% were female. There was no significant difference in amblyopia prevalence between males and females (P = 0.367).

Fifty-two (82.5%) subjects with amblyopia were from public schools (Table 1). There was statistical association between students from public school and amblyopia. (p=0.003).

From 63 children identified as amblyopic, 42(66.67 %) had bilateral and 21 (33.33 %) had unilateral am- blyopia. Hence a total number of 105 amblyopic eyes of 63 children were studied. Among unilateral ambly- opic children 9 had in the right and 12 had in the left eye as shown in table 2.

Table 2: Laterality and causes of amblyopia among school children at Wolliso town, Southwest Ethiopia, May 2018.

FIGURE 1: Distribution of amblyogenic factors with gender among school children , May 2018, Wolliso Town, Southwest Ethiopia.

Anisometropic amblyopia and isometropic amblyopia were the commonest types of amblyopia accounting 31 (49.2%) and 23(36.5%) of the subjects respectively

 

 

Sex

Total

 

 

 

 

 

Male

Female

N (%)

 

N (%)

N (%)

 

 

 

Laterality

2 (3.2)

7 (11.1)

9 (14.3)

Right Eye

Left Eye

6 (9.5)

6 (9.5)

12

(19)

Both Eyes

16

(25.4)

26 (41.3)

42

(66.7)

 

 

 

 

 

 

Cause

14

(22.2)

17 (27)

31

(49.2)

Anisometrop-

ic

 

 

 

 

 

16

(25.4)

7 (11.1)

23

(36.5)

Isometropic

Sensory Deri-

 

 

 

 

 

3

(4.8)

4 (6.3)

7

(11.1)

vational

 

 

 

 

 

Strabismus

 

 

 

 

 

2

(3.2)

0 (0)

2

(3.2)

 

 

 

 

 

 

(Fig 1). For both anisometropic and isometropic am- blyopia, myopia was the commonest type of refractive error, contributing 43 (80%) of the subjects.

From seven sensory derivational amblyopia five had unilateral, one had bilateral corneal opacity and one had ptosis. Both Strabismic cases were exotropia.

As far as the severity of amblyopia is concerned, mild amblyopia was seen in 39(37.14 %), moderate ambly- opia in 22(20.95%), and severe in 44(41.90%). Rela- tively severe amblyopia was higher than mild and

29

moderate as shown in table 3. Majority of severe amblyopia patients had sensory derivational am- blyopia. Severity of amblyopia was statistically associated with derivational amblyopia (p= 0.013). All the types of amblyopia were significantly more common in the public school students (P = 0.016).

DISCUSSION:

Amblyopia is the most common cause of monocu- lar vision loss in children with an estimated preva- lence of 1.6 to 3.6% (1). Early diagnosis and treat- ment of amblyopia result in better outcomes (13). In this population-based study, we reported the prevalence and pattern of amblyopia among school children aged 7–15 years at Wolliso town, South- west Ethiopia.

Prevalence of amblyopia varies due to different age-group of studied populations and different factors prevailing in that region, like literacy rate, frequency of visual screening programmes and geographical factors. Accordingly, the prevalence of amblyopia worldwide varies. In a multi-ethnic pediatric eye disease study (MEPEDS) conducted on African-Americans and Hispanics, amblyopia was detected in 2.6% of Hispanic/Latino children and 1.5% of African-American children (14). A study from Iran (2010) reported the prevalence of amblyopia was 2.32 in boys and 2.26% in girls (8). The criteria for diagnosis of amblyopia are almost the same in these studies. Prevalence of amblyopia among African countries varies from 0.3 to 9.1% (9, 10, 15).

The sampled population, study design (clinical/ population based), the criteria used to define am- blyopia and location could account for the differ- ence in these studies. With similar study design with ours, a cross-sectional study in Indian school children aged between 5 and 15 years showed that the prevalence of amblyopia was 1.1% (16). The results of these studies is very low compared to our study. The higher prevalence of amblyopia in the Ethiopian studies might be due to poor awareness amongst general population on importance of visu- al assessment and lack of regular school screening programs nation wide and limited knowledge on the conditions by guardians.

We found no significant difference in the preva- lence of amblyopia between different age groups. These finding is comparable with many other stud- ies in children and adults, where these studies have shown no increase or decrease in the prevalence of amblyopia with age (17,18). Most studies, like ours, have reported that the difference in the preva- lence of amblyopia is not significant for sex and the difference mostly results from sampling errors or differences in the response rate and participation of women and men in screening programs (6,19).

Our findings showed a higher prevalence of amblyo- pia in females than males which is also in line with studies from other countries (20, 21). Gender biases in eye health service delivery might be a reason for such difference in female students.

Two third of the cases in this study had bilateral am- blyopia, which is quite different from other studies made by Fu et al (5), (66.7%) and Chia et al. (3) (69.7%) . Bilateral amblyopia is predominant because isometropic amblyopia is common causes of amblyo- pia in our study.

The results of our study showed that the prevalence of amblyopia was 4 times higher in public school partici- pants as compared with those with private school chil- dren. It is obvious parents with better socioeconomic status send their children to private schools. And high- er socioeconomic status in parents/ guardians have a direct positive effect on use of effective health care services, leading to a decrease in the prevalence of visual disorders, including amblyopia (22).

The main cause of amblyopia varies between studies, depending on how the amblyopia is defined and the characteristics of the study sample. The type of am- blyopia seen in different aspect countries also varies. Our findings showed nearly half, 49.2%, of the ambly- opic cases had anisometropic amblyopia and 36.5% had isometropic amblyopia. Hence, in this study the amblyopia caused by the refractive error was 85.7 %, which was comparable with a report from china , (85.2%), (18), and India (86.9%) (23). In the present study, the prevalence of strabismus was 3.17%, simi- lar to other studies (24, 25). It is possible that Strabis- mic amblyopia is detected early due to the obvious deviation of eyes and therefore can be managed in a timely manner compared to other forms of amblyopia which may go undetected for a long time.

And besides lack of a school screening programs can be the reason for higher number of refractive error as a cause for amblyopia.

Limitation

Our study has some limitations. Small-angle strabis- mus and intermittent strabismus may have been missed given the nature of both conditions.

REFERENCES

30

This could have underestimated the prevalence of strabismus. The other limitation of the study is that we used a Snellen chart to measure visual acuity rather than an Early Treatment Diabetic Retinopa- thy Study chart, so the impact of ‘‘the crowding effect’’ could not be measured. Consequently, some children with mild amblyopia may have been missed, while others with more severe amblyopia may have been misclassified as having moderate amblyopia.

Conclusions

The result of this study showed that the prevalence of amblyopia among school children in Wolliso town, Southwest Ethiopia was higher than other Sub Saharan African countries. The lack of a regu- lar vision screening program in the study area could be considered as the main causes for late diagnosis of amblyopia. Therefore, a regular school based vision screening initiatives program is recommended.

Competing interest

The authors declare that this manuscript was ap- proved in its form and that no competing interest exists.

ACKNOWLEDGEMENT

This study was supported by a grant from CBM. The study sponsor had no involvement in the study design; in the collection, analysis and interpreta- tion of data; in the writing of the report ; and in the decision to submit the paper for publication. We are indebted to the kindness of all the staffs who were unduly supportive in all ways throughout the study period. We are also grateful to the school directors and teachers who facilitated the data col- lection within the respective schools.

1.Ciuffreda KJ, Levi DM, Selenow A. Amblyopia: Basic and clinical aspects. 1st ed. Boston, MA: Butterworth -Heinemann; 1991. pp. 343–48

2.Pi LH, Chen L, Liu Q et al. Prevalence of eye diseases and causes of visual impairment in school-aged chil- dren in Western China. J Epidemiol 2012;22:37–44.

3.Yekta A, Fotouhi A, Hashemi H et al. Prevalence of refractive errors among schoolchildren in Shiraz, Iran. Clin Experiment Ophthalmol 2010a;38:242–248.

4.Ann L Webber, Joanne Wood. Amblyopia: prevalence, natural history, functional effects and treatment Clin

Exp Optom 2005; 88: 6: 365–375. 10.

5.Pediatric Eye Disease Investigator Group, A randomized trial of atropine vs patching for treatment of moder- ate amblyopia in children. Arch Ophthalmol 2002;120268- 278)

6.Isenberg SJ. Amblyopia can be treated without occlusion atropine. Ophthalmology. 2006;113:893

7.Eileen EB . Amblyopia and Binocular Vision. Prog Retin Eye 2013; 33: 67-84.

31

8. Felius J, Chandler DL, Holmes JM et al. Evaluating the burden of amblyopia treatment from the parent and child’s perspective. J Aapos.2010;14:389–95.

9.Kumah BD, Ebri A, Abdul-Kabir M et al. Refractive error and visual impairment in private school children in Ghana. Optom Vis Sci 2013; 90(12): 1456-1461.

10.Megbelayin EO. Prevalence of amblyopia among secondary school students in Calabar, south Nigeria. Niger J Med2012: 21(4): 407-411.

11.Araoye MO. Research methodology with statistics for health and social sciences. In: Subject Selection. Ilorin: Nathadex Publishers; 2004. p. 115‑120.

12.Von Noorden GK. Classification of amblyopia. Am J Ophthalmol. 1967;63:238–44

13.Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS 2000;4: 194–199.

14.Multi-Ethnic Pediatric Eye Disease Study Group. Prevalence of amblyopia and strabismus in African Ameri-

can and Hispanic children ages 6 to 72 months the multi-ethnic pediatric eye disease study. Ophthalmology. 2008;115:1229–36.

15.Naidoo KS, Raghunanadan A, Masshige K et al. Refractive error and visual impairment in African children in South Africa. Invest Ohthalmol VisSci. 2003; 44: 374-380.

16.Siddharam S. Janti, A. M. Raja, Adnan Matheen, C. Charanya, R. Pandurangan. “A cross- sectional Study on Prevalence of Amblyopia in School Going Children”. Journal of Evolution of Medical and Dental Sciences 2014; 3(30): 8561-8565.

17.Nowak, M. S., Gos, R., Jurowski, P., & Smigielski, J. Correctable and non-correctable visual impairment among young males: A 12-year prevalence study of the Military Service in Poland. Ophthalmic & Physiologi- cal Optics 2009; 29: 443–448.

18.Wilson, G. A., & Welch, D. . Does amblyopia have a functional impact? Findings from the Dunedin Multidisciplinary Health and Development Study. Clinical & Experimental Ophthalmology 2013; 41:127– 134.

19.Chen X, Fu Z, Yu J et al. Prevalence of amblyopia and strabismus in Eastern China: results from screening of preschool children aged 36-72 months. Br J Ophthalmol. 2016;100(4):515–519.

20.Friedman DS, Repka MX, Katz J et al. Prevalence of amblyopia and strabismus in white & African American children aged 6 through 71 months: the Baltimore pediatric eye disease study. Ophthalmology. 2009;116 (11):2128–2134.

21.Rajavi Z, Sabbaghi H, Baghini AS et al. Prevalence of amblyopia and refractive errors among primary school children. J Ophthalmic Vis Res. 2015;10(4):408–416.

22.Lam N, Leat SJ. Barriers to accessing low-vision care: the patient’s perspective. Can J Ophthalmol. 2013;48 (6):458–462

23.Sunil Ganekal, Vishal Jhanji, Yuanbo Liang & Syril Dorairaj. Prevalence and Etiology of Amblyopia in Southern India: Results from Screening of School Children Aged 5–15 years, Ophthalmic Epidemiolo- gy, 2013;20(4) :228-231,

24.Chang CH, Tsai RK, Sheu MM. Screening amblyopia of preschool children with uncorrected vision and stere- opsis tests in Eastern Taiwan. Eye 2007;21:1482–8.

25.Dirani M, Chan YH, Gazzard G et al. Prevalence of refractive error in Singaporean Chinese children: the stra- bismus, amblyopia, and refractive error in young Singaporean Children (STARS) study. Invest Ophthalmol Vis Sci 2010;51: 13 1348-55.

33

Ezeala-Adikaibe Birinus A, Onodugo Obinna D, Oti Bibiana, Ekochin Fintan, Nwazor Ernest, Okoye Innocent, Mbadiwe Nkeiruka C, Orah-Chidimma Okpala, Onodugo Pascaline Ethiop Med J, 2022, Vol. 60 No. 1

ORIGINAL ARTICLE

CAREGIVER REPORTED INCIDENCE OF STATUS EPILEPTICUS IN PERSONS

WITH EPILEPSY IN ENUGU, SOUTHEAST NIGERIA.

Ezeala-Adikaibe Birinus A1,2, Onodugo Obinna D1, Oti Bibiana2, Ekochin Fintan2, Nwazor Ernest3, Okoye Innocent 4Mbadiwe

Nkeiruka C1, Orah-Chidimma Okpala1, Onodugo Pascaline 1

ABSTRACT

Background: Status epilepticus is a neurological emergency which may occur in people with epilepsy. Ascertaining the incidence of status epilepticus in the community is wrought with many challenges and few reports exist in sub–Saharan Africa, a region with a high burden of epilepsy.

Objective: The aim of this study was to describe reported incidence of status epilepticus among epilepsy patients attending neurol- ogy outpatient clinic in Enugu.

Methods: This was cross-sectional study carried out in the medical out-patient clinics in Enugu Nigeria. Data were collected using a semi-structured questionnaire. Informants were patients and their caregivers. Status epilepticus defined as seizures based on Interna- tional League Against Epilepsy criteria.

Results: Data of 154 patients were reviewed and analysed. A total of 56(36.4%) confirmed that they had experienced seizures that could be described as status epilepticus (males (36.3%) and females (36.5%)). P=0.98. About 54.5% of those with stroke and 47.9% of patients who had cluster seizures reported a history of status epilepticus. Factors that correlated with having status epilepticus were history of cluster seizures, family history of epilepsy and having no past history of seizure related admissions.

Conclusions: The reported incidence of status epilepticus among epilepsy patients attending tertiary hospital clinics in Enugu is high. Factors that may account for this includes, non-adherence, or greater seizure severity. Careful patient education will improve emergency management of epilepsy to reduce the morbidity related to epilepsy in the community.

Keywords: Status Epilepticus, Cluster seizures, Epilepsy, Nigeria.

INTRODUCTION

Status epilepticus (SE) is a neurological emergency which may occur in people with epilepsy (PWE) as well as in those with- out epilepsy. It is associated with high morbidity, mortality and low quality of life thus in PWE episodes of SE have added clinical relevance (1,2). In 2015, the International League Against Epilepsy defined SE as a bilateral tonic–clonic activity lasting longer than 5 minutes, and absence SE and as focal SE as exceeding 10 minutes (3). Because of the time-locked defi- nition of SE ascertaining the incidence of SE in the community is wrought with many challenges (4) thus most available stud- ies are hospital based. In a review of population-based studies, Sanchez et all (4) reported an overall incidence of SE 9.9 to 41 per 100,000/year ranging from 3.5 to 41 per 100 000 per year. Recent studies from Europe have reported incidence rate of

36.1to 81.1 per 100 000 per year based on the new ILAE 2015 definition of SE(5,6).

Few studies have reported on SE in Africa(7,8). Bhalla et al (7) in 2014 reported an incidence of 10.8 per 100 000 population and Kariuki et al (8) reported a prevalence rate of 2.3 per 1000. Apart from using different definitions for SE, these studies included people without epilepsy and children. Based on few available studies in SSA, SE in Africa is reported to be high in Children, hospital-based studies and PWE who are not on anti- epileptic drugs (9,10). Most cases of documented SE are likely

to be seizures with predominantly motor features. In Austria, the age and sex adjusted incidence of a first episode of non- convulsive SE and SE with prominent motor phenomena was 12.1 and 24 per 100 000 adults per year, respectively (5).

In Sub-Saharan Africa (SSA), risk factors for SE include infec- tions and non-adherence to medication. In Kenya, for example, documented risk factors for SE were neurologic impairments, acute encephalopathy, previous hospitalization, and presence of antibody titers to falciparum malaria and HIV (8). Risk factors for SE and seizure clusters seizure (SC) have been reported to be similar (11,12). SE is a strong determinant of quality of life in PWE/their caregivers and the cost of treating epilepsy (1,13,14) . In SSA, SE may be treated at home and possibly in unorthodox way which may result in high morbidity and mor- tality.

Despite the potential for poor outcomes of SE in PWE, there is little, or no research related to the subject in Nigeria. Recogniz- ing incidence and patterns of SE is helpful in preventing unto- ward consequences of SE. The aim of this study was to describe the caregiver reported frequency and pattern of SE in PWE attending neurology outpatient clinic in Enugu.

1Department of Medicine University of Nigeria Teaching Hospital Enugu, Nigeria. 2Department of Medicine Enugu State University Teaching Hospital Enugu, Nigeria.3Department of Medicine Federal Medical Center Owerri.4 Odimegwu Ojukwu Teaching Hospital Awka.

*All correspondences email: [email protected]

METHODS

This was a cross-sectional descriptive study carried out in 3 major hospitals in the city of Enugu, Enugu State Nigeria. The Hospitals were the University of Nigeria Teaching Hospital, Enugu State University Teaching Hospital, and the Memfys Hospital for Neurosurgery. These three tertiary hospitals offer both secondary and tertiary epilepsy care in the city and receive patients from all parts of southeast Nigeria and beyond.

Study participants :The plan was to collect the data of all con- secutive consenting epilepsy patients who attend the neurology clinic of these hospitals. All consecutive consenting patients accompanied by caregivers in which case the caregiver must have been an eyewitness of the seizure were included in the study. We excluded patients with possible psychogenic non- epileptic seizures and single epileptic seizures. Cases where seizure duration could not be truly determined with some level of certainty were excluded from the present analysis. Cases of incomplete data or illegible lasting less than 5 minutes were also excluded. The study period was 9 months.

Data collection tools and procedures: Data was collected using

asemi-structured questionnaire. The questionnaire contained open ended and as well as multiple choice questions and con- sisted of three principal sections. The first section was on gen- eral information about the respondents such as age and sex and related characteristics. The second section contained questions on the age on onset of epilepsy, age of first treatment and fami- ly history. The third section was focused on clinical characteris- tics of seizures such as prediction of seizures, seizure triggers, duration of seizures in minutes or recurrent seizures during which the patients did not recover consciousness. The question- naire was constructed in simple English to match the expected reading level of most persons that completed primary school (6 years of basic education). Cues to remember seizure duration were given to informants. Such cues include questions like (1) do you think that seizures lasted as long as the time you have been in this clinic? (2) did seizures last as long as it took you to get to a hospital or call for help? The study questionnaire was designed by the principal investigator and reviewed by the oth- er authors and senior colleagues in neurology both in Enugu and outside. The mean time for filling out the questionnaire was 5 minutes. All questionnaires were filled in the English lan- guage either by the caregiver (self-administered) and some- times with help from the investigators. Data were collected by neurology registrars, senior registrars and consultants.

Completed questionnaires were retrieved the same day. In cases where the respondent did not understand English, a translation in the local language was used. In such cases, the items on the questionnaire were read out to the respondents, and their en- dorsed options were ticked by the investigator. The study proto- col was reviewed by the ethics committee of the Teaching Hos- pitals. All participants gave their informed consent after reading or having the consent form read for them.

34

Operational definitions: SE was defined as seizures lasting more than 5 minutes for generalized seizures and 10 minutes for focal seizures3. CS was defined as series of seizures close- ly grouped in time with shorter than normal inter ictal periods or as an increase over the patient's typical seizure frequency in a day or week (15). Epilepsy was defined based on the In- ternational League Against Epilepsy criteria.

Data analysis: The SPSS version 22 (IBM Corporation, New York, USA) was used for data management and statistical analysis. Data were presented in tables. The statistical methods included Mann-Whitney U test for unpaired observations and Chi-squared test for comparison of categorical data. Distribu- tion of types of seizures was calculated as the percentage of participants. Mean and median were calculated, and values were presented as tables where applicable. In all, p < 0.05 was regarded as statistically significant. Conclusions were drawn at this level of significance at 95% confidence level.

RESULTS

Description of participants: Data of 154 PWE were reviewed and analysed. Males were 80(51.9%) and 74(48.1%) were females. The male to female ratio was 0.9:1. Most participants were aged 20-29 years (42.9%) with a mean age of 32.4(17.3) years. Males were older than females by almost 7 years (p<0.0). Other characteristics of the patients are shown in Table 1. Before presenting to the hospital 40(26%) used tradi- tional herbal drugs while 36(23.4%) resorted to prayer as a sole means of treatment.

Seizure characteristics: Reported seizures characteristics are shown in Table 2. The mean age of onset of epilepsy in the cohort was 20.9 years (with a median of 17 years); earlier in females (14.4 years) than males 26.3 years) (p <0.01). The peak age of onset of epilepsy in SE was 0 to 9 years. The mean time taken from the age of onset to the age of going to the hospital was similar in both males and females. P=0.2. The 6-month seizure freedom was 9.7%. More males reported a family history of epilepsy. P=0.03. About 45.5% reported a clinical history of generalized seizures. Among those that had focal seizures clinically, 38(45.2%) could always predict the onset of seizures while the rest did so sometimes. Clinically seizures were reported to be similar every time by 107 (69.5%).

35

Table 1. Age and gender distribution Patients’ demographic and clinical characteristics.

Gender

Male (%)

Female (%)

Total (%)

p-value

 

 

 

 

 

N (%)

80(51.9)

74(48.1)

154(100)

0.63

Age (years)

 

 

 

 

Mean age (sd)

35.8(18.9)

28.7(14.5)

32.4(17.3)

0.01

Median age

29.5

28.7

26

 

Age group

 

 

 

 

< 20

11(13.8)

14(18.9)

25(16.2)

 

20-29

29(36.3)

37(50)

66(42.9)

 

30-39

15(18.8)

13(17.6)

28(18.2)

 

40-49

8(10)

3(4.1)

11(7.1)

 

≥50

17(21.3)

7(9.5)

24(15.6)

0.1

Level of education

 

 

 

 

No education

15(18.8)

4(5.4)

19(12.3)

 

Primary

13(16.3)

9(12.2)

22(14.3)

 

Junior secondary

6(7.5)

14(18.9)

20(13)

 

Senior secondary

30(40.7)

32(43.2)

62(40.3)

 

Tertiary

16(20)

15(20.3)

31(20.1)

0.04

Occupation

 

 

 

 

Students

17(21.3)

28(37.8)

45(29.2)

 

Employed

37(46.3)

31(41.9)

68(44.2)

 

Unemployed

17(21.3)

13(17.6)

30(19.5)

 

Retired

9(11.3)

2(2.7)

11(7.1)

0.05

Substance use

 

 

 

 

Alcohol use

22(27.5)

6(8.1)

28(18.2)

<0.01

Tobacco

11(13.8%)

3(4.1)

14(9.1)

0.04

Marijuana

5(6.3)

-

5(3.2)

0.03

Glue

-

1(1.4)

1(0.6)

0.3

Alternative treatment

 

 

 

 

Herbal

25(31.3)

15(20.3)

40(26)

0.12

Prayer house

16(20)

20(27)

36(23.4)

0.3

Drug store

7(8.8)

3(4.1)

10(6.5)

0.24

 

 

 

 

 

36

 

Table 2. Gender distribution of seizure characteristics

 

 

 

 

 

 

Gender

Male (%)

Female (%)

Total (%)

p-value

 

 

 

 

 

Age of onset

 

 

 

 

Mean age (sd)

26.3(21.7)

14.4(14.9)

20.9(15.3)

<0.01

Median age

18

12

17

 

Time taken before first hospital visit

 

 

 

 

(years)

1.6(4.5)

2.7(5.3)

2.1(0.4)

0.2

Mean age (sd)

Median (range)

0(0-28)

0(0-21)

0(0-28)

 

Last seizure episode

 

 

 

 

< 24 hours

18(22.5)

20(27)

38(24.7)

 

1-7 days

18(22.5)

16(21.6)

34(22.1)

 

1-4 weeks

16(20)

12(16.2)

28(18.2)

 

1-6 months

21(26.3)

18(24.3)

39(25.3)

 

>6 months

7(8.8)

8(10.8)

15(9.7)

0.97

Family History

16(19.8)

5(7.2)

21(14)

0.03

Prediction of seizures

 

 

 

 

Always

21(26.3)

17(23)

38(24.7)

 

Sometimes

17(21.3)

29(39.2)

46(29.9)

 

Never

42(52.5)

28(37.8)

70(45.5)

0.05

Seizures are similar

54(67.5)

53(71.6)

107(69.5)

0.58

History of status epilepticus

29(36.3)

27(36.5)

56(36.4)

0.98

Seizure related admissions

3(3.8)

11(14.9)

14(9.1)

0.02*

 

Total

80(51.9)

74(48.1)

154(100)

 

*Mann-Whitney U Test.

A total of 56(36.4%) confirmed that they had experienced pro- longed seizures that lasted more than 5 minutes for generalized seizures and 10 minutes for focal seizures in the past. Sex distri- bution SE showed that males (36.3%) and females (36.5%) re- ported a history of status in the past. P=0.98. Seizure related admissions were reported in 14(9.1%) of PWE more in females 11(14.9%) than males 3(3.8%). See Table 3. Figure 1, showed that history of SE appears to be bimodal; 40% below the age of 20 years and 50% after the after of 50 years.

Table 3 shows the proportion of PWE with various risk factors who had SE. About 54.5% of those with stroke, 47.9% of pa- tients who had CS reported a history of SE. A large proportion of dementia cases also had CS and SE although the overall number was small. Factors that correlated with past history of SE were: history of CS, family history of epilepsy and having no past history of seizure related admissions.

Table 3. Distribution of status epilepticus by various documented risk factors

Risk factor

N(%)

Status N(%)#

 

 

 

No risk factor

84(54.5)

28 (33.3)

Cluster seizures

73(47.4)

35(47.9)

Traumatic brain injury

34(22.1)

12(35.3)

Stroke

11(7.1)

6(54.5)

Alcohol abuse

5(1.9)

1(20)

Mental retardation

4(1.9)

-

Dementia

4(2.6)

3(75)

Meningitis

3(1.3)

2(66.7)

Migraine

3(1.9)

1(33.3)

AIDS

3(0.6)

-

Brain surgery

2(2.6)

-

Down’s syndrome

1(3.2)

1(100)

Psychosis

1(0.6)

-

Hypertension

20(13.3)

10(18.5)

Diabetes

5(3.2)

1(20)

Heart failure

1(0.6)

-

Total

154(100)*

54(36)

*Multiple risk factor was recorded. #Percentage of risk factors.

37

Table 4. Correlates of status epilepticus. Table 4. Correlates of status epilepticus.

 

Status Epilepticus

 

r (p-value)

Gender

 

Status epilepticus

-

Seizure cluster

23(<0.01)

Age

-0.02(0.84)

Gender (1 male, 2 female)

-0.00(0.98)

Family history

0.17(0.03)

Age of onset of epilepsy

0.12(0.15)

Seizure type (1 generalized, 0 focal)

0.01(0.74)

History injuries (1 yes, 2 No)

0.12(0.15)

Seizure related admissions (1 yes, 0 No)

-0.23(<0.01)

First point of care (0 hospital, 1 other places)

0.04(0.59)

Seizure semiology (1 similar, 0 varies)

-0.03(0.74)

Last seizure (1 less than 24 hours to 6 greater than 6

0.09(0.29)

months)

 

DISCUSSION

Seizure frequency and pattern are strong determinants of quali- ty of life in epilepsy as well as the burden of epilepsy. Alt- hough in PWE, seizures are generally sporadic or even infre- quent, however, they may experience prolonged seizures (status epilepticus) and even cluster seizures. Identification of SE in the community is very important because of the associat- ed high morbidity, mortality as well as the associated high di- rect and indirect health costs in epilepsy(13,14).

In the index study, the male to female ratio of PWE with a his- tory of SE was 0.9:1. SE was reported by 36.4%: males (36.3%) and females 36.5%). P=0.98. About 54.5% of PWE who had stroke experienced SE. A large proportion of demen- tia cases also had SE although the numbers were small. Fur- thermore, the age distribution of SE was bimodal (before 20 years and after 50 years), and a large proportion of PWE with SE also had experienced SC. Factors that correlated with SE were history of SC, family history of epilepsy and no history of seizure related admissions.

The seizure related characteristics in the index study were sim- ilar to other published works from Nigeria (16,17). The age distribution of the patients in the index study may suggest a changing pattern of epilepsy risk factors or increasing aware- ness of epilepsy in the country. Younger mean-age-of-onset in females may be attributed to a better health seeking behaviour among females. Another factor responsible for this may be relatively large proportion of individuals with hypertension, diabetes and stroke. These disorders are generally commoner in older males. Clinically, 54.5% had focal seizures, a finding which may be explained by the high rates of risk factors for focal seizures in the study. This is similar to previous studies (18). Six-month seizure freedom in the index study was a mere 9.7% while 24.7% reported within 24 hours of seizures. These

findings support previous reports on seizure control in PWE in Nigeria(17). These may be related to several factors including non-adherence, uses of unorthodox medicine, seizure severity and alcohol (18).

The sex and age distribution of PWE who reported a history of SE showed same sex distribution and a bimodal age distribu- tion. In the US, Dham et al(19) reported a bimodal distribution of SE with the first peak in the first decade of life and the sec- ond after 60 years. Double peak in the incidence of SE was also reported in a review by Sanchez et al(4). Current demo- graphic in Nigeria and SSA have shown a rise in the older age group; therefore, SE is likely to become a common problem and an important health issue in years to come. Similar to some previous studies, the gender distribution of SE has been report- ed to be similar in males and females. Male to female ratio varied also from one study to the other with some reporting more males and others more females (4). In Ethiopia, Amare et al(20) reported a male-to-female ratio of SE of 1.5:1 which is different from the index study. In a study by Kariuki et al (8) there was an equal gender distribution.

There are no community-based studies on SE in Nigeria. Com- munity-based studies are frequently limited by recall bias and the ability of onlookers to recognize seizure-types and record their duration appropriately. Even in hospital settings in Nige- ria, EEG monitory is not frequently carried out hence there are likely to be low rates of detection.

The definition of SE has evolved over the past decades, how- ever, the incidence of SE has not differed much using different definitions. Leitinger et al (5) reported that reducing the diag- nostic time of SE increased the incidence only moderately by 10%. The overall incidence of SE range from 5.2 to 41 per 100,000/year (7) with an average of 9.9 per 100 000. Kantanen, et al (6) reported an annual age-adjusted incidence of 81.1/100,000 based on the new ILAE 2015 definition of SE.

The age and sex adjusted incidence of a first episode of SE, Non-convulsive statue epilepticus and SE with prominent mo- tor phenomena (including Convulsive SE) was 36.1 per 100 000 adults per year in Austria (5). In SSA, Kiruiki and his col- leagues reported an overall prevalence of 2.3 per 1,000 from three sites in Kenya(8). Their study included children and were limited to predominantly motor seizures and people without epilepsy. The reported incidence of SE in the index study (36.3%) is similar in males and females. This finding is within the rates reported by previous studies. The prevalence of SE in this study may be affected by several factors listed in table 4 which have been linked to SE in previous studies. Further- more, our cohort may represent patients with severe forms of epilepsy.

The incidence of SE is affected by age, geographical location, comorbidities and possibly family history (6,21). Similar to the index study in most adult studies there is a spike after the age of 50 (5,22). Geographical factors affect socio cultural charac- teristics of the population as well as disease pattern(4). For an example, whereas in Kenya (8), Malaria and HIV were associ- ated with SE, in Finland (6) alcohol withdrawal was the single most common acute symptomatic etiology in the study by Kantenen et al (6,23). The relationship between SE and non- adherence and no previous hospital visit have also been docu- mented in PWE(8). These two factors are important in SSA because large treatment gap and poverty.

In the index study, SE was reported in 54.5% of those with a history of stroke and 35.3% of those with Traumatic Brain Injury (TBI). Other cases with small but significant proportion of SE were those with meningitis and alcohol abuse. These findings are in support of previous studies that reported stokes, TBI and infections as common causes of SE a pattern which tends to vary between countries (4). SE has also been reported to be common in neurodegenerative disorders (4). African studies have reported infections and non-adherence to be high on the list of risk factors(8-10,20). Sadarangani et al(10), in Kenyan children, found that 71% of SE cases had an infectious cause, 53% attributed to malaria. Likewise, Amare et al (20) described CNS infections as the primary source of SE in Ethi- opia. However, these studies were not limited to PWE. SE may also be related to the premorbid state of the patients (4,24,25). Metabolic disorders such as hyperglycemia, uremia and acidosis of other etiologies are common causes of SE in non-epilepsy patients and may trigger status in PWE. Another risk factor for SE reported in the literature is family history.

38

In a population-based twin study reported a high pattern of SE concordance between monozygotic twins compared to dizygot- ic twins, linking familial predisposition and possible genetics factors to the risk of developing SE(25). Family history of epi- lepsy was reported in 14% of our cohort and correlated to a history of SE in the index study.

Factors that may precipitate/cause SE can also precipitate SC. These risk factors include TBI, longer duration of epilepsy and poor seizure control(26). SE has a direct effect on mortality, quality of life and increased health cost. It leads to repeated admissions in the emergency room or even in the intensive care unit. In the index study seizure related admissions negatively correlated to a history of SE. The reason for this is not clear. Large prospective studies are needed to shed more light on this finding. SE is a condition for which data on incidence, etiolo- gy, risk factors and outcomes are required for proper decision- making and for the allocation of resources by policy makers. These resources need to be used in the development of strate- gies that help improve prevention, diagnosis and reduce mor- bidity and mortality.

Limitations: This study has some limitations. Firstly, data used in this might have been affected by recall bias which may affect the true incidence of SE. Secondly, the timing of seizures may not be very accurate and subjective. Thirdly, only predom- inately motor seizures are observable, and subtle form of sei- zure are likely to be overlooked. Our study addressed only sur- vivors. Mortality rates of SE are important in assessing the true burden of this complication of epilepsy.

Finally, questionnaires were administered in English which may introduce some language bias because some medical terms in English do not have direct local equivalents. These limitations notwithstanding, this study has provided data for comparison for future studies. Large multi-center and commu- nity-based studies are needed to accurately document the preva- lence of SE in Nigeria.

Conclusion:The reported lifetime history of SE among PWE attending a tertiary hospital clinic in Enugu is high. This may suggest both poor seizure control and/or seizure severity. Care- ful patient education will improve both adherence and emergen- cy management of epilepsy to reduce the morbidity of epilepsy in the community.

REFERENCES.

1.Scott RC, Surtees RAH, Neville BGR. Status epilepticus: pathophysiology, epidemiology, and outcomes. Arch Dis Child 1998;79:73–77.

2.Penovich P, A Clinical Update on the Importance of Recognizing Seizure Clusters. https://www.medscape.org/ viewarticle/863062

3.Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus– report of the ILAE Task Force on classification of status epilepticus. Epilepsia 2015;56:1515–23.

4.Sánchez S, Rincon F. Status Epilepticus: Epidemiology and Public Health Needs. J. Clin. Med. 2016, 5, 71

5.Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A et al. Epidemiology of status epilepticus in adults; population based study on incidence, causes and outcomes. Epilepsia 2019;60:53–62.

6.Kantanen A-M, Sairanen J, Kälviäinen R, Incidence of the different stages of status epilepticus in Eastern Finland: A population -based study, Epilepsy & Behav. , 2019;29:106413.https://doi.org/10.1016/j.yebeh.2019.07.014

7.Bhalla D, Tchalla AE, Mignard C, et al. First‐ever population-based study on status epilepticus in French Island of La Reunion (France) ‐ incidence and fatality. Seizure. 2014; 23:769–773.

39

8.Kariuki SM, Kakooza-Mwesige A, Wagner RG, Chengo E, White S, Kamuyu G, et al. For the SEEDS Writing Group. Preva- lence and factors associated with convulsive status epilepticus in Africans with epilepsy Neurology 2015; 84;(5): 1838-1845

9.Newton CR, Kariuki SM. Status epilepticus in sub-Saharan Africa: new findings. Epilepsia 2013;54(6):50–53.

10.Sadarangani M, Seaton C, Scott JA, Ogutu B, Edwards T, Prins A et al. Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. Lancet Neurol 2008;7:145–150.

11.Haut SR. Seizure clustering. Epilepsy Behav. 2006;8:50-55.

12.Haut SR, Shinnar S, Moshé SL, O'Dell C, Legatt AD. The association between seizure clustering and convulsive status epilepti- cus in patients with intractable complex partial seizures. Epilepsia. 1999;40:1832-1834.

13.Horváth L, Fekete I, Molnár M, Válóczy R, Sándor M, Fekete K. The Outcome of Status Epilepticus and Long-Term Follow- Up Frontiers in Neurology. 2017; 10:427 doi: 10.3389/fneur.2019.00427

14.Penovich PE, Buelow J, Steinberg K, Sirven J, Wheless J, Burden of Seizure Clusters on Patients With Epilepsy and Caregivers Survey of Patient, Caregiver, and Clinician Perspectives. The Neurologist 2017;22:207–214)

15.Penovich P, A Clinical Update on the Importance of Recognizing Seizure Clusters. https://www.medscape.org/ viewarticle/863062

16.Ezeala-Adikaibe B A, Orjioke C, Ekenze O, Uchenna U, Onodugo O, Orakwue M et al. Prevalence of active convulsive epilepsy in an urban slum in Enugu South East Nigeria. Seizure 2016;35:100–105

17.Onwuekwe I O, Onodugo O D, Ezeala-Adikaibe B, Aguwa E N, Ejim E C, Ndukuba K et al. Pattern and presentation of epilep- sy in Nigerian Africans: A study of trends in the southeast. Trans R Soc Trop Med Hyg 2009; 103(8):785-789.

18.Epilepsy: a public health imperative World Health Organization 2019. Last accessed

19.Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20:476–83.

20.Amare, A.; Zenebe, G.; Hammack, J.; Davey, G. Status epilepticus: Clinical presentation, cause, outcome and predictors of death in 119 Ethiopian patients. Epilepsia 2008, 49, 600–607. [CrossRef] [PubMed]

21.Ong CT, Sheu SM, Tsai CF, Wong YS, Chen SC. Age-dependent sex difference of the incidence and mortality of status epilepti- cus: a twelve-year nationwide population-based cohort study in Taiwan. Plos one 2015;10(3):e0122350.

22.Sairanen JJ, Kantanen AM, Hyppölä HT, Kälviäinen RK. Treatment delay in status epilepticus – more effective pre hospital symptom recognition warranted. Scand J Trauma Resusc Emerg Med 2019;27(1):28.

23.Kantanen AM, Reinikainen M, Parviainen I, Kälviäinen R. Long-term outcome of refractory status epilepticus in adults: a retro- spective population-based study. Epilepsy Res 2017;133:13–21.

24.Amare, A.; Zenebe, G.; Hammack, J.; Davey, G. Status epilepticus: Clinical presentation, cause, outcome and predictors of death in 119 Ethiopian patients. Epilepsia 2008, 49, 600–607. [CrossRef] [PubMed]

25.Neligan A, Shorvon S D,. Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes A Systematic Review Arch Neurol. 2010;67(8):931-940

26.Jallon P, Zifkin B G. Seizure precipitants. In: Engels J jr, Pedley T A eds Epilepsy a Comprehensive Textbook. 2nd edition. Wolters Kluwer/Lippincott Williams and Wilkins. Health. Philadelphia 2008. Volume 1. Pp 77-80.

27.Sillanpää M, Schmidt D. Seizure clustering during drug treatment affects seizure outcome and mortality of childhood onset epi- lepsy. Brain. 2008;131:938-944.

28.Haut SR, Shinnar S, Moshé SL. Seizure clustering: risks and outcomes. Epilepsia. 2005;46:146-149.

41

Alem Mekete, Birhanu Kotisso, Tessema Ersumo, Ethiop Med J, 2022, Vol. 60 No. 1

ORIGINAL ARTICLE

GASTROINTESTINAL ANASTOMOTIC LEAKS AND RISK FACTORS IN

FOUR UNIVERSITY HOSPITALS, ADDIS ABABA

Alem Mekete1, Birhanu Kotisso1, Tessema Ersumo1

ABSTRACT

Background: Studies on the incidence and risk factors for anastomotic leak (AL) related to gastrointestinal (GI) surgery are mainly from the developed world. Incidences of AL range from 1.0% to 41.0%, varying widely according to the site, definition, and type of GI resection. Multiple risk factors have been identified. AL typically manifests clinically around the seventh postoperative day. It increases morbidity, mortality, hospital stay and extra costs irrespective of improvements in surgical techniques.

Objective: To identify the pattern, risk factors, and mortality rate related to GI anastomotic leaks after GI resection and anasto- mosis.

Methods: A retrospective descriptive study of medical records of 352 patients for ALs following GI tract resection and anastomo- sis at four university hospitals in Addis Ababa during January 1, 2017 to December 31, 2018 was done. Data were analyzed using SPSS version 23 package. Descriptive statistics and logistic regressions were used to analyze the data. A p-value of <0.05 was used to define statistical significance.

Results: The overall rate of AL was 9.9 %. Low preoperative serum albumin and emergency procedure had statistically signifi- cant association. The mean hospital stay was 12 days. Anastomotic leak-associated death rate was 48%.

Conclusion: In this study, most patients had elective surgeries involving the colon. Most of them developed enteroenteric ALs with longer hospital stays, and higher death rates, affirming that AL significantly increases morbidity, mortality and cost.

Key words: GI resection, anastomotic leak, risk factors, mortality.

INTRODUCTION

Gastrointestinal (GI) surgery-associated anastomotic leaks (ALs) have been one of the main causes underlying postopera- tive morbidity and mortality irrespective of the continual im- provements in surgical procedures. The frequency and conse- quences of anastomotic failure (partial or complete disruption of anastomosis with leakage of contents) vary widely accord- ing to the sites, definitions, and types of resections within the GI tract (1, 2). Varying rates of ALs are found (1) based on the anastomosis site involved: rectum (8-41%), colon (3-29%), small intestine (1-3%), bile ducts (10-16%), pancreas (9-16%), stomach (1-9%), and esophagus (2-16%).

In systematic reviews of 97 studies, a total of 56 separated def- initions of AL were identified. Combination of clinical features and radiological investigations were used to define and detect anastomotic leak. However, there is no universally accepted definition of anastomotic leak at any site (3).

Studies conducted to identify the incidence and risk factors for anastomotic leak are from the developed world where patient characteristics and availability and utility of diagnostic tools are different from that in the developing world. Several studies have identified risk factors for GI anastomotic leakage with no general consensus on which risk factors consistently feature

(1).

An anastomotic defect in colon causes leakage of colonic con- tent into the abdominal and or pelvic space leading to peritoni- tis, abscess formation, and sepsis that can be fatal. The inci- dence of colorectal anastomotic leak (CAL) varies between 3% and 19%, with associated mortality rates ranging from 10 % to

20 %. Moreover, CAL is a risk factor for local recurrence of colorectal cancer (4).

AL typically becomes clinically apparent between the 5 and the 8 postoperative days, but many exceptions exist (5, 6). The occurrence of gastrointestinal AL is associated with signifi- cantly increased mortality, morbidity, and prolonged hospital stay as well as considerable extra costs (4, 7). Knowledge on the risk factors may influence procedure related decisions and treatment, and possibly reduce the rate of leakage.

The aims of this study were to evaluate the pattern of AL after GI resection and anastomosis, its perioperative risk factors, morbidity and mortality rates related to AL, and to provide surgical professionals, researchers and hospitals with baseline information for further investigation and guideline develop- ment to reduce rate of AL and improve outcome of patients.

MATERIALS AND METHODS

This was a multicenter retrospective study of medical records of patients with GI resection and anastomosis undertaken at Tikur Anbessa, Menelik II, Yekatit 12 and Zewditu Memorial Hospitals in Addis Ababa during the period of January 1, 2017 to December 31, 2018.

During the study period, a total of 556 patients had GI resec- tion and anastomosis. Of these, charts of 414 patients were retrieved and 62 patients were excluded from the study because four were pediatric patients, 12 patients had insufficient data, and 46 patients had bypass procedures. The documents of 352 patients make the basis for the analysis of this study.

1Addis Ababa University College of Health Sciences, School of Medicine, Department of Surgery *Corresponding author: E-mail: [email protected]

Structured questionnaires were prepared for data collection and the study proposal was approved by the Institutional Review Board of Addis Ababa University, College of Health Sciences. At the four hospitals, operating room registers, medical charts, discharge summaries, and death certificates of patients were used for data collection. Demographic fea- tures, comorbid conditions, diagnoses for which GI resection and anastomosis were performed, and presence or absence of perioperative infection, bowel preparation, antibiotic use, blood transfusion, and serum albumin level were determined. Emphasis was also made on the urgency of the operation, operating professional, and duration and type of the proce- dure as well as the duration of hospital stay and postopera- tive complications. The collected data were checked for completeness, and entered into computer and the SPSS ver- sion 23 package was used for statistical analysis.

42

RESULTS

The mean (±SD) age of patients was 48(±17) years; about 75% of patients were ≤ 60 years of age. Majority (72.2%) of patients were male and 257 (73.0%) were urban residents. The most common reasons for gastrointestinal anastomosis were redundant sigmoid colon and sigmoid volvulus (27.8%) fol- lowed by small bowel obstruction (SBO) (14.8%). The rest of the diagnoses in decreasing order of frequency included colo- rectal cancer (12.8%), esophageal cancer (12.2%), and end colostomy for 26 benign and 9 malignant diseases (9.9%), gastric cancer (5.4%), IBD (4.8%), and 10 penetrating and 3 blunt abdominal trauma (3.7%), and others (8.5%) including mesenteric ischemia, ileostomy or abdominal TB (10 each). Cancer accounted for 35.8% of all patients that underwent GI anastomosis (Table 1).

Table 1. Demographic distribution and diagnosis of 352 patients with gastrointestinal Anastomosis in Four

University Hospitals in Addis Ababa, January 2017 to December 2018

Variables

 

No of Patients

Percent

 

 

 

 

Sex

 

 

 

Male

 

254

72.2

Female

 

98

27.8

Age (Years)

 

 

 

15-30

 

80

22.7

31-60

 

182

51.7

>60

 

90

25.6

Mean(±SD)

48±17

 

 

Diagnosis

 

 

 

Esophageal cancer

 

43

12.2

Gastric cancer

 

19

5.4

Small bowel obstruction (SBO)

52

14.8

Colorectal cancer

 

45

12.8

Redundant sigmoid colon & sig-

98

27.8

moid volvulus (SV)

 

35

9.9

End Colostomy

 

Trauma

 

13

3.7

Inflammatory bowel disease

17

4.8

(IBD)

 

30

8.5

Other

 

As is shown in Table 2, most patients (79.9%) underwent elec- tive anastomotic procedures, in 224 (63.6%) procedures related to the colon. GI resection and anastomosis were performed in 41.8% of patients without preoperative mechanical bowel prep- aration. Serum albumin level was determined in 70.5% of pa- tients, out of which 15.3% had low serum albumin levels. Evi- dences of infection (pus and GI content in the peritoneum, ab-

scess or fistula) were noted during anastomosis in 6.8% of patients. Blood transfusion was given for 6.8% of patients. The type of operative procedures in decreasing order of frequency were colocolic anastomosis (33.5%), enteroenterostomy (18.2%), ileocolic anastomosis (15.6%), colorectal anastomo- sis (13.9%), esophagectomy (12.2%), gastrectomy (5.4%), and jejunotransverse (and coloanal anastomoses (0. 3% each).

The participating surgical disciplines included general, colo- rectal, and cardiothoracic surgery. Majority of the operations (70.8%) were performed by residents and general surgeons. Colorectal and cardiothoracic surgeons operated on 15.9% and 13.4% of patients respectively.

43

The surgical procedure lasted 90 minutes or more in 94.6%, 2 to 3 hours in 61.4%, more than 3 hours in 9.7%, and more than 5 hours in 0.6% of patients (Table 2).

Table 2. Types of procedures, surgical professionals and perioperative features in 352 patients with gastrointestinal

anastomosis, in Four University Hospitals in Addis Ababa, January 2017 to December 2018

Characteristics

N

%

Type of Surgical Procedures

 

 

Esophagectomy and anastomosis

43

12.2

Gastrectomy and anastomosis

19

5.4

Enteroenterostomy

64

18.2

Ileocolic anastomosis

55

15.6

Colocolic anastomosis

118

33.5

Colorectal anastomosis

49

13.9

Ileorectal anastomosis

2

0.6

Other

2

0.6

Operating Professionals

 

 

Surgery residents

137

38.9

Surgeons

215

61.2

Duration of Procedures

 

 

< 90

19

5.4

90-120

83

23.6

>120

250

71.0

Preop Characteristics

 

 

Urgency

 

 

Elective

267

75.9

Emergency

85

24.1

Presence of infection

 

 

Yes

24

6.8

No

328

93.2

Prophylactic antibiotics use

 

 

Yes

352

100.0

No

0

0.0

Preoperative bowel preparation

 

 

Yes

205

58.2

No

147

41.8

Preoperative hematocrit level

 

 

<35 %

50

14.2

> 35%

302

85.8

Preoperative low albumin level (n=248)

 

 

Yes

54

21.8

No

194

78.2

Not done

104

29.5

Pre or intraoperative blood transfusion

 

 

Yes

24

6.8

No

328

93.2

44

As depicted in Table 3, anastomotic leak was detected in 35 of 352 patients (9.9%) in this study. AL detection day varied from the 2nd to the 14th postoperative days; and majority of the leaks (21, 60%) were detected on the 5th to 8th postoperative days, and (10, 28.6%) on the 7th postoperative day. Majority of leaks (21, 60%) were detected by GI content or fluid dis- charge via incisional wounds or drainage tubes. Relaparotomy was performed on 8.8% of patients after GI resection and anastomosis, but 71.4% (25/35) of patients that developed anastomotic leak required relaparotomy, and the rest (10/35) were managed conservatively as enterocutaneous fistula whereas only 1.9% (6/311) of patients who did not develop leak required relaparotomy, for wound dehiscence and post- operative collection.

About 60.0% of patients stayed in hospital for one week or more, 54 (15.4%) for more than two weeks, and 34 (9.7%) stayed for more than three weeks. The mean postoperative hospital stay was 12±12.35 days, with a median stay of 8 days and IQR of 7 to 11 days. When conditions of patients on discharge were as- sessed, 25 patients (7.1%) died in hospital after GI anastomosis (Table 3).

On bivariate analysis (Table 4), emergency procedure, presence of infection, absence of mechanical bowel preparation, and low serum albumin level were significantly associated with AL. AL was significantly high with increase in age and prolonged dura- tion of surgery. Sex, duration of procedure, low preoperative HCT level, and pre or intraoperative blood transfusion was not significantly associated with the development of AL.

Table 3. Anastomotic leak and relaparotomy rates, duration of hospital stay, and outcome of 352 patients

with GI anastomosis in Four University Hospitals in Addis Ababa, January 2017 to December 2018

Characteristics

N

%

 

 

 

Presence of Leak

 

 

Yes

35

9.9

No

317

90.1

Postop date leak detected

 

 

5th day

6

17.1

6th day

4

11.4

7th day

10

28.6

2nd day

2

5.7

Other

13

37.1

How was the leak detected?

 

 

Sign of peritonitis

14

40.0

GI content discharge via wound

15

42.9

Abdominal ultrasound

0

0.0

Other

6

17.1

Relaparotomy done

 

 

No

321

91.2

Yes

31

8.8

Duration of hospital stay

 

 

<1 week

140

39.8

1-2 weeks

158

44.9

>2 weeks

54

15.4

Condition on discharge

 

 

Discharged improved

320

90.9

Dead in hospital

25

7.1

Discharged against medical advice

6

1.7

Referred to other hospital

1

0.3

 

 

 

45

Table 4. Bivariate analysis of factors associated with gastrointestinal anastomotic leak (AL)

Risk Factors

 

Presence of leak

 

Yes

No

P-Value

 

N (%)

N (%)

 

Age

 

 

0.098

15-30

5(6.2%)

75(93.8%)

 

31-60

16(8.8%)

166(91.2%)

 

>60

14(15.65%)

76(84.4%)

 

Sex

 

 

0.370

Male

23(9.1%)

231(90.9%)

 

Female

12(12.2%)

86(87.8%)

 

Urgency of Procedure

 

 

0.006

Elective

20(7.5%)

247(92.5%)

 

Emergency

15(17.6%)

70(82.4%)

 

Duration of Procedure

 

 

0.150

1.5-2hrs

5(6%)

78(94.0%)

 

>2-3hrs

23(10.6%)

193(89.4%)

 

3-5hrs

6(17.6%)

28(84.4%)

 

Presence of infection during anastomosis

 

0.011

Yes

6(25.0%)

18(75.0%)

 

No

29(8.8%)

299(91.2%)

 

Preoperative bowel preparation

 

 

0.002

Yes

12(5.9%)

193(94.1%)

0.665

No

23(15.6%)

124(84.4%)

 

Preoperative hematocrit level

 

 

0.122

<35 %

8(16.0%)

42(84.0%)

 

> 35%

27(8.9%)

275(91.1%)

 

Low preoperative albumin level

 

 

<0.0001

Yes

18(33.3%)

36(66.7%)

 

No

10(5.2%)

184(94.8%)

 

Pre or intraoperative blood transfusion

 

0.665

Yes

3(12.5%)

21(87.5%)

 

No

32(9.8%)

296(90.2%)

 

 

 

 

 

AL rate following enteroenterostomy (Table 5) was high (17.2%) followed by esophagectomy (16.3%), gastrectomy (10.5%), colorectal anastomosis (10.2%), ileocolic anastomo- sis (9.1%) and colocolic anastomosis (4.2%), but ileorectal anastomosis did not leak (P=0.019). Majority of the proce- dures (240 patients) were performed by residents and general surgeons. There were differences in the leak rates among the different surgical professionals, but the differences were not statistically significant (P=0.434).

Anastomotic leakage rate was found to be a little bit higher in malignant conditions than benign conditions. (13/126, 10.3% vs 22/226, 9.73%), but the difference was not statistically sig- nificant (P=0.357). AL was associated with significantly in- creased mortality, morbidity, and prolonged hospital stay (Table 6). The rate of death in patients who developed AL

was 48.3% compared to the 3.5% death rate in those who did not develop AL. Most patients (71.4%) with AL had relaparotomy compared to the 1.9% relaparotomy rate in those without AL. Majority of patients (62.9%) with AL stayed more than 3 weeks in hospital, whereas only 3.8% of patients without AL stayed that long.

46

Table 5. Anastomotic leak rate in comparison to type of operative procedure, surgical professional, and disease category

Characteristics (n=352)

 

Presence of Leak

 

 

Yes

No

 

 

35(9.9%)

317(90.1%))

P-Value

Type of Operative Procedure

 

 

0.019

Esophagectomy and anastomosis

7(16.3%)

36(83.7%)

 

17(89.5%)

 

Gastrectomy and anastomosis

2(10.5%)

 

53(82.8%)

 

Enteroenterostomy

11(17.2%)

 

50(90.91%)

 

Ileocolic anastomosis

5(9.09%)

 

113(95.76%)

 

Colocolic anastomosis

5(4.23%)

 

44(89.8%)

 

Colorectal anastomosis

5(10.2%)

 

2(100%)

 

Ileorectal anastomosis

0(0%)

 

2(100%)

 

Other

0(0%)

 

 

 

Operating Surgeon

 

 

0.434

Surgery Resident

13 (9.5%)

124(90.5%)

 

General Surgeon

11(10.7%)

92(89.3%)

 

Colorectal Surgeon

2 (3.6%)

54(96.4%)

 

Cardiothoracic Surgeon

7 (14.9%)

40(85.1%)

 

Upper GI surgeon

2 (22.2%)

7(77.8%)

 

Diagnosis

 

 

0.357

Esophageal Cancer

7(16.3%)

36(83.7%)

 

Gastric Cancer

2(10.5%)

17(89.5%)

 

Small bowel obstruction (SBO)

9(17.3%)

43(82.7%)

 

Colorectal cancer

2(4.4%)

43(95.6%)

 

Redundant sigmoid colon & sigmoid volvu-

3(3.1%)

95(96.9%)

 

lus

 

 

 

End colostomy

4(11.4%)

31(88.6%)

 

Abdominal trauma

1(7.7%)

12(92.3%)

 

 

 

 

 

Variables which were statistically significant on bivariate analysis were included in multivariate analysis (Table 6) to see their independent effect on the occurrence of AL. Absence of bowel preparation was strongly associated with AL on bi- variate analysis but became out of the range for significance on multivariate analysis. The variable that had strong inde- pendent association with AL was a low serum albumin level (p<0.0001).

Patients who had low serum albumin were 19 times more likely to develop AL compared to those who had normal serum albumin. The other variable which was independently associated with oc- currence of AL was emergency procedures (p=0.018) where pa- tients were 4.6 times more likely to develop AL than those who underwent elective procedures.

47

Table 6. The effect of AL on postoperative outcomes and multivariate analysis of variables

with occurrence of AL in GI anastomosis

Characteristic

 

 

Presence of leak

 

P value

 

 

 

 

 

 

Yes

 

No

 

 

 

 

 

 

 

 

N

%

N

%

 

Condition on discharge

Improved

15

51.7

305

96.5

<0.0001

 

Died

14

48.3

11

3.5

 

Hospital stay

<1 week

2

5.7

138

43.5

<0.0001

 

1-2 weeks

7

 

151

47.6

 

 

2-3 weeks

4

11.4

16

5.0

 

 

> 3 weeks

22

62.9

12

3.8

 

Relaparotomy

No

10

28.6

311

98.1

<0.0001

 

Yes

25

71.4

6

1.9

 

Multivariate analysis of factors significantly associated with AL on bivariate analysis

Characteristic

B

P value

AOR

95% C.I

 

 

 

Lower

Upper

 

 

 

 

Urgency (emergency)

1.527

0.018

4.606

1.306

16.242

Infection (yes)

0.513

0.444

0.599

0.161

2.226

Bowel prep (No)

0.300

0.554

1.349

0.500

3.642

Albumin (low)

2.979

<0.0001

19.670

5.629

68.733

 

 

 

 

 

 

DISCUSSION

Anastomotic leak is perhaps the most dreaded complication following intestinal surgery and is one of the leading causes of postoperative morbidity and mortality despite improvements in surgical care. The rates and complications of AL vary consider- ably depending on the definition, risk factors, site, and type of GI tract resection (1,2).

Majority of studies used a combination of clinical features and radiological investigations to define and detect anastomotic leak. The diagnostic methods commonly used when a leakage is suspected are CT scan, contrast enema, endoscopic examina- tion, and reoperation (8). In our series, except one patient who developed wound dehiscence and the leak was detected on re- operation, all ALs were detected and defined clinically only. There is no universally accepted definition of anastomotic leak at any site (3, 9).

In this study, the rate of AL increased with increase in age of patients and pronged duration of surgery, but the increase was not significant and congruent to the findings by others (4, 7, 10, and 11). In our study, female patients developed AL more fre- quently than males (12.2% vs. 9.1%) even though the variation was not statistically significant (P=0.370). In other studies, AL

occurred more commonly in male patients (12, 13). The varia- tion could be due to small sample size of female patients in our study.

Studies have identified risk factors for GI anastomotic leakage, but there is no universal agreement on which risk factors con- sistently feature (1). Amrika Seshadri (7) reported that serum albumin, need for blood transfusion and others as strongly as- sociated factors for AL. In a retrospective study, male sex, perioperative transfusion, presence of cardiovascular disease and proximal tumor location were predictive factors of anasto- motic leakage after gastrectomy for gastric cancer and the leak- age rate was 1.9% (13). In a prospective study, Nair et al (14) reported a 35.0% rate of anastomotic disruption in patients undergoing emergency small bowel anastomosis, a much high- er rate than our finding. There are clearly many patient and disease factors that contribute to anastomotic leak. AL has been associated with a 6% to 39% mortality rate (15). In this study, emergency procedure, the presence of infection, the ab- sence of bowel preparation, and low serum albumin were sig- nificantly associated with anastomotic leak, but on multivariate analysis only emergency procedures (P=0.018) and low serum albumin(P<0.0001) remained significantly associated with anastomotic leakage. This is because of the fact that patients were operated on without bowel preparation on emergency bases which possibly is a confounding variable. This finding is in line with the findings in several other studies (7, 14, and 16).

DISCUSSION

Anastomotic leak is perhaps the most dreaded complication following intestinal surgery and is one of the leading causes of postoperative morbidity and mortality despite improve- ments in surgical care. The rates and complications of AL vary considerably depending on the definition, risk factors, site, and type of GI tract resection (1,2).

Majority of studies used a combination of clinical features and radiological investigations to define and detect anasto- motic leak. The diagnostic methods commonly used when a leakage is suspected are CT scan, contrast enema, endoscopic examination, and reoperation (8). In our series, except one patient who developed wound dehiscence and the leak was detected on reoperation, all ALs were detected and defined clinically only. There is no universally accepted definition of anastomotic leak at any site (3, 9).

In this study, the rate of AL increased with increase in age of patients and pronged duration of surgery, but the increase was not significant and congruent to the findings by others (4, 7, 10, and 11). In our study, female patients developed AL more frequently than males (12.2% vs. 9.1%) even though the variation was not statistically significant (P=0.370). In other studies, AL occurred more commonly in male patients (12, 13). The variation could be due to small sample size of fe- male patients in our study.

Studies have identified risk factors for GI anastomotic leak- age, but there is no universal agreement on which risk factors consistently feature (1). Amrika Seshadri(7) reported that serum albumin, need for blood transfusion and others as strongly associated factors for AL. In a retrospective study, male sex, perioperative transfusion, presence of cardiovascu- lar disease and proximal tumor location were predictive fac- tors of anastomotic leakage after gastrectomy for gastric can- cer and the leakage rate was 1.9% (13). In a prospective study, Nair et al (14) reported a 35.0% rate of anastomotic disruption in patients undergoing emergency small bowel anastomosis, a much higher rate than our finding. There are clearly many patient and disease factors that contribute to anastomotic leak. AL has been associated with a 6% to 39% mortality rate (15). In this study, emergency procedure, the presence of infection, the absence of bowel preparation, and low serum albumin were significantly associated with anasto- motic leak, but on multivariate analysis only emergency pro- cedures (P=0.018) and low serum albumin (P<0.0001) re- mained significantly associated with anastomotic leak- age.This is because of the fact that patients were operated on without bowel preparation on emergency bases which possi- bly is a confounding variable. This finding is in line with the findings in several other studies (7, 14, and 16).

In general, the rate of AL varies depending on the tissue anas- tomosed, and the rates include, stomach, 1.1-3.3%, small in- testine, 1.0-3.8%, ileocolic, 2.0-6.5%, colocolic, 3.0-5.4%,

48

colorectal, 4.0-26%, and ileorectal, 5.0-19%. AL is known to be correlated with worse prognosis after curative resection for colorectal cancer (15). In the present study, the rates of AL were 16.3% in esophagogastrostomy, 10.5% in gastrectomy and gastrojejunostomy, 17.2% in enteroenterostomy, 9.1% in ileocolic anastomosis, 4.2% in colocolic anastomosis, and 10.2% in colorectal anastomosis. Compared to the preceding report, AL rates in gastric, small bowel and ileocolic anasto- mosis were higher in our study probably due to nutritional deficiencies or emergency procedures. Contrary to our finding where ileorectal anastomosis did not leak, higher incidences of AL, probably related to disease or patient factors, were found in other reports (1,15). The overall AL rate of 9.9% observed in this study is similar to the reported rates that ranged from 1.8% to 15.4% in many studies (2, 10, 16-19). Esophagogas- trostomy, ileocolic, colocolic and colorectal AL rates were comparable with the findings in other series (2, 4, 10, 11, 15, 16, 20, 21). In our series, anastomotic leakage rate was slightly higher in malignant than benign conditions (10.3 % vs 9.73%), but the difference was not statistically significant (P=0.357).

AL presents in a dramatic fashion early or more often in a far subtler fashion, often relatively late in the postoperative period (22). In majority of our patients (60.0%), in agreement with another report (6), AL was detected between the 5th and 8th postoperative days, and on the 14th postoperative day in one patient.

The consequences of AL are peritonitis, fistula or abscess for- mation, postoperative infection, and increased hospital costs and mortality (20, 23, 24). It causes considerable morbidity and mortality to the patient, and it doubles the length of hospi- tal stay (7).

In this study, 40.0% of patients developed peritonitis, and the death rate in patients who developed AL was 48.3% compared to the 3.5% in those who did not develop AL. Previous reports showed a 3% to 39% and 8 to 10-fold mortality rates after AL (2, 4, 7, 20). In our series, the mortality rate was higher than the above reported rates, which may be explained by lack of early suspicion, late clinical detection and or delayed interven- tion since this study could not find usage of diagnostic imag- ing techniques for the detection of leakage.

In our study, the risk of relaparotomy was high in patients with AL; most patients (71.4%) with AL had relaparotomy com- pared to the 1.9% relaparotomy rate in those without AL. Compared to a 3.8% of patients without AL, 62.9% of patients with AL stayed more than 3 weeks in hospital. AL is associat- ed with significantly prolonged hospital stay as well as consid- erable extra costs (4,7).

Conclusion and recommendation:

The incidence of AL in gastrointestinal anastomosis in our series was 9.9%. Low serum albumin and emergency proce- dures are strong risk factors for AL. The occurrence of AL significantly increases the rate of relaparotomy, sepsis, postop- erative mortality and duration of hospital stay.

Awareness of the risk factors, suspicion of AL, and thorough evaluation of patients may impact perioperative decision- making, surgical technique and patient care.

Optimization of nutrition prior to elective GI anastomosis may prevent AL and its far-reaching consequences.

Emergency GI resection and anastomosis should be handled with utmost care. Prospective studies should be conducted to identify determinant factors for AL. We also recommend the four hospitals to have better patient record keeping.

49

ACKNOWLEDGMENT

We would like to thank the administrations of Tikur Anbessa, Menelik II, ZM, and Yekatit 12 Hospitals for cooperation dur- ing data collection. We also thank the Addis Ababa University College of Health Sciences for funding the study.

REFERENCES

1.Chunsheng Li, Yakun Zhao, Zhenqi Han et al. Anastomotic leaks following gastrointestinal surgery: updates on diagnosis and interventions. Int J ClinExp Med. 2016; 9 (3):7031-7040.

2.Lipska MA, Bissett IP, Parry BR et al. Anastomotic Leakage after Lower Gastrointestinal Anastomosis: Men are at a higher Risk. ANZ J Surg. 2006 Jul;76(7):579-85.

3.J Bruce, Z H Krukowoski, G Alkhairz et al. Systematic Review of the Definition and measurement of anastomotic leak after GI Surgery. BJS. 2001;88:1157-168.

4. Neils Komen. New Approach towards risk assessment, diagnosis and preventive strategies of colorectal anastomotic leakage, Rotterdam 2014.

5.Theodore R. Schrock., Clifford W. Deveney, J E Dunphy . Factors Contributing to Leakage of Colonic Anastomoses. Ann Surg. 1973 May;177(5): 513–518.

6.Freek Daams, Misha Luyer, Johan F Lange. Colorectal anastomotic leakage: Aspects of prevention, detection and treatment.

World J Gastroenterol. 2013 Apr 21;19(15): 2293–2297.

7.Amrika Seshadri. Clinical Factors Influencing Bowel Anastomotic Leak. International Journal of Biomedical Research 2016;7 (6):350-355.

8.Hirst NA, Tiernan JP, Millner PA et al. Systematic review of methods to predict and detect anastomotic leakage in colorectal Surgery. Colorectal Dis.2016;16 (2):95–109.

9.Stefanus J van Rooijen, Audrey CHM Jongen, Zhou-Qiao Wu et al. Definition of colorectal anastomotic leakage: A consensus survey among Dutch and Chinese colorectal surgeons. World J Gastroenterol. 2017 Sep 7;23(33):6172–6180.

10.Andre L Moreir, Pokala R Kiran, Matthew Kalady et al. Anastomotic Leak After Ileocolic Anastomosis: Risk Factor Analysis, SSAT.2007 Posters.

11.Rizwan Sultan, Tabish Chawla, Masooma Zaidi. Factors affecting anastomotic leak after colorectal anastomosis in patients without protective stoma in tertiary care hospital. JPMA. 2014; 64:166-170.

12.Koianka Trencheva, Kevin P Morrissey, Martin Wells et al. Identifying Important Predictors for Anastomotic Leak After Colon and Rectal Resection: Prospective Study on 616 Patients. Ann Surg.2013;257:108–113.

13.Sung-Ho Kim, Sang-Yong So, Young-Suk Park et al. Risk Factors for Anastomotic Leakage: A Retrospective Cohort Study in a Single Gastric Surgical Unit. J Gastric Cancer 2015;15(3):167-175.

14.Nair A, Pai DR, Jagdish S. Predicting anastomotic disruption after emergent small bowel surgery. Dig Surg. 2006;23 (1-2):38- 43.

15.Benjamin R Phillips. Reducing gastrointestinal anastomotic leak rates: review of challenges and solutions. Open Access Surgery 2016;9:5–14.

16. Ahmad Sakr, Sameh Hany Emile, Emad Abdallah et al. Predictive Factors for Small Intestinal and Colonic Anastomotic Leak: a Multivariate Analysis. Indian Journal of Surgery.2017;79(6):555–562.

17.Pickleman J, Watson W, Cunningham J et al. The failed gastrointestinal anastomosis: an inevitable catastrophe?. J Am Coll Surg. 1999;188 (5):473-82.

18.Hamed Ahmed Abd, El Hameed El-Badawy. Anastomotic Leakage After Gastrointestinal Surgery: Risk Factors, Presentation

And Outcome. The Egyptian Journal of Hospital Medicine. 2014;57: 494-512.

19.Bodil Gessler, Olle Eriksson, Eva Angenete. Diagnosis, treatment and consequence of anastomotic leakage in colorectal sur- gery. Int J Colorectal Dis. 2017;32 (4): 549–556.

20.Mark A. Boccola, Joshu Lin, Warren M. Rozen et al. Reducing Anastomotic Leakage in Oncologic Colorectal Surgery: An Evi- dence-Based Review. Anticancer Res. 2010;30 (2):601-607.

21.Jones CE, Watson TJ: Anastomotic leakage following esophagectomy. ThoracSurgClin. 2015; 25:449-459.

50

22.Neil Hyman, Thomas L. Manchester, Turner Osler et al. Anastomotic Leaks after Intestinal Anastomosis:It’s Later than You Think. Ann Surg.2007;245: 254–258.

23.Bielecki K, Gadja A. The causes and Prevention of Anastomotic Leak after Colorectal Surgery. Klin Onkol. 1999;12: 25-30.

24.Jeffrey Hammond, Sangtaeck Lim, YinWan et al. The Burden of Gastrointestinal Anastomotic Leaks: an Evaluation of Clini-

cal and Economic Outcomes. J Gastrointest Surg. 2014;18(6): 1176–1185.

51

Tesfaye Kebede, Daniel Zewdineh ,Assefa Getachew , Kumlachew Abate . Ethiop Med J, 2022, Vol. 60 No. 1

ASSESSMENT OF THE LEVEL OF JOB SATISFACTION OF RADIOLOGISTS

PRACTICING IN ETHIOPIA

Tesfaye Kebede MD1 , Daniel Zewdineh MD2, Assefa Getachew MD3, Kumlachew Abate MD4

ABSTRACT

Background: Professional satisfaction is a key factor in delivering quality medical care. However, the level of professional satisfaction of radiologists, among others, in Ethiopia has not been assessed so far. In light of this, this study hopes to determine the Level of Professional Satisfaction in Ethiopian Radiologists.

Methods: The study is a cross-sectional survey of the level of professional satisfaction among Ethiopian practic- ing radiologists who have at least 2 years of experience. We compiled the list of participants that came for the 2017 annual conference to the Radiological Society of Ethiopia (RSE) meeting and used a self-administered struc- tured questionnaire.

Results: Eighty radiologists participated in the study of which 2/3rd was males, and 53.9% were younger than 45yrs of age, with an overall satisfaction rate of 62.8%. Male radiologists (p = 0.01) aged 35-44 (P-value =0.02) and working in large cities outside Addis (P = 0.01), as well as radiologist in clinical practice were found to be somewhat or extremely satisfied (p= 0.03). Meanwhile, radiologists of younger age, females, and those working in small towns (p= 0.001), were more dissatisfied. In addition, only 32% of the radiologist are either very satisfied or extremely satisfied with their monthly income which was significantly associated with the overall level of job satisfaction (p=0.001)

Conclusions: The survey demonstrated a comparable level of professional satisfaction of Ethiopian radiologists with those of other countries. Professional satisfaction is associated with work arrangement, gender, and age group in addition to years of experience, and place of work. It was also able to determine that income has a major influence on professional satisfaction.

Keyword: Ethiopia, Job Satisfaction, Radiologists

INTRODUCTION

Satisfaction of medical professionals is a key factor in delivering quality medical care. It is important to note that, not only is it vital to keep the professional moti- vated to stay in their respective specialty; it is also an indirect measure of patient outcome (1). In addition, it affects patient care by also increasing the tendency of professionals to unionize and participate in a strikes (2, 3).

Professional satisfaction is also strongly associated with patient satisfaction (4-6). According to a study in Japan, having a high income as well as, working in large hospitals were associated with high satisfaction, whereas, older age and night shifts were associated with dissatisfaction (8).

Factors affecting work satisfaction may also vary de- pending on time, with changes in practice, patient load, and income over time. Published works also show that close to half of all radiology professionals reported a decreased level of satisfaction in their job, as compared to five years prior (7, 8).

Although there are published research works in Ethiopia that analyze the radiological services, no published works so far investigate the level of satis- faction among radiology professionals. Therefore, the main aim of this survey is to do a baseline as- sessment of the level of professional/ job satisfac- tion of radiologists in local practice.

METHODS

Study design

This was a cross-sectional survey conducted on a source population of 140 radiologists who attended the 22nd annual radiology conference in 2017

Study setting

The study was conducted in Addis Ababa, Ethiopia during the 22nd annual conference of the Radiology Society of Ethiopia.

1Associate professor of Radiology, College of Health Sciences, Addis Ababa University, 2Professor of Radiology College of Health Sciences, Addis Ababa University, 3Associate professor of Radiology College of Health Sciences, Addis Ababa Univer- sity, 4Assistant Professor of Radiology St. Paul Hospital Millennium Medical College

Correspondent author Tesfaye Kebede. Email: [email protected]

Study population and procedure

The study participants were all radiologists who have a minimum work experience of two years. 40 out of 140 radiologists who have work experience of less than two years were excluded from the study. The remaining 100 met the inclusion criteria. Among those eligible, 80 of them consented to participate in the survey.

Data collection and analysis

Data was collected using a structured questionnaire which contains sociodemographic characteristics, area and type of practice, staffing character, work sched- ule, number of institutions that the radiologist is work- ing or practicing in, stability within the current institu- tion, and career plans. Satisfaction was measured us- ing a five-level Likert scale. Data was entered into SPSS version 20 and analyzed. Descriptive and ana- lytical statistics were used as applicable. The depend- ent variable was satisfaction and independent varia- bles included age, sex, years of experience, income, and type of practice, and multivariate logistic regres- sion was used to test the association between the two variables. Statistically, a significant association was taken for p values <0.05.

Ethical considerations

Participation in the survey was voluntary. Informed consent was obtained from all respondents, and indi- vidual identifiers were not used during data collection. Ethical clearance was obtained from the Research and Ethics Committee of the Department of Radiology. Permission was obtained from the radiology society.

RESULTS

Out of the 100 eligible radiologists, 80 of the partici- pants in the study complied making the response rate 80 %. Around 2/3rd of the respondents were males and 55.1% of them were <45yrs of age (Table I).

All levels of professional experience above 2 years were represented and only 1.3% of the respondents were above the age of 65 (figure I & II). Among the participants, 68% of the respondents had 2-10 years of experience, while 31.3% had above 10 years (figure II). 74 (92.5%) of the respondents were general radiol- ogists and only 6 (7.5%) were subspecialists.

Concerning the area of practice, 88.8% of the re- spondents were practicing either in Addis Ababa or other larger cities. 88.4% were in clinical practice during the time of data collection and 70% percent of the respondents were full-time employees. Those who were working in private practice accounted for 41.3% of the respondents and the rest were working in gov- ernment institutions and uninformed services (Table II). The data showed that half of the respondents were working in only one institution while the remaining half was working in two or more institutions.

52

The overall satisfaction level of radiologists in this study was 62.8%., 31.3% of respondents reported to be satisfied with their current monthly income and 53.8% of respondents were indifferent. Con- cerning stability of respondents, 83.8% of respond- ents were stable during the past two years with 52.3% having no plan to change their current working place within the next one year. Among the participants, 78.8% also had a plan to keep the current practice rather than change practice or ca- reer path (Table I).

Radiologists who were male and in the age group of 35 -44 were more likely to be satisfied than the females or younger, and older age groups (P-value

=0.02 & 0.01 respectively). (Table II) Radiologists working in larger cities other than Addis Ababa also reported to be satisfied than those working in Addis and smaller cities. Those who were working in small cities reported more dissatisfaction than those radiologists working in Addis Ababa and other large cities, respectively (P -value = 0.00). Those radiologists in clinical prac- tice also reported better satisfaction than those who were in academic practice (P-value = 0.03). (Table II)

The study also found that those radiologists who had longer years of experience (>11yrs) were more likely to encourage college-age students to join medicine than those who had <10years of experi- ence (P- value= 0.01) (table II).

Figure I: Age distribution of Ethiopian radiologists participated in the survey, Addis Ababa, 2017 GC.

Figure II: Category of years of professional experi- ences of Ethiopian radiologists, Addis Ababa, 2017GC

53

Table: I:- Professional and Practice Characteristics of Ethiopian radiologists, Addis Ababa 2017GC

 

 

Frequency

Percent

 

 

 

 

Area of Practice

Addis Ababa

42

52.5

 

Other large cities

29

36.3

 

Small cities

9

11.3

 

Total

80

100

Full-Time Practice

Private

41

51.3

 

Government

37

46.3

 

Uninformed services

2

2.5

 

Total

80

100

Staffing Character

Academic

22

27.5

 

Clinical

58

72.5

 

Total

80

100

Work Schedule

Full time

56

70

 

Part-time

2

2.5

 

Both

22

27.5

 

Total

80

100

Number of institutions

One

40

50

 

Two

29

36.3

 

More than two

11

13.8

 

Total

80

100

Satisfaction with Income

Extremely satisfied

4

5

 

very satisfied

21

26.3

 

indifferent

43

53.8

 

very dissatisfied

10

12.5

 

Extremely dissatisfied

2

2.5

 

Total

80

100

Institutions the Past 2yrs

No

13

16.3

 

Yes

67

83.8

 

Total

80

100

Plan to Change Work Place

Yes next 6months

16

20

 

Yes next one year

22

27.5

 

No

42

52.5

 

Total

80

100

Career Plan

keep practicing

63

78.8

 

change practice

16

20

 

Make career change

1

1.3

 

Total

80

100

54

Table II. Satisfaction According to their Socio-demographic and Practice Characteristics of Ethiopian radiologists

`Category

Encourage

p-

Recom-

p-

Satisfaction Compared to what was before 2yrs

 

 

College Ages

Val-

mend Radi-

Val-

 

 

 

 

 

to Join Medi-

ue

ology

ue

Highly/

No change

Extremely/

p-Value

 

cine n(%)

 

 

 

Somewhat

n(%)

Somewhat

 

 

 

 

n(%)

 

Satisfied

 

Dissatisfied

 

 

 

 

 

n(%)

 

n(%)

 

Age Category

 

 

 

 

 

0.02

 

 

 

 

 

 

 

<=35

10(76.9%

0.18

19(95.0%

0.17

16(64%)

3(12%)

4(16%)

 

35-44

16(88.9%

6

14(82.4%

5

15(79%)

0(0%)

4(21.1%)

 

45-54

14(73.7%

 

11(73.3%

 

8(40%)

8(40%)

4(20%)

 

55-64

13(100%

 

13(100%

 

9(60%)

4(26.7%

2(13.3%)

 

>=65

 

 

1(100.0%

 

1(100%)

0(0%)

0(0.0%)

 

Sex

 

 

 

 

 

 

 

0.01*

Female

17(85%)

0.89

23(95.8%)

0.13

14(48.3%)

9(31%)

4(13.6%)

Male

36(83.7%)

7

35(83.3%)

4

35(68.6%)

6(11.8%)

10(19.6%)

 

Years of Experience

 

 

 

 

 

 

 

0.06

0 to 5 Years

14(87.5%)

0.01

24(96%)

0.19

20(69%)

3(10.3%)

4(13.8%)

 

6 to 10 Years

17(68%)

*

14(77.8%)

3

17(65.3%)

5(19.2%)

4(15.4%)

 

 

 

>=11 Years

22(100%)

 

20(87%)

 

12(48%)

7(28%)

6(24%)

 

Level of Training

 

 

 

 

 

 

 

0.23

General radiologist

50(84.7%)

0.60

55(88.7%)

0.41

47(63.5%)

14(18.9%)

11(14.9%)

 

Subspecialist

3(75%)

6

3(75%)

5

2(33.4%)

1(16.7%)

3(50%)

 

Place of Practice

 

 

 

 

 

 

 

<0.00*

Addis Ababa

28(82.4%)

0.59

30(88.2%)

0.98

23(54.7%)

13(31%)

4(9.5%)

Other Large Cities

20(83.3%)

6

22(88%)

3

21(72.4%)

1(3.4%)

7(24.1%)

 

Small Cities

5(100%)

 

6(85.7%)

 

5(55.6%)

1(11.1%)

3(33.3%)

 

Academic

15(78.9%)

0.46

13(86.7%)

0.87

13(59.1%)

3(13.6%)

6(27.3%)

 

Clinical

38(86.4%)

 

45(88.2%)

 

36(62.1%)

12(20.7%)

8(13.8%)

 

Satisfaction with

 

 

 

 

 

 

 

 

income

 

 

 

 

 

 

 

<0.00*

Extremely satisfied

3(100%)

0.10

2(50%)

0.06

4(100%)

0(0%)

0(0%)

very satisfied

16(100%

1

21(100%)

4

19(90.45)

2(9.5%)

0(0%)

 

 

 

 

Indifferent

30(81.1%)

 

30(85.7%)

 

24(55.8%)

12(27.9

7(16.3%)

 

very dissatisfied

3(60%)

 

4(80%)

 

1(10%)

%)

7(70%)

 

Extremely

1(50%)

 

1(100%)

 

1(50%)

0(0%)

0(0%)

 

dissatisfied

 

 

 

 

 

1(50%)

 

 

working in the same

 

 

 

 

 

 

 

 

institution during

45(83.3%)

0.67

48(88.9%)

0.59

39(58.3%)

13(19.4%)

13(19.4%)

0.03*

the Past 2yrs

Yes

 

3

 

4

 

 

 

 

Plan to Change

 

 

 

 

 

 

 

 

Work Place

 

 

 

 

 

 

 

0.04*

Yes next 6months

6(66.7%)

0.30

12(92.3%)

0.81

74(3.8%)

4(25%)

3(18.8%)

Yes next one year

14(87.5%)

1

16(88.9%)

4

15(68.2%)

3(13.6%

4(18.2%)

 

 

 

 

No

33(86.8%)

 

30(85.7%)

 

27(64.3%)

8(19%)

7(16.7%)

 

Career Plan

 

 

 

 

 

 

 

<0.00

Keep practicing

53(84.1%)

-

45(84.8%)

0.13

40(63,5%

12(19%)

11(17.5%)

Change practice

 

 

13(100%)

5

9(56.3%)

2(12.5%)

3(18.8%)

 

 

 

 

 

Make career change

 

 

0(0%)

 

0(0%)

1(100%)

0(0%)

 

 

 

 

 

 

 

 

 

 

* Statistical test was calculated at P<0.05

DISCUSSION

The survey revealed that the overall satisfaction of radiologists is 62.8%. Given the relatively low level of satisfaction, most radiologists have been stable at their current positions for two years and have no plans of moving to other places in the coming year or changing career paths. Middle-aged male radiologists and those working in the larger cities outside the capital city, Addis Ababa, have a higher level of satisfaction than younger and female radiologists and those working in the capital or smaller regional cities.

So far many studies have been published locally and internationally addressing issues of satisfaction among Ethiopian healthcare workers including general practi- tioners and specialists (9-12). However, since the dis- cipline differs substantially from other medical spe- cialties in terms of the level of interaction with pa- tients, and the speed of technological evolution, the results of these studies cannot be directly extrapolated to radiologists (13).

Radiologist satisfaction can be affected by many fac- tors, such as income, physical working environment, freedom to choose work method, recognition for good work, job security, and career prospects (14, 15). There are also differences in the level of satisfaction among the different age groups and gender. Most works of literature also demonstrated changes in the level of job satisfaction over time (7, 15, 16).

The level of job satisfaction also was shown to be different among radiologists working in different countries and even in different institutions within a

specificcountry. This is due to the difference in the determinants of job satisfaction, and the overall satisfaction of radiologists in the published works of literature, which ranged from 49.5% to 93% (7, 8, 14, 15). Our result also fell within this range.

Despite few reports which showing no difference in satisfaction among males and females (14, 15), most literature report the contrary (7, 14, 16, 17). Similarly, our study showed most males reported a higher level of satisfaction than females. In the authors' opinion, Gender differences in satisfaction among radiologists, found both in our study and other works of literature, arise from the different factors and tools used to meas- ure satisfaction.

In contrast to most studies that reported that academic, non-government practitioners reported more satisfac- tion than private practitioner (7, 15, 17), our results indicate that academic radiologists have a low level of satisfaction than radiologists in private practice (P- value 0.03). The authors attribute this to the work overload and working environment. Most private radiology services are well equipped compared to the academic radiology departments, which are all gov- ernment-owned.

55

In addition, radiology equipment downtime in the academic departments is long due to a shortage of budget for equipment maintenance and a lack of preventive and corrective maintenance agreements. On the other hand, private radiologic facilities usu- ally get maintained quickly because of lack of bu- reaucratic channels and the income they present. As a result, these factors may contribute to the low levels of satisfaction reported by academic radiolo- gists in comparison to private practitioners.

A high level of job satisfaction was also reported from those working in the same institution for two years and above with intentions of staying for at least one more, during the data collection. The possible explanation may be related to fulfillment within their given employment. Job satisfaction is one factor for radiologist turnover intention (18).

Similar to reports in other pieces of literature, our survey showed that there is no statistically signifi- cant difference in the level of satisfaction between full-time and part-time employees(14, 16). Like- wise, working in single or multiple institutions was not associated with differences in the level of satis- faction.

Conclusion and Recommendations

This survey showed that Ethiopian radiologists have a level of satisfaction comparable with radiol- ogists in the rest of the world. Being female, younger than 35 and older 44, academic radiolo- gists as well as, working in the capital city, Addis Ababa, were associated with a low level of satis- faction.

The authors recommend investigating factors af- fecting the level of job satisfaction among radiolo- gists and running comparative studies between the different disciplines or specialties.

Acknowledgement

The authors would like to thank all those who par- ticipated in the survey and the radiological Society of Ethiopia for facilitating data collection.

Conflict of Interest

The authors declared no sources of financial sup- port or conflict of interest

56

REFERENCES

1.Haas JS, Cook EF, Puopolo AL, Burstin HR, Cleary PD, Brennan TAJJogim. Is the professional satisfaction of general internists associated with patient satisfaction? 2000;15(2):122-8.

2.Burke RJJSS, Medicine. Stress, satisfaction, and militancy among Canadian physicians: a longitudinal investigation. 1996;43(4):517-24.

3.Kravitz RL, Shapiro MF, Linn LS, Froelicher ESJAjoph. Risk factors associated with participation in the Ontario, Canada doctors' strike. 1989;79(9):1227-33.

4.A. Katz, Maron-Katz A. Better outcome means more job satisfaction: a pilot project in Winnipeg and Halifax to enhance physician-patient communication. Can Fam Physician. 1999.

5.Haas JS, Cook EF, Puopolo AL, Burstin HR, Cleary PD, Brennan TA. Is the professional satisfaction of general internists associated with patient satisfaction? J Gen Intern Med. 2000;15(2):122-8.

6.Sundquist J, Johansson SE. High demand, low control, and impaired general health: working conditions in a sample of Swedish general practitioners. Scandinavian journal of public health. 2000;28(2):123-31.

7.Zafar HM, Lewis RS, Sunshine JH. Satisfaction of radiologists in the United States: a comparison between 2003 and 1995. Radiology. 2007;244(1):223-31.

8.Beitzel K, Ertl L, Grosse C, Reiser M, Birgit E-W. Job Satisfaction of Radiologists in Germany - Status Quo. RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin. 2011;183:749-57.

9.Yami A, Hamza L, Hassen A, Jira C, Sudhakar MJEjohs. Job satisfaction and its determinants among health workers in Jimma university specialized hospital, southwest Ethiopia. 2011.

10.Temesgen K, Aycheh MW, Leshargie CTJH, outcomes of Job satisfaction and associated factors among health professionals working at Western Amhara Region, Ethiopia. 2018;16(1):1-7.

11.Gedif G, Sisay Y, Alebel A, Belay YAJBrn. Level of job satisfaction and associated factors among health care professionals working at University of Gondar Referral Hospital, Northwest Ethiopia: a cross-sectional study. 2018;11(1):1-7.

12.Mengistu MM, Bali AGJSJoPH. Factors associated with job satisfaction among healthcare workers at public hospitals of West Shoa zone, Oromia regional state, Ethiopia: a cross-sectional study. 2015;3(2):161-7.

13.Graham J, Ramirez AJ, Field S, Richards MA. Job Stress and Satisfaction Among Clinical Radiologists. Clinical Radiology. 2000;55(3):182-5.

14.Magnavita N, Fileni A, Bergamaschi A. Satisfaction at work among radiologists. La radiologia medica. 2009;114(8):1330.

15.Sone M, Mizunuma K, Nakajima Y, Yasunaga H, Ohtomo K. Job satisfaction, income, workload, workplace, and demographics of Japanese radiologists in the 2008 survey. Japanese journal of radiology. 2013;31(5):364- 70.

16.Kubik HJSmw. Professional satisfaction of radiologists in Switzerland. 2011;141(3940).

17.Buddeberg-Fischer B, Christen S, Weishaupt D, Hoffmann A, Kubik-Huch RA. Professional satisfaction of radiologists in Switzerland. Swiss medical weekly. 2011;141:w13271.

18.Yeo J-D, Ko I-HJJotKSoR. An Analysis on Factors Affecting Radiologists' Turnover Intention. 2016;10(2):89 -99.

57

Yemesrach Fereja, Lars Aabakken ,Hailemichael Desalegn Mekonnen, Ethiop Med J, 2022, Vol. 60, No. 1

DYSPEPSIA AND PREVALENCE OF CLINICALLY SIGNIFICANT ENDOSCOPY FINDINGS IN A GASTROENTEROLOGY REFERRAL CLINIC IN ETHIOPIA

Yemisrach Fereja1, Lars Aabaakan2, Hailemichael Desalegn Mekonnen1*

ABSTRACT

Background: The clinical features and endoscopic findings of dyspepsia are not well studied in Ethiopia. Dys- pepsia is the predominant presentation of patients to Gastrointestinal (GI) Clinics in our country and Endoscopic findings are not routinely recommended to patients. Yet, identifying which patients need an urgent Endoscopy diagnosis is important to diagnose organic causes at an earlier stage. This study assessed the prevalence of dys- pepsia, associated factors, and clinically significant endoscopic findings and alarm symptoms in referral GI clin- ic in Ethiopia

Methods: A retrospective cross-sectional record review was conducted among adults who came with complaints of dyspepsia from September 1, 2015, to August 31, 2017 at St Paul hospital millennium medical college GI clin- ic. SPSS version 23 was utilized for data analysis. Descriptive data are presented as frequencies and percentages for categorical variables. To see the effect of each independent variable on the outcome, binary logistic regres- sion was used, and the strength of the association was assessed by computing odds ratio. A P value of <0.05 was considered statistically significant.

Results: From 3542 patients seen at GI clinic, dyspepsia was diagnosed in 418 i.e. in 21.6% of cases. The endo- scopic diagnosis showed a high prevalence of gastric cancer of 8.8%. Functional dyspepsia was diagnosed in 15.5% and a high prevalence of non-specific Gastro-duodenitis were reported, especially in younger cases with no associated alarm symptoms. Anemia and weight loss were independent predictors for organic causes.

Conclusion: Weight loss and anemia were important predictor of gastric cancer and should alarm physicians for an early endoscopy in these patients. The study also supports to restrict upper GI endoscopy in individuals <45 years of age and no alarm symptoms.

Keywords: Dyspepsia, Upper GI Endoscopy, Ethiopia, Alarm symptoms

BACKGROUND

Dyspepsia is defined as a group of symptoms consist- ing mainly of epigastric pain, burning, and postprandi- al fullness (1). It can also include nausea, belching, and bloating (1). Dyspepsia is also defined as predom- inant epigastric pain lasting at least for one month and can be classified into organic and functional. In or- ganic dyspepsia, specific pathology like peptic ulcer disease, GERD, and malignancies are identified on upper gastrointestinal endoscopy. In contrast, endos- copy will be normal in functional dyspepsia. There are also other non-luminal causes including pancreatic and gall bladder diseases that should be excluded (1, 2). The reported prevalence of dyspepsia ranges from

1.8to 57% across different countries with an average prevalence of 20.8% among population studies; this variability is explained partly by the use of different criteria for dyspepsia (3). There has been an increased prevalence of dyspepsia in women, smokers, NSAIDs users, and among H. pylori positive people (3). Pa- tients with dyspepsia generate substantial health care costs, with abnormal health care seeking behavior and

considerable anxiety affecting their quality of life (4,5,6).Weight-loss related to dyspepsia should be considered as an alarm sign indicating GI malig- nancy (7).

The prevalence of dyspepsia in African countries like Nigeria and Rwanda ranges from 29 to 38.9%. In Ethiopia, it is the most frequent indication for an upper GI endoscopy, and it is increasingly becom- ing an important cause of morbidity (8). Although gastrointestinal endoscopy is a primary diagnostic tool for dyspepsia, it is not widely available. There are only two training centers in Ethiopia with a GI fellowship program; because of this, there are few well-trained physicians to diagnose and treat dys-

pepsia adequately.

In this study, we assessed the burden of dyspepsia, Endoscopic findings of those patients referred with symptoms and from this, we identified alarm symptoms that could predict an organic pathology.

1.St. Paul’s Hospital Millennium Medical College

2.Oslo University Hospital

* Corresponding author e-mail address: [email protected]

MATERIALS AND METHODS

This was a retrospective cross-sectional study carried out in the GI clinic of St. Paul's Hospital Millennium Medical College (SPHMMC) from September 1, 2015, to August 31, 2017. SPHMMC is one of the two major tertiary referral hospitals in Ethiopia with Gas- troenterology and Hepatology fellowship program. The Endoscopy unit is a recognized regional training site and accredited by World Endoscopy Organization as an African training center. The GI clinic accepts patients referred from different parts of the country. The hospital has 350 beds, sees an annual average of 300,000 patients. It has a catchment population of more than 5 million.

58

Statistical analysis

Descriptive data are presented as frequencies and percentages for categorical variables, mean, and standard deviation for quantitative variables. To see the effect of each independent variable on the outcome, binary logistic regression was used, and the strength of the association was assessed by computing odds ratio. Variables with p-value <0.2 in the two variables analyses and relevant with the objective of the study were included in the multi- ple binary logistic regression model. Multiple bi- nary logistic regressions were run, and the differ- ences between variables were explored. P-values of less 0.05 were considered statistically signifi- cant.

After obtaining ethical clearance from the Institutional review board, data were extracted from medical rec- ords of patients and information regarding age, sex, symptoms, risk factors, and endoscopy diagnosis rec- orded. It was a two years chart review from patients who have visited the clinic and all patients with an initial presentation of Dyspepsia and physician diag- nosis of Dyspeptic syndrome were included. Patient data with incomplete medical records were excluded. Dyspepsia was diagnosed based on the treating gastro- enterologist diagnosis found and traced from the chart. Data were coded, cleaned and entered, into SPSS ver- sion 23, and all statistical tests were performed with the same statistical package.

RESULTS

Patient characteristics

Out of the 3542 patients seen at GI clinic; 418 (21.6%) were diagnosed with dyspep- sia and requested to have an Endoscopy. The mean age of the participants was 42 (ranging from 15-97). A total of 40.7% of patients were from Addis Ababa. The pa- tients consisted of 60% males and 40% females. Demographic characteristics of the participants were depicted in table 1 below.

Table 1: Patient diagnosed with Dyspepsia at St. Paul’s Hospital GI Clinic, 2013-2015 G.C.

(N=418)

 

 

 

 

 

Demographic Variable

 

Number

Percent

 

 

 

 

Sex

 

 

 

Male

 

251

60

Female

 

167

40

 

 

 

 

Mean Age

 

42 years

 

 

 

 

 

Region

 

 

 

Addis Ababa

 

170

40.7%

Out of Addis

 

248

59.3%

 

 

 

 

*No complete data for occupation, marital status was found

Clinical features of patients with dyspepsia

Three hundred ninety-seven (95%) patients had epi- gastric pain. Weight loss and dysphagia as alarm symptoms occurred in 112 (26.7%) and 35(8.3%) pa- tients, with organic and functional dyspepsia, respec- tively. (See Table 2).

Table 2: Clinical presentation of patients at St.

Paul’s Hospital GI Clinic, 2013-2015 G.C.

(N=418)

Clinical

 

Num-

Per-

Func-

Organ-

Presentation

ber

cent

tional

ic

 

 

 

 

dyspep-

Dys-

 

 

 

 

sia **

pepsia*

 

 

 

 

 

**

 

 

 

 

 

 

Epigastric

 

397

95.0

61

336

pain

 

 

 

 

 

 

 

 

 

 

 

Epigastric

 

409

98.0

64

345

burning

 

 

 

 

 

 

 

 

 

 

Postprandial

298

71.0

50

248

fullness

 

 

 

 

 

 

 

 

 

 

Early satiety

280

66.9

48

232

 

 

 

 

 

Weight loss

112

26.7

21

91

 

 

 

 

 

 

Dysphagia

 

35

8.3

2

33

 

 

 

 

 

 

Upper

GI

163

38.9

14

149

bleeding

 

 

 

 

 

 

 

 

 

 

 

Symptoms

of

9

2.1

0

9

GOO *

 

 

 

 

 

 

 

 

 

 

 

*Gastric outlet obstruction

**Patient with clinical symptoms, but normal EGD and imaging findings and decision from treating physician after assessment of the pa- tient

***Patients with Endoscopic findings of an organic cause

Endoscopic findings

From a total 418 patients with dyspepsia, who under- went endoscopy, functional dyspepsia constituted 15.5% while the remaining 84.5% presented has some endoscopic findings. The reported diagnosis on endos- copy were 18.5% duodenal ulcer, 16.4% GERD, 8.8% gastric cancer, while 6.6% had gastric ulcer (See Ta- ble 3).

59

Table 3: Endoscopic findings in dyspeptic pa- tients at St. Paul’s Hospital GI Clinic, 2013-2015 G.C.

Endoscopic

Freq.

Percent

finding

 

 

Gastric Cancer

37

8.8

 

 

 

Duodenal Ulcer

62

14.7

 

 

 

Gastric Ulcer

19

4.5

 

 

 

Gastric and Duo-

9

2.1

denal ulcers

 

 

 

 

 

GERD&

31

7.5

GERD& + Duode-

7

1.7

nal ulcer

 

 

 

 

 

Gastritis

103

24.6

 

 

 

Duodenitis

17

4.0

 

 

 

GERD& + Gastri-

30

7.2

tis

 

 

 

 

 

Bile reflux gas-

8

1.9

tropathy*

 

 

 

 

 

Gastro-duodenitis

7

1.7

 

 

 

Others

22

5.3

 

 

 

Normal

65

15.5

 

 

 

Total

418

100.0

 

 

 

*physicians report of an endoscopy finding & Gas- tro-esophageal reflux disease

Associated factors for Dyspepsia

From this study, NSAIDs were used in 9.5%, 10.4% were consuming alcohol. H. pylori bacteria was positive in 12.3% of FD patients and 20.9% of organic dyspepsia. (See Table 4)

60

Table 4: Factors predicting Organic Dyspepsia at St1. Paul’s Hospital GI Clinic, 2013-2015 G.C.

Variable

 

Total(n=418)

P-value

Crude

Adjusted

 

 

n(%)&

 

OR (95% CI)

OR (95% CI)

 

 

 

 

 

 

Age

<45

303(72.5)

0.01

1

 

 

45-60

71(16.9)

 

1.18(1.45-11.02)

0.83(0.22-3.10)

 

>60

44(10.6)

 

2.15(0.64-6.68)

 

 

 

 

 

 

 

Sex

Male

249(59.5)

0.05

1.68(0.99-2.86)

1.12(0.50-2.53)

 

 

 

 

 

 

 

NSAID *use

No

202(83.4)

0.07

1

 

 

Yes

40(16.6)

 

0.26(0.06-1.13)

 

 

 

 

 

 

 

Alcohol hab-

No

257(85.)

0.11

1

 

 

 

 

 

 

 

 

 

H.Pylori

Neg.**

306(78.)

0.02

1

 

 

Positive

83(21.4)

 

0.48(0.22-1.06)

0.56(0.18-1.80)

 

 

 

 

 

 

*Non-steroidal Anti-inflammatory drugs ** Negative

The presence of weight loss and anemia were signifi- cantly associated with the presence of gastric cancer (see table 5). A biopsy result was collected for 37 pa- tients with Gastric mass, out of this 29 had adenocar- cinoma, and one participant had a Histologic diagno- sis of lymphoma.

&Missing data for H.pylori,Alcohol,NSAIDs

DISCUSSION

Dyspepsia was prevalent in our study. Patients presenting with dyspepsia may have a range of diagnosis from normal endoscopy finding to the diagnosis of cancer.

Table 5 Factors predicting gastric cancer at St. Paul’s Hospital GI Clinic, 2013-2015 G.C.

Variables

 

Total (n=37),n(%)

P-value

Crude OR 95% CI

Adjusted OR (95% CI)

 

 

 

 

 

 

Age

<45

23(62.2)

 

1

 

 

 

 

 

 

 

 

45-59

8(21.6)

0.01

4.00(1.45-11.)

2.14(0.41,11.21)

 

 

 

 

 

 

 

>60

6(16.2)

0.18

2.15(0.696.60)

2.160.34,13.84)

 

 

 

 

 

 

Sex

Male

20(54.1)

 

1

 

 

 

 

 

 

 

 

female

17(45.9)

0.12

1.90(0.834.30)

0.98(0.24, 4.05)

 

 

 

 

 

 

Smoking

No

31(83.8)

 

1

 

habit

 

 

 

 

 

Yes

6(16.2)

0.05

0.26(0.07-0.93)

2.05(0.35,12.02)

 

 

 

 

 

 

 

weight loss

No

16(43.2)

 

1

 

 

 

 

 

 

 

 

Yes

21(56.7)

<0.01

0.04(0.01-0.17)

2.23(4.95,109.0)

 

 

 

 

 

 

Anemia

No

15(40.5)

 

1

 

 

 

 

 

 

 

 

Yes

22(59.5)

0.01

0.22(0.09-0.53)

3.09(1.05, 9.14)

 

 

 

 

 

 

Understanding which patients with dyspepsia could have cancer and prediction based on risk factors and non-invasive tests is important to prioritize and limit the need for endoscopy.

Dyspepsia accounted for 21.6% of patients seen at GI/ Hepatology clinic. This result was closer to a meta- analysis, which reported an overall pooled prevalence of 20.8% (3). Numbers are lower than a prospective study done in Rwanda, which showed a prevalence of 38.9%. This was a prospective study done in 356 health workers and as the study population is focused to a certain group, it might have increased the preva- lence (5). Another study from the Northern part of Ethiopia, Gondar, has found a prevalence of 54.4% (9) This study has a larger sample size and it is focused on endoscopy findings as an entry point and included an eight-year study, which leads to a higher recruit- ment of patients with dyspepsia .

Gastric cancer was found in 8.8% of dyspeptic pa- tients. Previous Ethiopian studies have shown a preva- lence of gastric cancer ranging from 0.3-3.6% (9,12,16,22). The prevalence is higher in our study, possibly because it is a tertiary referral center and the catchment area is also considered to have higher prev- alence of gastric cancer from previous studies (23)

The presence of weight loss increased the presence of gastric cancer by 23-fold while anemia increased the prediction by three-fold. This is consistent with differ- ent studies that reported alarm features as strong pre- dictors of upper GI cancer (25, 26).

Functional dyspepsia with normal upper endoscopy was found in 15.5%, which is comparable to studies in Nigeria (15.4%), UAE (15%) (11) and lower than a study done in Mekelle, Ethiopia (12). Females had a slightly higher proportion of functional dyspepsia. Younger age (<45 years), female gender and lack of alarm symptoms (weight loss and anemia) were indi- cators of functional dyspepsia. This supports to defer endoscopy for such group of patients.

Gastritis was the commonest endoscopy diagnosis in this study, followed by duodenal ulcer and GERD. Data from Lagos, Nigeria have also shown a higher prevalence of gastritis (59.9%) (11,13,15)

This study showed a higher prevalence of GERD compared to a previous Ethiopian report from 2004,

61

where the prevalence was 2.3%. This could be due to changes in life style and global increase in non- communicable diseases, which could increase GERD prevalence (22).

H.pylori was detected in 19.6%, which was lower compared to previous studies in Ethiopia, which reported a prevalence of 65-83%(8) (16, 17). This disparity may be due to the widespread use of H.pylori eradication therapy that reduced the prev- alence of H.pylori in our setup. The patient recruit- ment may also be different. NSAIDs use was 9.5%, and it was associated with GERD and gastri- tis on endoscopy. Higher frequency of dyspepsia in persons taking NSAIDs has also been reported from a meta-analysis (19). Another study has also estimated that 4% of all dyspepsia in the communi- ty is attributable to NSAID use in subjects aged 40 –49 years (20). Alcohol use was lower in our study compared to a study that reported 34% in southern Ethiopia (6). In this study, the behavioral risk fac- tors such as smoking and alcohol use had no rela- tionship with organic dyspepsia, which is con- sistent with a study from southern Ethiopia (6). However, different studies in Africa and the west- ern world have shown an increased risk of dyspep- sia in people who smoke and drink alcohol (21) (13). This inconsistency may be due to incomplete chart documentation as a limitation of this retro- spective study.

An important limitation of our study is the retro- spective nature, which was associated with poor documentation of potential risk factors for dyspep- sia and gastric cancer. On the other hand, the study was performed in a major referral center and inclu- sion of many patients in the referral clinic is the main strength of the study.

CONCLUSION

Dyspepsia was a common diagnosis in our clinic patients. Weight loss and anemia were important predictors of gastric cancer and should alarm phy- sicians for an early endoscopy in these patients. The study also supports to defer upper GI endosco- py in individuals <45 years of age and no alarm symptoms.

REFERENCE

1.Tack J, Talley NJ. Functional dyspepsia—symptoms, definitions and validity of the Rome III criteria. Nature reviews Gastroenterology & hepatology. 2013 Mar;10(3):134-41.

2.Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016 May 1;150(6):1257-61.

62

3.Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015 Jul 1;64(7):1049-57.

4.Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Effect of dyspepsia on survival: a longitudinal 10- year follow-up study. Official journal of the American College of Gastroenterology| ACG. 2012 Jun 1;107 (6):912-21..

5.Bitwayiki R, Orikiiriza JT, Kateera F, Bihizimana P, Karenzi B, Kyamanywa P, Walker TD. Dyspepsia preva- lence and impact on quality of life among Rwandan healthcare workers: A cross-sectional survey. South Afri- can Medical Journal. 2015;105(12)

6.Ayele B, Molla E. Dyspepsia and Associated Risk Factors at Yirga Cheffe Primary Hospital, Southern Ethio- pia. Clin Microbiol. 2017;6:3.

7.Jones MP, Talley NJ, Eslick GD, Dubois D, Tack J. Community subgroups in dyspepsia and their association with weight loss. Official journal of the American College of Gastroenterology| ACG. 2008 Aug 1;103 (8):2051-60.

8.Mathewos B, Moges B, Dagnew M. Seroprevalence and trend of Helicobacter pylori infection in Gondar Uni- versity Hospital among dyspeptic patients, Gondar, North West Ethiopia. BMC Research Notes. 2013 Dec;6 (1):1-4.

9.Getahun GM, Abubeker ZA. Upper Gastrointestinal Endoscopy findings at Gnodar university Hospital, North- western Ethiopia: An eight year analysis.International Journal Of Pharmaceuticals And Health Care Research. 2015;(May). ISSN:-2306-6091

10.Mubarik M, Bhat FA, Malik GM. dkk. Diagnostic yield of upper GI endoscopy and ultrasonography in pa- tients of dyspepsia. JK-Practitioner. 2012;17(4):15-9.

11.Ugiagbe RA, Omuemu CE. Non-ulcer dyspepsia: An endoscopic review. African Journal of Medical and Health Sciences. 2013 Jan 1;12(1):6.

12.Kiros YK, Tsegay B, Abreha H. Endoscopic and Histopatological correlation of Gastrointestinal disease in , Ayder referral hospital, Mekelle University northern Ethiopia.Ethiopian Medical Journal. 2017 Sep 20;55(4).

13.Hameed L, Onyekwere CA, Otegbayo JA, Abdulkareem FB. A clinicopathological study of dyspeptic subjects in Lagos, Nigeria. Gastroenterology insights. 2012 Jan;4(1):39-42.

14.Sarfraz T, Hafeez M, Shafiq N, Tariq H, Azhar M, Ahmed KN, Jamal N. Histopathological analysis of gastric mucosal biopsies in non ulcer dyspepsia. Pakistan Armed Forces Medical Journal. 2016 Dec 31;66(6):857-61.

15.Singh P, Goswami KC, Gupta BB. Gastric mucosal biopsies in non ulcer dyspepsia: A histopathologic study. Asian Journal of Medical Sciences. 2016;7(2):80-4.

16.Asrat D, Nilsson I, Mengistu Y, Ashenafi S, Ayenew K, Al-Soud WA, Wadström T, Kassa E. Prevalence of Helicobacter pylori infection among adult dyspeptic patients in Ethiopia. Annals of Tropical Medicine & Parasitology. 2004 Mar 1;98(2):181-9.

17.Tadesse E, Daka D, Yemane D, Shimelis T. Seroprevalence of Helicobacter pylori infection and its related risk factors in symptomatic patients in southern Ethiopia. BMC research notes. 2014 Dec;7(1):1-5.

18.Kidd M, Louw JA, Marks IN. Helicobacter pylori in Africa: observations on an ‘enigma within an enigma’ . Journal of gastroenterology and hepatology. 1999 Sep;14(9):851-8.

19.Ofman JJ, Maclean CH, Straus WL, Morton SC, Berger ML, Roth EA, Shekelle PG. Meta‐analysis of dyspepsia and nonsteroidal antiinflammatory drugs. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2003 Aug 15;49(4):508-18.

20.Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, Axon A, Leeds HELP Study Group. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. The American journal of gastroenterology. 2000 Jun 1;95(6):1448-55.

21.Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. American Journal of Gastroenterology. 2004 Nov 1;99(11):2210-6.

22.Taye M, Kassa E, Mengesha B, Gemechu T, Tsega E. Upper gastrointestinal endoscopy: a review of 10,000 cases. Ethiopian medical journal. 2004 Apr 1;42(2):97-107.

23.Bane A, Ashenafi S, Kassa E. Pattern of upper gastrointestinal tumors at Tikur Anbessa Teaching Hospital in Addis Ababa, Ethiopia: a ten-year review. Ethiopian medical journal. 2009 Jan 1;47(1):33-8.

24.Gado A, Ebeid B, Abdelmohsen A, Axon A. Endoscopic evaluation of patients with dyspepsia in a secondary referral hospital in Egypt. Alexandria Journal of Medicine. 2015 Sep 14;51(3):179-84.

25.Abdeljawad K, Wehbeh A, Qayed E. Low prevalence of clinically significant endoscopic findings in outpa- tients with dyspepsia. Gastroenterology research and practice. 2017 Jan 22;2017.

26.Khademi H, Radmard AR, Malekzadeh F, Kamangar F, Nasseri-Moghaddam S, Johansson M, Byrnes G, Brennan P, Malekzadeh R. Diagnostic accuracy of age and alarm symptoms for upper GI malignancy in pa- tients with dyspepsia in a GI clinic: a 7-year cross-sectional study. PLoS One. 2012 Jun 13;7(6):e39173.

63

Alemu Adeba, Dessalegn Tamiru ,Tefera Belachew. Ethiop Med J, 2022, Vol 60, No, 1

ORIGINAL ARTICLE

MAGNITUDE AND ASSOCIATED FACTORS OF UNDIAGNOSED DIABETES MELLITUS

AMONG MID-ADULTHOOD URBAN RESIDENTS OF WEST ETHIOPIA

Alemu Adeba,1*Dessalegn Tamiru1, Tefera Belachew1

ABSTRACT

Introduction: People are more likely to die due to biological impairment than chronological aging. Diabetes is a public health prob- lem, whereby diagnosing proves challenging for health providers. Likewise, the prevalence of undiagnosed diabetes in west Ethio- pia is unnoticed.

Aim: To investigate the magnitude and associated factors of undiagnosed diabetes mellitus among middle aged adult urban popu- lations in west Ethiopia.

Methods: A community based cross-sectional study was conducted from 01 March 2019 -August 2019 on 266 undiagnosed middle aged urban residents. Data was collected using questionnaires, anthropometric measurements, and biomarkers as per WHO steps. Fasting blood glucose ≥ 126mg/dl in the morning was taken as diabetes and FBS>100-125mg/dl, pre-diabetes (impaired FBS). SPSS version 24 multivariable logistic regression analysis was applied, and associated factors were considered statistically significant at 95%CI with p <0.05.

Results: The overall magnitude of newly diagnosed raised fasting blood sugar was 7.14% among urban residents in west Ethiopia. Of this, 2.25% was had diabetes and the remaining 4.89 % was pre-diabetes. Having a sleep disorder, sedentary lifestyle, increased: waist circumference, waist to height ratio, BMI, triglycerides, and blood pressure were significantly associated with elevated fasting blood glucose. On multivariable logistic analysis, having a high BMI and elevated blood pressure were four (AOR: 4.87; p=0.049), and five (AOR: 5.22; p=0.005) times more associated with diabetes mellitus, respectively. Sleep apnea (p=0.023) was also shown to have significant association with diabetes.

Conclusions: This study revealed undiagnosed diabetes was prevalent and associated to common risk factors in west Ethiopia. Therefore, age targeted community-based education and early detection are significant to reduce its burden.

Key words: Undiagnosed diabetes, risks, Middle aged, urban

INTRODUCTION

Diabetes Mellitus (DM) is one of the four major non- communicable diseases (NCDs) causing a high morbidity and mortality, globally. It is a metabolic disorder of multiple eti- ologies characterized by chronic hyperglycemia induced from defects of insulin secretion and action or both (1).

Long standing elevated blood glucose leads to micro and macro vascular complications (2) and becomes a serious health problem unless early screened (3). Complication from undiagnosed diabetes could lead to significant decline in quality of life (4) and have a higher risk for premature death

(5) unless prevented.

Globally, the magnitude of diabetes has been increasing among adults; According to International diabetes Federation Atlas report, as of 2017, there are451 million people living with diabetes, with projections as tall as 693 million by 2045

(6). Domestically, the prevalence of diabetes is higher in urban than rural areas (7).

In 2014, about 179.2 million people lived with undiagnosed DM worldwide with Africa having the highest percentage compared to other regions; about 62.3% of the people with the diseases do not know the effects, and about 13.4 million were undiagnosed (8; 9; 10).

In Ethiopia, the magnitude of diabetes mellitus is increasing. According to the WHO report, the number of cases docu- mented in 2000 (800,000), is rising and that it would hit an estimated 1.8 million by 2030(11, 12). Evidence from studies conducted in Ethiopia: in Gondar and Bahir Dar city were 2.3% and 10.2% individuals lived with undiagnosed DM, respectively (13, 14). Another study conducted in 2014 in Ethiopia showed, about 1,603,100 people (75.1% of popula- tion) were undiagnosed for diabetes mellitus (1, 15).

However, different factors, not quite understood by the com- munity, contributed to risk of diabetes development. Alt- hough undiagnosed diabetes is prevalent, it was not ad- dressed well in west Ethiopia. So far, nothing has been done at community level. Therefore, this study aims to investigate the magnitude and associated factors of undiagnosed diabetes among middle aged adult urban residents in west Ethiopia.

METHODS

Study design and setting:

Acommunity-based cross-sectional study was conducted purposively in the hub of western Ethiopian Town, Nekemte, which is located 328km from Addis Ababa. It is divided into

1*Department of Food and Nutritional sciences, Wollega University, Ethiopia

1,1Department of Nutrition and Dietetics, Faculty of Public Health, Jimma University, Ethiopia

6 sub cities administratively with an altitude ranging from 1960 to 2170 Meters above sea level. Its average annual rain- fall and temperature ranges are 1854.9mm and 14oc to 26oc, respectively. The total population of the city projection in 2017 was estimated to be 117,819, of which 51 % (60,088) of them were adults.

Study period: Study was conducted on 266 people in their mid -adulthood from 1March 2019-1 August 2019.

Sample size: The minimum sample size was calculated using single proportion formula, by taking the prevalence of ab- dominal obesity the most common component of metabolic syndrome with 19.6% among healthy Ethiopian adults (16). Hence with a margin of error of 5%, confidence level of 95%, and 10% gnawing away, we had minimum sample of 266 par- ticipants.

Sampling techniques: Within decision the appropriate sam- pling method was identified for specific area and study partici- pants. Accordingly, randomly one commune/kebele was select- ed by lottery method from six kebeles and one kebele not adja- cent to the other was selected purposively. Totally two kebeles were selected. Each study participants were selected through simple random sampling techniques.

Eligibility: Adults aged 40-65years who were eligible to par- ticipate in the study were asked to undergo diagnosis and re- spond questionnaires to be included in the study. While who were already on medication for NCDs, pregnant, lactating, serious mental conditions, bariatric surgery and physically dis- ables were excluded.

Measurements: Data was collected using structured self- administered questionnaire, and anthropometric measurements take of each participant. Fasting blood sugar (FBS) level was determined using samples taken early in the morning, with readings ≥126 mg/dLbeing classified as diabetes and 100- 125mg/dl, pre-diabetes. In addition, other biomarkers like cho- lesterol level and blood pressure other biomarkers like choles- terol level and blood pressure were also collected to assess common associated risk factors of diabetes.

64

Analysis: The data was analyzed using SPSS version 24 (IBM corporation, NY, USA). Frequency, percentage, and de- scriptive summaries were used to explain the amount of study participants in the analysis. Descriptive statistics was used to summarize and describe various sample characteristics as well as the association between high blood glucose and other risk factors. The binary regression computed the crude OR and vari- ables with p values less than 0.2 were entered into multivaria- ble logistic regression model to control potential confounding effects in the model. The strength of associations between inde- pendent and outcome variables was assessed using AOR with a 95% CI and p values ≤0.05 were considered statistically signifi- cant predictors of undiagnosed DM.

Ethical review and confidentiality:

Permission was sought from the Institutional Review Board (IRB), Institute of Health, Jimma University (Approval No.IHRPGD/596/2019) to conduct this study. The households willing to participate in the study signed consent form. Confi- dentiality of the respondents was ensured, and each household had its own identification number. Subjects were free to partici- pate in the study without any coercion.

RESULTS

Socio-demographic and lifestyle characteristics: Out of two hundred sixty-six undiagnosed participants, majority (62.8%) of them were females and more than half (54.89%) were living below poverty threshold (<1.25dollar/day). The average age of adults in our study was 52.2 years, with participants aged 41-48 years accounting for 54.5%.Regarding lifestyle, majority (75.2%) of them live a sedentary life, and about 40.6% have fragmented sleep types, 24.8% had history of alcohol intake, 1.1% are current khat chewers and 2.3% smoke cigarette. (Table 1).

65

Table 1 Socio-demographic and lifestyle characteristics of participants, west Ethiopia ,2019 (n=266)

 

 

Raised fasting blood sugar

 

Sex

Female

Present (%), n=19

Absent (%), n=247

12(4.51)

155(58.27)

 

Male

7(2.63)

92(34.59)

Age in years

Range from 41-48 years

10(3.7)

135(50.75)

 

Range from 49-56 years

5(1.8)

72(27.07)

 

Range from 57-64years

4(1.5)

140(52.63)

Educational status

Illiterate

5(1.89)

81(30.45)

 

Some school

10(3.78)

109(40.98)

 

Diploma

3(1.13)

30(11.28)

 

Degree and above

1(0.38)

27(10.15)

Marital status

Unmarried

1(0.38)

12(4.51)

 

Married

15(5.64)

163(61.28)

 

Widowed

2(0.75)

54(20.30)

 

Divorced

1(0.38)

18(6.77)

Daily income

≥1.25USD

10(3.78)

110(41.35)

 

<1.25UD

9(3.38)

137(51.50)

Physical activity

Low

18(6.77)

224(84.21)

 

Moderate >120<150M’/W

0

13(4.89)

 

Vigorous>15oM’/W /3days

1(0.38)

10(3.78)

Smoking

Current

0

6(2.26)

 

Former

2(0.75)

19(7.14)

 

Never

17(6.39)

222(83.46)

Alcohol consumption

Current

3(1.13)

23(8.65)

 

Former

4(1.5)

36(13.53)

 

Never

12(4.51)

188(70.68)

Chewing of chat

Current

0

3(1.13)

 

Former

2(0.75)

16(6.02)

 

Never

17(6.39)

228(85.71)

Healthy diet

Low DD score

13(4.89)

168(63.16)

 

Medium DD score

6(2.26)

70(26.32)

 

High DD score

0

9(3.38)

DM: diabetic mellitus, DD: dietary diversity, USD: US dollar,

Prevalence of undiagnosed Diabetes:

The prevalence of pre-diabetes (impaired fasting blood glu- cose) and diabetes of the participants was 4.89 % and 2.25 %, respectively (Table 2). Participants with elevated fasting blood sugar (FBS>126mg/dl) were linked to Wollega Univer- sity Specialized Hospital chronic care unit for further diagno- sis and follow up.

Table2. Description of fasting blood sugar by sex, west Ethiopia, 2019 (n=266)

 

 

Pre-diabetes

 

 

 

(%)

Diabetes (%)

Variables

Female

FBS >100-

FBS>126mg/

Sex

8(3.01)

4(1.5)

 

Male

5(1.88)

2(0.75)

Total

 

4.89

2.25

 

 

 

 

Factors associated with undiagnosed diabetes mellitus: From 266 participants, 7.14 % were newly diagnosed, of which the actual diabetes accounts for 2.25%. The magnitude of diabetes is shown to significantly be associated with sleep disorders, sedentary lifestyle, increased: waist circumference, waist to height ratio, BMI, blood pressure, TG and HDL on binary analysis. The multivariate logistic regression analysis showed that only sleep related problems, increased BMI and high blood pressure were independently associated with diabetes (Table 3).

The mean fasting blood glucose level was 99.7(29.60 mg/dl) with (95%CL: 96.12, 103.27; p<0.0001). The prevalence of diabetes significantly increased with high BMI (6%) when compared to participants with BMI <25 Kg/m2 (1.1%) by a factor of AOR: (4.87 (1.01, 23.45), P=0.048). More than half (69.3 %) of the study participants have central obesity (high waist circumference).

66

The prevalence of diabetes was shown to be higher in these participants (7.14 %) as compared to 0.8 % of the participants with normal/low waist circumference (AOR=1.61 (1.14, 18.53), P =0.702). However, it was shown not to be significantly asso- ciated (Table 3).

In addition, our study revealed those participants with sleep apnea had 3.5 (OR=41.37 CI= (1.02, 11.81, p=0.046) times higher chance of having diabetes than those with normal range of sleeping hours. Participants with sleep apnea AOR: (0.19 (0.05, 0.80), P=0.023) and elevated blood pressure >130/85mmHg AOR: (5.22 (1.67, 16.33), P=0.005) were sig- nificantly associated with undiagnosed DM (Table 3).

Table 3: Multivariate analysis to identify factors associated with undiagnosed diabetes among urban residents

 

 

Undiagnosed Diabetes

 

P-

 

 

Variable

Categories

Present (%

Absent (%)

COR (95% CI)

value

AOR (95% CI)

P-value

Sleep

Has apnea

4(1.5)

88(33.08)

3.47(1.02,11.81)

0.046

0.19(0.05,0.80)

0.023

 

Deprived <6hrs

6(2.26)

102(38.34)

2.68 (1.91,7.93)

0.074

0.35(0.10,1.18)

0.089

 

Normal(6-8hrs)

9(3.38)

57(21.43)

1

 

1

 

Sedentary life

Yes

12(4.51)

188(70.68)

1.84(1.70,4.94)

0.200

0.80(0.25,2.50)

0.697

 

No

7(2.63)

59(21.18)

1

 

1

 

WC (Male/

≥ 94cm/80cm

17(6.39)

139(52.26)

0.15(0.04,0.67)

0.013

1.61(1.14,18.53)

0.702

Female)

<94cm/80cm

2(0.75)

108(40.60)

1

 

1

 

Waist to ht. ratio

>0.49/0.50(M/F)

17(6.39)

148(55.64)

5.69(1.29,25.16)

0.022

1.99(1.19,20.88)

0.565

(M/F)

<0.49/0.50(M/F)

2(0.75)

99(37.22%)

1

 

1

 

BMI

≥25 kg/m2

16(6.02)

103(38.72)

0.14(0.04,0.47)

0.002

4.87(1.01,23.45)

0.049

 

<25 kg/m2

3(1.13)

144(54.14)

1

 

1

 

Elevated

≥135/85mmHg

10(3.78)

39(14.66)

0.17(0.07,0.44)

0.000

5.22(1.67,16.33)

0.005

BP

<135/85mmHg

9(3.38)

208(78.20)

1

 

1

 

Raised Triglycer-

≥150mg/dl

10(3.78)

44(16.54)

5.13(1.97,13.36)

0.001

1.27(0.34,4.80)

0.722

ides

<150mg/dl

9(3.38)

203(76.32)

1

 

1

 

HDL low in (mg/dl) <40 ,50 for M/F

8(3.01)

43(16.17)

3.45(1.31,9.09)

0.012

0.38(0.11,1.31)

0.123

 

>40 ,50 for M/F

11(4.14)

204(76.79)

1

 

1

 

DISCUSSION

The current magnitude of diabetes mellitus is 7.14%. This re- sult is slightly higher than the estimated Ethiopian prevalence of DM by IDFA (5.2%) (17). and studies conducted on some urban residents of Ethiopia like Gonder city (5.1%) (17), Des- sie Town (6.8%), (18),Mizan-Aman Town (6.5%) (19), and in Hosana, south Ethiopia (5.7%) (20).

Contrary to the above comparison, the magnitude of undiag- nosed diabetes is low when compared with a study conducted on 2013 on HIV/AIDS patients taking HAART in Ethiopia (8% )(21), whereas, in Jimma town 15% had Impaired Glucose Tolerances (12). Likewise, the prevalence of undiagnosed DM was lower than studies done in North India, Punjab (8.3%)

(22), Pakistan (26.3%)(23) , Bangladeshi (9.7%) (24) and pre- vious studies in African Countries( 25,26, 27,28,) This differ- ence might be due to variations in socio-demographic and life- style behavior factors. Different scholars agree that a sleep dis- order is highly associated with diabetes. For instance, diabetic patients often have a high prevalence of obstructive sleep apnea (OSA) (29). Clinical studies have shown an increase in serum glucose in patients with OSA, independent of obesity (30, 31). In this study, we observed an independent association (P=0.023) between high fasting blood glucose and sleep apnea.

CONCLUSIONS

The magnitude of undiagnosed diabetes mellitus among adult urban residents was found to be high. On multivariate analysis it was shown that having a high body mass index, sleep disor- der and elevated blood pressure were significantly associated

with diabetes mellitus. Therefore, age targeted community- based education on early detection and prevention of diabetes, as well as its complications are significant to save adult life.

67

ACKNOWLEDGEMENT

We thank Jimma University, participants, data collectors, Che- leleki health center, Wollega University specialized hospital, and Nekemte municipal for their cooperation for the study.

Competing Interest:

All the authors declare that they have neither financial nor non- financial competing interests.

REFERENCES

1.IDF. IDF diabetes atlas. International diabetes Federation; 2013.

2.Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indi an J EndocrinolMetab. 2016;20(4):546. doi:10.4103/2230-8210.183480

3.WHO. Global Status Report on Noncommunicable Diseases 2014. World Health Organization; 2014.

4.Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based stud- ies with 4.4 million participants. The Lancet 2016; 387:1513–30.

5.WHO. Global Report on Diabetes. World Health Organization; 2016.

6.Cho N, Shaw J, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for

2045. Diabetes Res ClinPract. 2018; 138:271–281. doi: 10.1016/j.diabres.2018.02.023.

7.Ogurtsova K, da Rocha Fernandes J, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res ClinPract. 2017; 128:40–50. doi:10.1016/j. diabres.2017.03.024

8.Hall V, Thomsen RW, Henriksen O, et al. Diabetes in sub-Saharan Africa 1999-2011: epidemiology and public health implica- tions. A systematic review. BMC Public Health 2011; 11:564.

9.Motala A, Ramaiya K. Diabetes: the hidden pandemic and its impact on sub- Saharan Africa Diabetes leadership forum; 2010.

10.Roglic G. Who global report on diabetes: a summary? Int J Non-Communicable Dis 2016; 1.

11.Tesfaye T, Shikur B, Shimels T, et al. Prevalence and factors associated with diabetes mellitus and impaired fasting glucose level among members of federal police Commission residing in Addis Ababa, Ethiopia. BMC EndocrDisord 2016; 16:68. 14.

12.YemaneT, Belachew T, Asaminew B, Befekadu O. Type II diabetes mellitus in Jimma Town, Southwest Ethiopia. Eth J Health Sci 2007;17(2).

13.Worede A, Alemu S, Gelaw YA, et al. The prevalence of impaired fasting glucose and undiagnosed diabetes mellitus and asso- ciated risk factors among adults living in a rural Koladiba town, Northwest Ethiopia. BMC Res Notes 2017; 10:251.

14.Bantie GM, Wondaye AA, Arike EB, et al. Prevalence of undiagnosed diabetes mellitus and associated factors among adult residents of Bahir Dar city, northwest Ethiopia: a community- based cross- sectional study. Bantie GM, et al. BMJ Open 2019;9: e030158. doi:10.1136/bmjopen-2019-030158.

15.Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res ClinPract. 2014;103 (2):150–160. doi: 10.1016/j.diabres.2013.11.001.

16.Tran A, GelayeB, GirmaB, et al. Prevalence of Metabolic Syndrome among Working Adults in Ethiopia. International J. Hyper- tension, 2011; 193719.

17.Atlas D. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.

18.Toyba Endris1 Abebaw Worede2 Daniel Asmelash. Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Stud. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019:12 2799–2809; https://www.dovepress.com/terms.

19.Aynalem SB, Zeleke AJ. Prevalence of Diabetes Mellitus and Its Risk Factors among Individuals Aged 15 Years and Above in Mizan-Aman Town, Southwest Ethiopia, 2016: A Cross Sectional Study. Int J Endocrinol. 2018 Apr 26; 2018:9317987. doi: 10.1155/2018/9317987. PMID: 29853887; PMCID: PMC5944196.

20.Dereje, N., Earsido, A., Temam, L. and Abebe, A., 2020. Prevalence and Associated Factors of Diabetes Mellitus in Hosanna Town, Southern Ethiopia. Annals of Global Health, 86(1), p.18. DOI: http://doi.org/10.5334/aogh.2663

21.Sachithanan than V, LohaE, Gose M. Prevalence of diabetes mellitus, hypertension and lipodystrophy in HAART receiving HIV patients in Southern Ethiopia. Internat STD Rese &Revi2013;1(1):1-11.

22.Jaya Prasad Tripathy, J. S. Thakur, GursimerJeet, Sohan Chawla, Sanjay Jain, Arnab Pal, Rajendra Prasad & Rajiv Sa- ran. Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabetology& Metabolic Syndrome volume 9, Article number: 8 (2017)

23.Basit A, Fawwad A, Qureshi H, et al. Prevalence of diabetes, pre-diabetes, and associated risk factors: second National Diabetes

Survey of Pakistan (NDSP), 2016–2017. BMJ Open 2018;8: e020961. doi:10.1136/ bmjopen-2017-020961

24.Akter, Shamima, Rahman, M Mizanur, Abe, Sarah Krull & Sultana, Papia. (2014). Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bulletin of the World Health Organization, 92 (3), 204-213A.

25.World Health Organization. http://dx.doi.org/10.2471/BLT.13.128371

26.Balde NM, Diallo I, Balde MD, Barry IS, Kaba L, Diallo MM, Kake A, Camara A, Bah D, Barry MM, Sangare-Bah M, and Maugendre D. Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and

68

associated risk factors. Diabetes Metab, 2007;33(2):11420.

27.Mbanya JC, Cruickshank JK, Forrester T, Balkau B, Ngogang JY, Riste L, Forhan A, Anderson NM, Bennett F, and Wilks R. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care, 1999;22(3):434-40.

28.Abebe SM, Berhane Y, Worku A andAssefa A. Diabetes mellitus in Northwest Ethiopia: a community-based study. BMC Pub- lic Health, 2014;14(97):1-8.

29.Nigatu T. Epidemiology, complications, and management of diabetes in Ethiopia: a systematic review. J Diabetes, 2012;4:174- 80.

30.Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing, and glucose metabolism in hypertensive men: a population- based study. J Intern Med 2001; 249 (2):153-61.

31.Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin re- sistance. Am J RespirCrit Care Med 2002; 165 (5): 670-6.

32.Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep disorder breathing and insuline resistance in middle-aged and overweight men. Am J RespirCrit Care Med 2002; 165(5): 677-82.

69

Syibrah Khuzaimah Zahid, Wan Muhamad Mokhzani, Ahmad Fardi Sulaiman, Wan Zainira Wan Zain, Siti Zarqah Omar. Ethiop Med J, 2022, Vol. 60, No. 1

CASE REPORT

A RARE CASE OF INTESTINAL OBSTRUCTION SECONDARY TO METASTASIS

DERMATOFIBROSARCOMA PROTUBERANS

Syibrah Khuzaimah Zahid1,2,3, Wan Muhamad Mokhzani1,2, Ahmad Fardi Sulaiman3, Wan Zainira Wan Zain1,2, Siti Zarqah

Omar4

ABSTRACT

Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue sarcoma, which arises from the dermis. It behaves as a low to intermediate-grade malignancy, is locally aggressive, and frequently has local recurrence but rarely metastasize. The most common organ of metastasis reported is the lungs. Here we present a rare case of metastasis dermatofibrosarcoma protuberans (DFSP) that presents with intra-abdominal mass causing intestinal obstruction. Exploratory laparotomy and en-bloc resection of the tumor were done followed by adjuvant chemotherapy.

Keywords: Dermatofibrosarcoma protuberans, Metastasis, Intestinal obstruction

INTRODUCTION

Dermatofibrosarcoma protuberans is a rare slow- growing fibrohistiocytic, intermediate-to low-grade malignancy. It accounts for approximately 0.1% from all cancers and 1-6% of soft tissue sarcoma (1-3). It usually occurs in young to middle-aged individuals and commonly affects trunk, proximal extremities, head, and neck (1,4). Most cases present with slow- growing bluish or brownish erythematous skin nod- ules. It could also present as a keloid scar (1,5). DFSP typically arises in the dermis, has indolent growth but could be locally aggressive as it spreads into the sub- cutaneous tissue and muscles (1,2). It rarely has dis- tant metastasis with the lung the most common site of metastasis. Intra-abdominal metastasis is rare (1,2,4,5). Treatment for DFSP is either wide local excision or Mohs surgery. It frequently recurs locally in cases of incomplete excision with a recurrence rate of up to 53% being reported (5,6).

Clinical presentation

We report a 41-year-old female with a previous histo- ry of dermatofibrosarcoma protuberans of the left shoulder 1 year before the current presentation. Her initial presentation was a mass over the left shoulder progressively increasing in size over 4 months with core biopsy consistent with DFSP. There were no dis- tant metastases on imaging. She underwent wide local excision of the tumor and histopathology reported tumor margin of less than 3 cm. Adjuvant radiothera- py was planned but she defaulted due to logistic rea- sons. Her current presentation is an intestinal

obstruction for 3 days in December 2018. Exami- nation revealed intra-abdominal mass measuring 15 cm x 15 cm over the left flank. The prior surgi- cal wound over the left shoulder was well-healed with no evidence of local recurrence. Abdominal x -ray showed dilated proximal small bowel.

Contrast-enhanced CT thorax, abdomen, and pel- vis showed a well-defined intra-abdominal mass measuring 15x 17x 20 cm causing intestinal ob- struction and evidence of lung metastasis (Figure A and B). She subsequently underwent laparotomy and tumor debulking. Intraoperative findings showed a multilobulated soft tissue tumor measur- ing 20cm x 20cm along the mesenteric plane with extension into the retroperitoneum. Complete exci- sion of the tumor was achieved. The tumor dis- placed the descending colon and retroperitoneal structure medially and caused external compres- sion on the small bowel. The intestine and its asso- ciated vascular trunks were preserved.

Histopathological examination of the tumour showed a fairly circumscribed and unencapsulated tumour composed of fibroblastic spindle-shaped cells arranged in a herringbone pattern, with a mi- totic index of 6/10 HPF. Immunostaining was posi- tive for CD 34 (Figure E, F, and G). The histo- pathology assessment was consistent with meta- static high-grade fibrosarcoma.

Post-surgery she was started with intravenous chemotherapy ifosfamide and doxorubicin for 4 cycles. Her condition did not improve post chemo- therapy and she developed tumor recurrence.

1 Department of Surgery, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia 2 Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

3 Department of Surgery, Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia

4 Department of Pathology, Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia * Corresponding author e-mail address: [email protected]

70

Subsequent CT scan showed a recurrent left intra- abdominal mass measuring 5cm x 7cm x 5cm (Figure C and D). Managed as recurrent metastatic intra- abdominal DFSP, she was planned for second line chemotherapy with gemcitabine and docetaxel. Her condition continued to deteriorate due to disease pro- gression. She was not able to undergo the second line chemotherapy and subsequently succumbed to disease progression.

Figure E: Spindle tumor cells arrange in Herring

Bone pattern adjacent necrosis (arrow).

Figure A

Figure B

Figure F: The spindle tumor cells are pleomorphic having hyperchromatic nuclei with presence of mitosis, mitotic index of 6/10 HPF(arrow)

Figure C

Figure G: CD34 immunostain highlights the tumor cells in brown colour.

Figure D

Figure A & B: showed heterogenous intra-abdominal mass occupying over the lower left side of the abdomen, that possible arising from proximal jejunum or descending colon.

Figure C & D: Repeated CT showed a recurrent new lesion of intra-abdominal mass over the left side abdo- men, possibly the location near the previous lesion. The lesion was smaller in size compared to the previous.

DISCUSSION

Dermatofibrosarcoma protuberans (DFSP) is a mes- enchymal neoplasm that typically involves both der- mis and subcutaneous tissue (1,7). It commonly oc- curs in the trunk followed by the extremities, head, and neck (3,5). The lesion is usually painless, has in- dolent growth but is locally invasive with invasion into the underlying fascia, muscles, or bones (1,4,7). Even though this tumour is aggressive locally, distant metastasis is not common with less than 5% reported cases in the literature (6). It has hematogenous spread, typically to the lungs. Cases of metastases to the retro- peritoneum, mediastinum, bones, the kidney, brain, omentum, scalp, ovaries, liver, and heart have been reported (4,8).

It is difficult to diagnose DFSP since the early clinical symptoms are non-specific, it is slow growing and mimics another non-malignant tumour such as dermatofibroma. Dermatofibroma appears similar clinically and is distinguished from DFSP by the ab- sence of extension to deeper structure and the size of the lesion (3,5). The standard diagnosis of DFSP is by tissue biopsy with histopathological and immunohisto- chemical assessment. Imaging is for the assessment of extension to the deeper and surrounding structures as well as for operative planning. Computed tomography and MRI are both acceptable options, but MRI pro- vides a better assessment of the tissue infiltration and depth of involvement. It is also useful for preoperative and post-operative evaluation (5).

The histological features in DFSP are characterized by spindled cells arranged in a distinct herringbone or storiform pattern and immunohistochemical staining positive for CD-34 (1,2,4,7). There are several histo- logical variants of DFSP that have been described including myxoid, pigmented, atrophic, giant cell fi- broblastoma (GCF), and DFSP with fibrosarcomatous change (5). Dermatofibrosarcoma protuberans with fibrosarcomatous areas (DFSP-FS) is recognized as a high-grade type of variant, with higher rates of local recurrence and potential for distant metastasis. This case presentation is most consistent with the DFSP-FS subtype (2). The diagnosis of DFSP-FS is based on Enzinger and Weiss’s criteria. It includes the

71

presence of fibrosarcomatous changes of more than 5 mitoses/10 HPF, fascicular growth pattern, increased cellularity, and atypia in at least 5% of the tumor tissue (9).

The standard treatment for DFSP is wide local excision with a margin of more than 3 cm. The alternative approach includes Mohs micrographic surgery (MMS) which requires immediate micro- scopic examination of the margins in order to en- sure a tumor-free margin (1,3,5,7). The recurrence rate associated with MMS is less than 2% with no reports of distant metastasis (2,10).

MMS applies systematic horizontal sectioning compared to the traditional method which applies vertical sections which only assess limited tumor margin. In MMS, all sides of tumour are assessed using a frozen section which allows for a complete evaluation of tumour margins (11).

DFSP is a radiosensitive tumour and indication for radiotherapy includes the margin-positive tumour, unresectable tumour, or recurrent tumour (5). Ty- rosine kinase inhibitor such as Imatinib, Sunitinib, and Sorafenib has been shown to induce regression of DFSP and has been applied clinically in recur- rent, metastatic, or advanced diseases (5,7). The response rate of tyrosine kinase inhibitor in this clinical scenario of distant intra-abdominal metas- tasis is unknown as the efficacy of tyrosine kinase inhibitor in DFSP is only proven in the adjuvant setting after resection of primary high-risk tumors (12). Conventional chemotherapy has a limited role in the treatment of DFSP and is associated with poor response rates and clinical outcomes (5). Doxorubicin and ifosfamide for five or six cycles are the common regimes that are applicable in DFSP (5). In regards to this case, it is one of the rare cases of aggressive DFSP-FS that presents with intestinal obstruction due to intra-abdominal DFSP-FS metastasis. We, therefore, advocate a close follow-up protocol in all cases of DFSP which not only leads to a higher rate of compliance to adjuvant treatment but also provides a platform for early detection of possible tumor recurrence.

REFERENCES

1.Chan IL, Carneiro S, Menezes M, Ramos-e-Silva S. Dermatofibrosarcoma protuberans: A case report. Case

Rep. Dermatol.2014 May; 6(2): 134–139.

2.Soleymani T, Ni C, Laury A, Wu JJ. Massively Metastatic Dermatofibrosarcoma Protuberans With Fibrosar- comatous Transformation Years After Surgical Resection. Dermatol Surg [Internet]. 2018 Feb;44(2):315-318. Available from doi: 10.1097/DSS.0000000000001223.

72

3.Lyu A, Wang Q. Dermatofibrosarcoma protuberans: A clinical analysis. Oncol Lett [Internet]. 2018 May;16 (2):1855-1862. Available from doi:10.3892/ol.2018.8802.

4.Ta R, Banerjee S. Dermatofibrosarcoma protuberans: A rare presentation with lung and abdominal metastasis.

Med. J. Dr. D.Y. Patil Univ. 2016 Sept; 8(5): 663.

5.Reha J, Katz SC. Dermatofibrosarcoma Protuberans. Surg Clin North Am [Internet]. 2016 Oct;96(5):1031-46. Available from doi: 10.1016/j.suc.2016.05.006.

6.Zorlu F, Yildiz F, Ertoy D, Atahan IL., Erden E. Dermatofibrosarcoma protuberans metastasizing to cavernous sinuses and lungs: A case report. Jpn. J. Clin. Onco l[Internet].2001; 31(11):557–561. Available from https:// doi.org/10.1093/jjco/hye117.

7.Andee Zulkarnain Z, Kok Kwong J,Guan CL, Thangaratnam R, Krishnan N. Two Cases of Dermatofibrosar- coma Protuberans. Int. J. Case Rep. Med [Internet]. 2013 March; 2013: 1–7. Available from doi: 10.5171/2013.813114.

8.Kreze, A. et al. Metastasis of dermatofibrosarcoma from the abdominal wall to the thyroid gland: Case report.

Case Rep. Med [Internet]. 2012; 2012: 1–5 . Available from doi: 10.1155/2012/659654.

9.Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant me- tastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol [Internet]. 2016 Sep;17(3):261-266. Availa- ble from doi: 10.1007/s10195-016-0415-x.

10.Foroozan M, Sei JF, Amini M, Beauchet A, Saiag P. Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review. Arch Dermatol [Internet]. 2012 Sep;148(9):1055- 1063. Available from doi: 10.1001/archdermatol.2012.1440.

11.Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the litera- ture. Cancer [Internet]. 2004 Jul 1;101(1):28-38. Available from doi: 10.1002/cncr.20316.

12.Koseła-Paterczyk H, Rutkowski P. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas. Expert Rev Anticancer Ther [Internet]. 2017 Dec;17 (12):1107-1116. Available from doi: 10.1080/14737140.2017.1390431.

73

Ajayi Aal , Babalola Oe , Ethiop Med J, 2022, Vol. 60, No. 1

CASE REPORT

PERSISTENT HICCUPS IN MEN WITH COVID 19: TWO CASES FROM NIGERIA

Ajayi Aal , MD,MPH 1, Babalola Oe 2

ABSTRACT

Hiccups are defined as extraordinary type of respiratory movement involving a sudden inspiration (intake of air) due to an involuntary contraction of the diaphragm accompanied by closure of the glottis (the vocal apparatus of the larynx). The abrupt inspiration is the result of a sudden contraction of the diaphragm. The classification of hiccups is by their duration. Acute hiccups are of less than 48 hours duration, persistent last over 2 days, and in- tractable last over a month.

It is a rare but distinct chemosensory presentation of COVID 19 disease and seldomly reported from Africa. We report 2 cases of persistent hiccups in Nigerian men with RT-PCR positive cases of mild COVID-19 disease. Both men (aged 59, 63 years) had associated fever, anosmia and ageusia, with hiccups onset 2-4 days after COVID- 19 diagnosis, and in one case it persisted for 10 days, including for 3 days after SARS-CoV-2 negativity.

Keywords: Hiccups, COVID-19 signs, Nigeria, SARS-CoV-2

INTRODUCTION

Hiccups (singultus) are generated by a reflex arc with phrenic (C3-C5), Vagus and intercostal sympathetic afferents ( T6- T12) with central integration at spinal cord C3-C5, and medulla oblongata Dopaminergic neurons, close to the respiratory center and reticular formation, causing efferent phrenic (C3-C5) motor diaphragmatic contractions 1. Here we report on two cases of Hiccups seen in COVID-19 patients in Abuja, Nigeria.

Case 1: A 59-year-old man with fever ( 38oC), head- ache, cough, dyspnea seen at the Gwagwalada -Abuja quarantine center, who later tested positive for Corona virus disease (COVID -19 )by Reverse transcriptase polymerase chain reaction (Rt-PCR) after 3 days of mild illness based on the Sp02 criteria. The RT -PCR test was undertaken at National Center for Disease Control (NCDC) National Reference Laboratory, Gaduwa, Abuja. Hiccups onset was on the 4th day of SARS-CoV-2 positivity, the frequency was roughly 20/minute and lasting a total of 10 days. The hiccups was associated with anosmia/ageusia, anorexia , in- somnia, and exacerbated by eating or drinking. The patient received azithromycin, zinc, vitamin D initial- ly . Ivermectin 12mg daily for 5 days was later add- ed, starting after the 2nd day of PCR positive test, af- ter which remarkable clinical improvement occurred, but the hiccups persisted. This constitutes standard of care in Nigeria. The pulse oximetry ( SpO2% ) was initially 97 and serum creatinine ( 1.1 mg/dl ) and hepatic enzymes were normal .Chlorpromazine 50mg- daily for 3 days was administered to treat

the hiccups, but it did not exert any benefit. Patient was not tried on Metoclopramide. Four days after ivermectin dosing commenced, the patient tested negative to SARS-CoV-2 by repeat RT-PCR. He was afebrile, and with SP02% of 99, but the hic- cups continued until 3 days after his SARS-CoV-2 PCR negativity. After stoppage of his treatment (he was on ivermectin for five days) and viral clearance at home, his residual symptoms were arthralgia, myalgia and forgetfulness. ( Table 1)

Table 1. Table of Laboratory results with reference values.

Case 1

Lab Parameter

Finding

Reference

values

 

SpO2%

97%

 

 

 

 

 

 

Serum creatinine

1.1 mg/dl

 

 

 

 

 

 

Liver enzymes

 

 

 

ALT

34 i.u./l

15-45 i.u/l

 

Alanine

 

 

 

Aminotransferase

 

 

 

AST

29i.u.

15-42i.u./l

 

Aspartate

 

 

 

Transaminase

 

 

 

Serum Creatinine

93

70-110 umol/l

 

 

 

 

 

Serum Albumin

42

35-50g/l

 

 

 

 

 

Globulin

27g/l

20-40 g/l

 

Platelet count

215 x109/l

100-400 x 109/l

 

 

 

 

1.Division of Hypertension and Clinical Pharmacology, Keck Department of Medicine, Baylor College of Medicine, 1 Bay- lor Drive Houston, Texas TX 77030. USA

2.IVERCOVID Research Group, Rachel Eye Center, Abuja FCT, and Binghampton University, Jos Nigeria.

* Corresponding Author: E-mail: [email protected]

Case 2. A 63-year-old man with hiccups of more than

4days duration, with onset after RT-PCR SARS-CoV -2 positivity. He had mild COVID- 19, with fever, cough anosmia/ageusia. The hiccups frequency was about 1-5 /minute and caused insomnia. He received Vitamin D, azithromycin, Vitamin C but was yet to receive ivermectin, which was not preferred by the attending physician. He self-discharged against medi- cal advice without conversion and was lost to follow up. He promised to seek medical treatment elsewhere. Both cases were seen between December 2020 and February 2021.

DISCUSSION

Persistent hiccups (> 48 hours) has recently been re- ported atypically in COVID-19 patients 2, 3,4,5. In the case reported by Prince et al2 , hiccups was in fact the only presenting symptom. Only a routine X-ray and CT scan showed typical ground glass opacities in the lungs. This suggests that hiccups can be the first pre- senting sign, and clinicians in the COVID 19 era must have a high index of suspicion in that regard. In the case reported by Bakheet et al, the patient also had fever and sore throat as part of the presenting symp- toms. Equally, CT scans revealed typical ground glass appearance and a bloated abdomen. There was no case of hiccups in patients recruited to our recent con- trolled study of ivermectin in COVID-19 patients seen from May to November in Lagos, Nigeria6.

74

Although, racial differences in chemosensory symp- toms of COVID-19 are reported globally7, our new cases which are the first to be published in black Africans, indicate that persistent hiccups is a differ- ential diagnostic symptom for COVID-19 in Nigeri- ans. Both cases were men, aged about 60 years, with hiccups onset after SARS-CoV-2 positivity. Both had fever, cough and associated anosmia/ ageusia with hiccups, indicative of SARS-CoV-2 neurotropism and chemosensory loss. One patient had normal biochemical hepatic and renal functions with persistent and frequent hiccups lasting 10 days, but with no major arterial hypoxemia. His SPO2% was 99 on recovery at home. Significantly, he re- gained smell and taste sense before , but his hiccups continued for 3 days after SARS-CoV-2 RT- PCR negativity, and he had residual symptoms of ar- thralgia, myalgia, and amnesia

Since hiccups was not reported in the initial wave of COVID -19, It is not clear if this symptom is SARS -CoV-2-variant-dependent.

CONCLUSION

Persistent hiccups should be sought as COVID-19 chemosensory symptom, in patients suspected of COVID-19 in the tropics, and older men may be more susceptible.

REFERENCE

1.Stenger M, Schneemann M, Fox M. Systematic Review : the pathogenesis and pharmacological treat-

ment of hiccups. Aliment Pharmacol Ther 2015, 42 (9) : 1037-50.

2.Prince G, Sergel M. Persistent hiccups as an atypical presenting complaint of COVID-19. Am J Emerg Med 2020, 38(7) : 1546 e5 – 1546 e6. Doi. 10.1016/ajem. 2020.04.045.

3.Bakheet N, Fouad R, Kassem AM, Hussin W, El- Shazly M. Persistent hiccup : A rare presentation of

COVID -19. Respir Investig 2020 doi : 10. 1016/j.resinv.2020. 11.003

4.Ali SK, Muturi D, Sharma K. Be Wary of Hiccups: An Unusual Case of COVID-19. Cureus. 2021 Jan

28;13(1):e12974. doi: 10.7759/cureus.12974. PMID: 33654635; PMCID: PMC7914000.

5.Alvarez-Cisneros, T., Lara-Reyes, A. & Sansón-Tinoco, S. Hiccups and psychosis: two atypical presenta- tions of COVID-19. Int J Emerg Med 14, 8 (2021). https://doi.org/10.1186/s12245-021-00333-0

6.Babalola OE, Bode CO, Ajayi AA, Alakaloko FM, Akase IE, Otrofanowei E et al. Ivermectin shows clin- ical benefits in mild to moderate COVID 19: A randomized controlled double blind, dose response study in Lagos. QJM: An International Journal of Medicine 2021. doi.https//doi.org/10.1093/qjmed/hcab035

7.Von Bartheld CS, Hagen MM, Butowt R. Prevalence of Chemosensory Dysfunction in COVID-19 pa- tients : A systematic review and meta-analysis reveals significant ethnic differences. ACS Chem Neuro- sci 2020, 11(19) : 2944-2961.

75

Yonas Ademe, Abebe Bekele Ethiop Med J, 2022, Vol. 60 No. 1

BRIEF COMMUNICATION

E-LEARNING IN SURGICAL EDUCATION: EXPERIENCE FROM THE DEPART-

MENT OF SURGERY, ADDIS ABABA UNIVERSITY

Yonas Ademe*1, Abebe Bekele 2

ABSTRACT

Background: E-learning, or electronic learning, is the delivery of learning and training through digital resources. The department of Surgery, School of Medicine, Addis Ababa University, has recently been using digital E- learning strategies to supplement traditional methods of clinical teaching. This study was conducted to assess our clinical medical students' opinions, interests, and access to e-learning strategies.

Methods: This was a cross-sectional study conducted on 171 clinical year 1 and 2 medical students between June 1 and 15, 2021. Data were collected anonymously by an online survey method using a 15-item structured question- naire. Data were analyzed using nonparametric statistical methods with the help of SPSS software package 26. Results: Most, 162 (95%) medical students confirmed e-learning methods as very helpful and informative. A sig- nificant proportion, 147 (89.1%) of the students participating in the survey own a personal computer and the ma- jority, 142 (83.1%) have basic ICT (Information, Communication, and Technology) skills. However, 57 (33.3%) of the respondents reported not having free Internet access on their personal computers.

Conclusions: The results of our survey showed that most medical students are very interested in E-learning as one modality of teaching and learning. Most students have personal computers at their disposal and have the skill set to use these devices. However, not all of them have access to free and fast Internet service.

Keywords: E-learning, surgical education, Case-Based Collaborative Learning

INTRODUCTION

METHODS

 

E-learning is a type of education where students com- municate with teachers and other students via e-mail, electronic forum, videoconferencing, chat rooms, bul- letin boards, and other computer-based communica- tion. (1) Dichtanz points to the time and space compo- nent of E-learning and emphasizes that E-learning is a collection of teaching and information packages in further education that is available at any time and any place and is delivered to learners electronically. (2) For Chang E-learning is an umbrella concept which comprises almost anything related to learning in com- bination with information and communication tech- nology. (3)Distance learning evolution can be classi- fied into three generations: The first was "textual", based on printed text only and supported by regular correspondence and mail. The process was known as "education at a distance", "correspondence study" or "correspondence education". The second was "analogical". ". Besides printed texts, the phone, fax, radio-television teaching was used too. Both textual and analogical distance learning models were used mostly in situations when schools were too far away when there were no schools, or simply when adequate teachers couldn't be found.

The third generation of distance learning is called "digital". As information technology is rapidly developing, teaching and learning materials are digitized and stored in databases and repositories. Due to the usage of modern ICT, a collaboration of participants involved in the learning process is highly facilitated. The progression of the Internet has set the ground for the rapid development of distance learning based on the Web. (4) In Ethio- pia, the first two generations of E-learning have been used for several decades by several institu- tions. But, with the widespread availability of ICT services in the country and the recent COVID-19 pandemic, the third generation of E-learning is becoming very relevant. (5,6)The following are some of the advantages of E-learning over tradi- tional learning. Digitalization, ICT, and Internet technologies open up new possibilities in creating and implementing the teaching process. Digitaliza- tion of teaching and learning materials ensures the availability of vast information, easy manipulation of contents, offers the possibility of real-time up- date and exchange,

*Addis Ababa University, College of Health Sciences, School of Medicine, Department of Surgery *Correspondence Email: [email protected]

and it also allows for recording of lessons for possible repetition in the future. Additionally, E-learning al- lows easy communication between the teacher and students that overcome distance in space. This is espe- cially an important advantage in the current era of COVID-19 where we have to maintain social distanc- ing. The Internet is offering new forms of communica- tion most similar to face-to-face communication such as communication via multipoint videoconference. (1) E-learning has gained increased momentum during the COVID-19 era where traditional classroom teaching was universally interrupted in fear of the spread of the virus. A few weeks after the first case was reported in Ethiopia, most schools, including medical schools, resorted to E-learning strategies to help continue the teaching-learning process where students could attend lectures, seminars, and case discussions from distance. In this regard, the Addis Ababa University, College of Health Sciences adopted the "Lecturio" and "ScholarRx" digital comprehensive E-learning re- sources. Some departments in the school have also taken the initiative to provide internet-based lectures and discussion sessions to supplement the traditional form of teaching during this pandemic using interac- tive software such as "Zoom" and "Google Meet".

Our department of Surgery has been using digital E- learning strategies to supplement traditional courses (i.e., traditional classroom lectures and face-to-face patient-based practical clinical teaching) for both un- dergraduate and postgraduate programs over the one year after COVID-19. Honorary and full-time faculty members from abroad also took this opportunity to help in the teaching-learning process by preparing CBCLs sessions (Case-Based Collaborative Learning) and lectures. And we've observed that the students have been benefiting a lot from these sessions and

lectures. .However, it was also observed that students did not benefit to the best of what the E-learning can offer. Our first hypothesis was built on information gathered from informal conversations with students. We've hypothesized that some of the challenges were from the teaching stuff but most appear to originate from the lack of enough digital equipment for the stu- dents. Lack of access to a fast and reliable Internet service has also been identified as another potential obstacle. To this end, we've prepared an online survey and collected data from the students to assess if the students own ICT equipment necessary for E-learning or have access to it and more importantly if the stu- dents accept E-learning as a new form of learning. We hoped this would provide us with some information on how to expand the E-learning service in our depart- ment particularly and our school in general.

76

OBJECTIVES

∙ To see how interested the students are in E- learning as a possible form of learning.

∙ To assess if students own personal computers and have free internet access necessary for E- learning.

∙ To examine students' opinions on the current E-learning strategies being utilized at our de- partment.

METHODOLOGY

This was a cross-sectional study conducted be- tween June 1 and 15, 2021 on clinical year 1 and 2 medical students enrolled at Addis Ababa Univer- sity, College of Health Sciences, School of Medi- cine. The respondents were a subset of clinical medical students who received supplementary E- learning-based lectures and practical clinical ses- sions during their surgical rotations. The survey was conveniently sent online to 200 students and a total of 171 respondents completed and submitted the online survey, yielding an 85.5 percent re- sponse rate. Incomplete questionnaires with miss- ing data were discarded. All data from participants were kept confidential by maintaining the study subjects' anonymity and written informed consent was collected before administering the data collec- tion tool. Written ethical clearance letters were obtained from the departmental research and ethics committee.

Google forms (Google's web-based software) was used to collect data anonymously, using a 15-items structured questionnaire. The data collection tool was pretested on an initial sample of ten medical students. The findings and observations obtained were used to modify the initial questionnaire and the data collection process accordingly.Data were analyzed using SPSS software package 26. De- scriptive statistics formed the mainstay of the sta- tistical analysis. Accordingly, frequencies of varia- bles were analyzed using counts and percentages.

RESULTS

We had a total of 171 respondents, age range from 21 to 27 years, and 87 (50.9%) were males. Results of the survey regarding the questions Do you own a computer? (yes/no) showed that 147 (89.1%) of the students participating in the survey own a com- puter and among those 114 (77%) have free Inter- net access on their PC.

Sixty-five (57.1%) of them have access to the internet at the school of medicine premises only, 12 (10.5%) only at their home, and only 36 (32.3%) have access to the internet both at the school of medicine and at their home. The majority (56.3%) of students admit they have difficulties with streaming online videos with the speed of the Internet that they get.

We then asked if the students have basic ICT skills such as browsing through the web confidently. One hundred forty-two (83.1%) students reported they have these basic skills. We found that 167 (97.9%) students have attended at least one E-learning session during their medical training. In addition, 162 (95%) of them confirmed they're very interested to pursue more E-learning sessions since they are very helpful and informative. We also wanted to know which form of E-learning they were more interested in (E-learning as a substitute to a traditional course or as a supple- ment to a traditional course). The majority 122 (75.8%) would prefer E-learning as a supplement to the traditional form of learning (see table 1).

Table 1: Students’ interest in E-learning, medical students of Addis Ababa University, 2021

Form of E-learning

Number

Percentage

 

 

 

Supplement to the

122

75.8

traditional form

 

 

 

 

 

Substitute to the

40

24.2

traditional form

 

 

 

 

 

Total

162

100

 

 

 

When asked about the presumed benefits of E- learning, the following were reported: ease of access to information, the possibility of repetition of lessons when necessary, and E-learning as a means of pre- venting the spread of COVID-19 were reported by the students to be the top three advantages of E-learning.

Many recognized E-learning as an advantage for peo- ple with restricted mobility (see table 2).

77

Table 2: Advantages of E-learning, medical stu- dents of Addis Ababa University, 2021

Advantages of

Number of

Percentage

E-learning

students

 

 

 

 

Learning from own

130

76

home

 

 

Everything in the

87

50.9

same place

 

 

Easy access to in-

150

87.7

formation

 

 

Freedom in choos-

118

69

ing teaching mate-

 

 

rials

 

 

Possibility of repe-

147

86

tition if necessary

 

 

Favorable for peo-

107

62.6

ple with restricted

 

 

mobility

 

 

Means of prevent-

131

76.6

ing COVID-19

 

 

 

 

 

Other advantages

3

1.8

 

 

 

The biggest drawback of E-learning was identified to be the cost of the internet followed by a lack of physical interaction with teachers. Students also have concerns about the side effects of working long hours on computers (see table 3).

Table 3: Disadvantages of E-learning, medical students of Addis Ababa University, 2021

Disadvantages of

Number of

Percent-

E-learning

students

age

No compulsion for

62

36.5

learning

 

 

No physical interaction

96

57.6

with teachers

 

 

No physical interaction

36

21.2

with fellow students

 

 

Side effects of working

80

47.1

long hours on comput-

 

 

ers

 

 

Cost of internet

102

60

 

 

 

Other disadvantages

16

9.4

 

 

 

As a prototype model, the department of surgery has been conducting a series of case-based collab- orative learning (CBCL) for its clinical students on a one-session per week basis for the past 5 months.

.Ninety-nine out of 171 of our respondents reported they have participated in at least one of these sessions, of which seventy (70.7%) reported that the sessions were very helpful to them, 12 (12%) students reported they would rather have a traditional session with the teacher, and 17 (17.3%) students had no opinion about the sessions. Eighty-four (85.2%) said they would recommend such sessions to be continued to their fel- low students.

DISCUSSION

The results of our survey showed that most medical students are very interested in E-learning as one mo- dality of teaching and learning. Most students have personal computers at their disposal and have the skill set to use these devices. However, not all of them have access to free and fast Internet service. Our students are very aware of the many advantages of E-learning but identified the cost of the Internet as a major disad- vantage. Most of the students who attended CBCL interactive sessions were very happy with the sessions and recommend similar sessions to their fellow stu- dents. Based on our experience, we strongly recom- mend that the department of surgery and the school of medicine integrate E-learning into its pedagogical strategy. Free/cheap and strong internet should be made universally accessible to all students to support advanced learning. Continuous skills development training should also be provided to students.

78

We believe this study will be of significant im- portance in providing basic information regarding the utilization of E-learning as a supplementary, if not an alternative, teaching method in clinical medical education. However, the study does not provide an in-depth analysis on the issue and there is also a possibility of a lack of genuine data from respondents on the account of fear of breach in confidentiality. With these limitations in mind, we recommend further, larger-scale studies on the subject matter.

ACKNOWLEDGMENTS

The authors would like to thank the faculty of the Department of Surgery, School of Medicine, Col- lege of Health Sciences, Addis Ababa University for actively utilizing E-learning platforms to sup- plement traditional clinical teaching. We would also like to thank the study participants for their participation in the study

Competing interests

The authors declare that they have no conflicts of interest.

Abbreviations

PC: Personal Computer

ICT: Information Communications Technology

CBCL: Case-Based Collaborative Learning

REFERENCES

1.Zeljka Pojkaj, Blazenka Knezevic. E-Learning: Survey on Students' Opinions. Proceedings of the ITI 29th Int. Conf. on Information Technology Interfaces. 2007. p.22-27.

2.Rekkedal, T., Quist-Eriksen S. Internet Based E-learning, Pedagogy and Support Systems. 2002.

3.Chung Q. B. Sage on the Stage in the Digital Age: The Role of Online Lecture in Distance learning. The Electronic Journal of e-Learning. 2005. Volume 3 Issue 1, p. 1-4.

4.4.Požgaj, Ž. Distance learning – reality or vision, Proceedings of 15th International Convention MIPRO, Opatija. 2002. p.19-24.

5. .Kelly CM, Vins H, Spicer JO, Mengistu BS, Wilson DR, Derbew M, et al. The rapid scale up of medical education in Ethiopia: Medical student experiences and the role of e-learning at Addis Ababa University. PLoS One. 2019. Sep 5;14(9):e0221989.

6.6. Hagos, Y. and Negash, S. The adoption of e-learning systems in low income countries: The case of Ethiopia. International Journal for Innovation Education and Research. 2014. 2(10), 79-84.

79

EDITORIAL POLICY

FOCUS AND SCOPE

The Ethiopian Medical Journal (EMJ) is the official Journal of the Ethiopian Medical Association (EMA) and de- voted to the advancement and dissemination of knowledge pertaining to the broad field of medicine in Ethiopia and other developing countries. EMJ is an open access, double blind peer-reviewed medical journal publishing scientifically valued and influential research outputs in the area of clinical medicine, conventional modern medi- cine, biomedical research, Preventive medicine, traditional medicine, and other related researches in the broad area of Medicine. Prospective contributors to the Journal should take note of the instructions of Manuscript preparation and submission to EMJ which is available on the journal website.

OVERVIEW

Ethiopia’s oldest medical journal, The Ethiopian Medical Journal (EMJ) is the official organ of the Ethiopian Med- ical Association (EMA). The EMJ is devoted to the advancement and dissemination of knowledge pertaining to the broad field of medicine in Ethiopia and other developing countries. The journal first appeared in July 1962 and has been published quarterly (January, April, July, October) without interruption ever since. It has been published in both online (eISSN 2415-2420) (www.emjema.org) and hard copy (ISSN0014-1755) versions. The EMJ continues

to play an important role in documenting and disseminating the progress of medical sciences, and in providing evidence for health policy and clinical practice in Ethiopia and Africa at large. Our online journal is open access. Hard copies of the issues of the journal are distributed to institutions and organizations (national and international) based on official subscription.

PEER-REVIEW POLICY

The scientific quality of articles published on EMJ are assessed through a rigorous double-blind peer review sys- tem. The integrity of the manuscript with respect to its originality, scientific soundness, methodological relevance and significance to the broad field of medicine is determined by the help of independent researchers in the specific area of the submitted manuscript. The peer-reviewers are recruited from different national and international institu- tions with relevant professional and research experience.

The Ethiopian Medical Journal uses a double-blind review system for all manuscripts. Each manuscript is reviewed by at least two reviewers. The reviewers are not aware of the list of authors submitting the manuscript sent for their review. The reviewers act independently, and they are not aware of each other’s identities. The reviewers are se- lected solely based on their relevant expertise for evaluating a manuscript. They must not be from the same institu- tion as the author(s) of the manuscript, nor be their co-authors in the recent past. The purpose of peer review is to assist the authors in improving papers and the Editorial Board in making decision on whether to accept or reject a

manuscript. Reviewers are requested to decline if they have a conflict of interest or if the work does not fall within their expertise.

MANUSCRIPT MANAGEMENT AND PEER-REVIEW PROCESS

Manuscripts are sent for review only if they pass the initial evaluation (pre-review by the Editorial Board) regard- ing their style, methodological accuracy, thematic scope, and ethical scientific conduct. Special care is taken to complete the initial (pre-review) evaluation in 3-5 days. The Journal policy is to minimize time from submission to publication without reducing peer review quality. Currently the total period from the submission of a manuscript until its publication takes an average of six months. Peer reviewers are requested to respond within four weeks. During the review process, the Editor-in-Chief may require authors to provide additional information (including raw data) if they are necessary for the evaluation of the manuscript. These materials shall be kept confidential and must not be used for any other purposes. The entire review process takes place under the supervision of the Editor- in-Chief in an online environment, with the assistance of the Journal Secretariat. The online system also allows authors to track the manuscript review progress.

80

The detailed procedures for manuscript review include:

∙ Within one week of receipt of a manuscript, the Editorial Board will review it in reference to (i) conformity with the Journal's "guidelines to authors" (available online on the journal website and published with all issues starting from February 2016), (ii) relevance of the article to the objectives of the EMJ, (iii) clarity of presenta- tion, and (iv) plagiarism by using appropriate software.style.

∙ The Editorial Board has three options: accept manuscripts for external review, return it to the author(s) for revision, or reject it. A manuscript not accepted by a board member is blindly reviewed by another board member. If not accepted by both, the manuscript is rejected by the Editorial Board. Decision will be made by the suggestion of a third Editorial Board member if the decisions of first two do not concur.

∙ Once accepted for external review, the Editorial Board identifies one reviewer for brief communica-tion, case reports, and teaching articles or two or more reviewers with appropriate expertise for original articles. The reviewers will be asked to review and return manuscripts with their comments online within two weeks of their receipt. Reviewers have four options; accept, accept with major revision, accept with minor revision, or reject.

∙ A Manuscript accepted subject to revision as suggested by reviewers will be returned to the corresponding author. Author(s) will be given four weeks to respond to reviewers' comments, make necessary changes, and return the manuscript to the Editorial Board. A manuscript not returned in time will be considered withdrawn by the author(s).

∙ Manuscripts with minor revisions will be cleared by the Editorial Board and accepted for publication. Those with major revisions will be returned to external reviewers and follow the procedures as outlined for the initial review.

RESPONSIBILITIES

Responsibility of authors

Authors are required to submit manuscripts according to the author’s guidelines of EMJ. This is provided in the ‘Guidelines to Authors’ on the journal website and also appears in each issue of the Journal. Authors must guar- antee that their manuscripts are their original work, that they have not been published before, and are not under consideration for publication elsewhere. Parallel submission of the same paper to another journal constitutes mis- conduct and eliminates the manuscript from further consideration. Work that has already been published elsewhere cannot be reprinted in the Ethiopian Medical Journal. Additionally, if any related work has been submitted or pub- lished elsewhere, authors should notify the journal and submit a copy of it with their submission and describe its relation to the submitted work. Authors are exclusively responsible for the contents of their submissions and must make sure that the authors listed in the manuscript include all and only those authors who have significantly con- tributed to the submitted manuscript. If persons other than authors were involved in important aspects of the re- search project and the preparation of the manuscript, their contribution should be acknowledged in the Acknowl- edgments section.

It is the responsibility of the authors to specify the title and code label of the research project within which the work was created, as well as the full title of the funding institution. In case a submitted manuscript has been pre- sented at a conference in the form of an oral presentation (under the same or similar title), detailed information about what was published in proceedings of the conference shall be provided to the Editor-in-Chief upon submis- sion. Authors are required to properly cite sources that have significantly influenced their research and their manu- script. Parts of the manuscript, including text, equations, pictures, tables and graphs that are taken verbatim from other works must be clearly marked, e.g. by quotation marks accompanied by their location in the original docu- ment (page number), or, if more extensive, given in a separate paragraph. Full references of each quotation (in-text citation) must be listed in the separate reference section in a uniform manner, according to the citation style used by the journal. References section should list only quoted/cited, and not all sources used for the preparation of a manuscript.

When authors discover a significant error or inaccuracy in their own published work, it is their obligation to promptly notify the Editor-in-Chief and cooperate with him/her to retract or correct the paper. Authors should dis- close in their manuscript any financial or other substantive conflict of interest that might have influenced the pre- sented results or their interpretation. By submitting a manuscript, the authors agree to abide by the Editorial Poli- cies of the Ethiopian Medical Journal.

81

Complaints and appeals

In case that the authors have serious and reasonable objections to the reviews and decision on their manuscripts, they can appeal to the Editor-in-Chief and the Editorial Board will assess whether the review is objective and whether it meets academic standards. If there is a doubt about the objectivity or quality of review and the decision, the Editor-in-Chief will assign additional reviewer(s). Additional reviewers may also be assigned when reviewers’ decisions (accept or reject) are contrary to each other or otherwise substantially incompatible. The final decision on the acceptance of the manuscript for publication rests solely with the Editor-in-Chief. The decision on appeal may take extra time due to the regular work of the journal.

Responsibilities of the Editorial Board

The Editor-in-Chief is responsible for deciding which articles submitted to the journal will be published. The deci- sions are made based exclusively on the manuscript's merit. They must be free from any racial, gender, sexual, religious, ethnic, or political bias. When making decisions the Editor-in-Chief is also guided by the editorial policy and legal provisions relating to defamation, copyright infringement and plagiarism. Members of the Editorial Board including the Editor-in Chief must hold no conflict of interest about the articles they consider for publica- tion. Members who feel they might be perceived as being involved in such a conflict do not participate in the deci- sion process for a manuscript. The information and ideas presented in submitted manuscripts shall be kept confi- dential. Editors and the editorial staff shall take all reasonable measures to ensure that the authors/reviewers remain anonymous during and after the evaluation process in accordance with the type of reviewing in use. The Editorial Board is obliged to assist reviewers with additional information on the manuscript, including the results of check- ing manuscript for plagiarism.

Responsibilities of reviewers

Reviewers are required to provide qualified and timely assessment of the scholarly merits of the manuscript. The reviewer takes special care of the real contribution and originality of the manuscript. The review must be fully ob- jective, and the judgment of the reviewers must be clear and substantiated by arguments. The reviewers assess a manuscript for the compliance with the the profile of the journal, the relevance of the investigated topic and ap- plied methods, the scientific relevance of information presented in the manuscript, and the presentation style. The review has a standard format. It is submitted through the online journal management system where it is stored per- manently. The reviewer must not be in a conflict of interest with the authors or funders of research. If such a con- flict exists, the reviewer is obliged to promptly notify the Editor-in-Chief. The reviewer shall not accept for re- viewing papers beyond the field of his/her full competence. Reviewers should alert the Editor-in-Chief to any well- founded suspicions or the knowledge of possible violations of ethical standards by the authors including any dupli- cate submissions or publications during the review process. Reviewers should recognize relevant published works that have not been considered in the manuscript. They may recommend specific references for citation but shall not require citing papers published in the Ethiopian Medical Journal, or their own papers, unless it is justified. The reviewers are expected to improve the quality of the manuscript through their suggestions. If they recommend cor- rection of the manuscript prior to publication, they are obliged to specify the way this can be achieved. Any manu- script received for review must be treated as confidential document.

ETHICAL CONSIDERATIONS

Researches Involving Human Participants

Manuscripts of research outputs conducted on human participants should be carried out only by or strictly super- vised by, suitably qualified and experienced investigators and in accordance with a protocol that clearly states the aim of the research, the reasons for proposing that it involves human subjects, the nature and degree of any known risks to the subjects, the sources from which it is proposed to recruit subjects, and the means proposed for ensuring that subjects’ consent will be adequately informed and voluntary. The protocol should be scientifically and ethical- ly approved by one or more suitably constituted review bodies, independent of the investigators basically operating within the legal framework of each specific country or territory at which the study was conducted and operating with the internationally reputed ethical standards.

82

Explicitly:

∙ Any studies involving human participants should be approved by legally registered and accredited institutional review board (IRB) or equivalent research ethics review committee.

∙ Compliance with the ethical practices and its approval by the responsible IRB should be declared at submis- sion and the review board approval document should be submitted upon request by EMJ

∙ How the informed consent was sought should be explained clearly with required details.

Any clinical investigation must be conducted according to the principles expressed in ethical principles for medical research involving human subjects with the internationally reputed ethical standards specifically ac- cording to Declaration of Helsinki.

∙ Clinical trials should provide trial registration details, the study protocol, and trial study report guideline ac- cording to the specific study design.

Dealing with unethical behavior

Anyone may inform the Editor-in-Chief at any time of suspected unethical behavior or any type of misconduct by giving the necessary credible information/evidence to start an investigation.

∙ The Editor-in-Chief makes the decision regarding the initiation of an investigation.

∙ During an investigation, any evidence should be treated as confidential and only made available to those strict- ly involved in the process.

∙ The accused will always be given the chance to respond to any charges made against them.

∙ If it is judged at the end of the investigation that misconduct has occurred, then it will be classified as either minor or serious.

∙ Minor misconduct (with no influence on the integrity of the paper and the journal, for example, when it comes to misunderstanding or wrong application of publishing standards) will be dealt directly with authors and re- viewers without involving any other parties. Outcomes include:

∗ Sending a warning letter to authors and/or reviewers.-

∗ Publishing correction of a paper, e.g. when sources properly quoted in the text are omitted from the reference list.

∗ Publishing an erratum, e.g. if the error was made by editorial staff.

In the case of major misconduct, the Editor-in-Chief may adopt different measures:

∗ Publication of a formal announcement or editorial describing the misconduct. ∗ nforming officially the author's/reviewer's affiliating institution.

∗ The formal, announced retraction of publications from the journal in accordance with the Retraction Policy.

∗ The formal, announced retraction of publications from the journal in accordance with the Retraction Policy.

∗ A ban on submissions from an individual for a defined period.

∗ Referring a case to a professional organization or legal authority for further investigation and action ∗ The above actions may be taken separately or jointly. If necessary, in the process of resolving the

case relevant expert organizations, bodies, or individuals may be consulted.

∙ When dealing with unethical behavior, the Editorial Board will rely on the guidelines and recommendations provided by the Committee on Publication Ethics (COPE).

Plagiarism prevention

The Ethiopian Medical Journal does not publish plagiarized papers. The Editorial Board has adopted the stance that plagiarism, where someone assumes another's ideas, words, or other creative expression as one's own, is a clear violation of scientific ethics. Plagiarism may also involve a violation of copyright law, punishable by legal action. Plagiarism includes the following:

Self-plagiarism, which is using one's own previous work in another context without citing that it was used previously;

∗ Verbatim (word for word), or almost verbatim copying, or purposely paraphrasing portions of another author's work without clearly indicating the source or marking the copied fragment (for example, using quotation marks) in a way described under Responsibilities of authors;

83

Copying equations, figures or tables from someone else's paper without properly cit- ing the source and/or without permission from the original author or the copyright holder.

Any manuscript which shows obvious signs of plagiarism will be automatically rejected. In case plagiarism is dis- covered in a paper that has already been published by the journal, it will be retracted in accordance with the proce- dure described under Retraction policy, including blacklisting the author(s). To prevent plagiarism, submitted man- uscripts will go through rigorous plagiarism detection process using standard software. The results obtained are verified by the Editorial Board in accordance with the guidelines and recommendations of the Committee on Publi- cation Ethics (COPE).

Confidentiality

EMJ is committed to ensuring the integrity of the peer review process, in accordance with COPE guidelines. Until publication, we strictly keep confidentiality of manuscripts or materials submitted. Reviewers are also required to treat all submitted manuscripts confidentially to make the review process strictly confidential. They should not share information about the manuscript under their review with any third parties. Any breach of confidentiality during the review process will follow COPE guidelines.

Conflict of interest

According to the World Association of Medical Editors (WAME), existence of conflict of interest should be re- ported if there is a divergence between an individual’s private interests (competing interests) and his or her respon- sibilities to scientific and publishing activities such that a reasonable observer might wonder if the individual’s behavior or judgment was motivated by considerations of his or her competing interests. It is the responsibility of authors to disclose any financial/other interest that may have influenced the development of the manuscript. If the reviewers perceive any possible conflict of interest for manuscripts they are assigned to review, they should dis- close it and they should decline the review of such manuscripts if needed. The same also applies to the editors.

Retraction policy

Legal limitations of the publisher, copyright holder or author(s), infringements of professional ethical codes, such as multiple submissions, bogus claims of authorship, plagiarism, fraudulent use of data or any major misconduct require retraction of an article according to Retraction guidelines | COPE: Committee on Publication Ethics. Occa- sionally, a retraction can be used to correct numerous serious errors, which cannot be covered by publishing cor- rections. A retraction may be published by the Editor-in-Chief, the author(s), or both parties consensually. The retraction takes the form of a separate item listed in the contents and labeled as "Retraction". The original article is retained unchanged, except for a watermark on the PDF indicating on each page that it is “retracted”.

OPEN ACCESS

Open access policy

The Ethiopian Medical Journal is published under an Open Access license. All its contents are available free of charge. Users can read, download, copy, distribute, print, search the full text of articles, as well as to establish HTML links to them, without having to seek the consent of the author or publisher. The right to use content with- out consent does not release the users from the obligation to give the credit to the journal and its content in a man- ner described under Copyright & Licensing.

Article processing charge

The Ethiopian Medical Journal does not charge authors or any third party for publication in its regular quarterly Issues. Both manuscript submission and processing services, and article publishing services are free of charge. There are no hidden costs whatsoever.

COPYRIGHT & LICENSING

Copyright

Authors retain copyright of the published papers and grant to the publisher the non-exclusive right to publish the article, to be cited as its original publisher in case of reuse, and to distribute it in all forms and media.

84

Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with the original article published in the Ethiopian Medical Journal. Authors can enter into separate, addi- tional contractual arrangements for the non-exclusive distribution of the journal's published version of their work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publica- tion in this journal.

Self-archiving policy

Authors are permitted to deposit publisher's version (PDF) of their work in an institutional repository, subject based repository, author's personal website (including social networking sites, such departmental websites at any time after publication. Full bibliographic information (authors, article title, journal title, volume, issue, pages) about the original publication must be provided and links must be made to the article's DOI and the license.

Disclaimer

The views expressed in the published works do not express the views of the Editors and the Editorial Staff of the Ethiopian Medical Journal. The authors take legal and moral responsibility for the ideas expressed in the articles. The Publisher (The Ethiopian Medical Association) shall have no liability in the event of issuance of any claims

for damages. The Publisher will not be held legally responsible should there be any claims for compensation.

.

85

GUIDELINES FOR AUTHORS

The Ethiopian Medical Journal (EMJ) is the official Journal of the Ethiopian Medical Association (EMA) devoted to the advancement and dissemination of knowledge pertaining to the broad field of medicine in Ethiopia and other developing countries. Prospective contributors to the Journal should take note of the instructions of Manuscript preparation and submission to EMJ as outlined below.

Article types acceptable by EMJ

Original Articles (vide infra) on experimental and observational studies with clinical relevance Brief Communications

Case Series

Case Reports

Editorials, Review or Teaching Articles: by invitation of the Editorial Board. Correspondences/Letters to the Editor

Monographs or set of articles on specific themes appearing in a Special Issues of the Journal Book reviews

Perspectives,

Viewpoints

Hypothesis or discussion of an issue important to medical practice Letter to the Editor

Commentaries

Advertisements Obituaries

N.B. Articles are not acceptable if previously published or submitted elsewhere in print or electronic format, except in the form of abstracts in proceedings of conferences.

Content and format of articles:

Title: The title should be on a separate page. It should not have acronyms or abbreviations. The title should be descriptive and should `not exceed 20 words or 120 characters including space. The title page should in- clude the name(s) and qualification of the author(s); the department or Institution to which the study/research is attributed and address of the corresponding Author. If the author has multiple affiliations only use the most preferred one.

1.Original Articles

2,500 words, excluding Abstracts, References, Figures and Tables. The manuscript of the Article, should ap- pear under the following headings:

a)Abstract: The abstract of the Article is prepared on a separate paper, a maximum of 250 words; it

should be structured under the titles: a) Background; b) Methods; c) Results; d) Conclusions. Briefly sum- marize the essential features of the article under above headings, respectively. Mention the problem being addressed in the study; how the study was conducted; the results and what the author(s) concluded from the results. Statistical method used can appear under Methods paragraph of the Abstract, but do not insert abbreviations or references in the Abstract section.

Keywords: Provide three to six key words, or short phrases at the end of abstract page. Use terms from medical subject heading of Index Medicus to assist in cross indexing the Article.

b)Introduction : Should provide a short background and context of the study and provide the ra- tionale for doing the study. It should not be a detailed review of the subject and should not include conclu- sions from the paper.

c)Patients or (Materials) and Methods: should contain details to enable reproducibility of the study by others. This section must include a clear statement specifying that a free and informed consent of the subjects or their legal guardians was obtained. Corresponding author should submit a copy of institution review Board (IRB) clearance or letter of permission from the hospital or department (if IRB exempt)

86

with the manuscript. For manuscripts on clinical trials, a copy of ethical approval letter from the con- cerned body should be submitted with the Manuscript. If confidential data is being used for publication (such as student grades, medical board data, or federal ethics board data), then appropriate support/ agreement letter should be included. Photos of patients should disguise the identity or must have obtained their written consent. Reference number for ethical approval given by ethics committee should be stated. In general, the section should include only information that was available at the time the plan or protocol for the study was being written; all information obtained during the study belongs in the Results section.

d)Results: This section should present the experimental or observational data in text, tables or figures. The data in Tables and Figures should not be described extensively in the text.

e)Discussion: The first paragraph should provide a summary of key finding that will then be discussed one by one in the paragraphs to follow. The discussion should focus on the interpretation and significance of the results of the study with comments that compare and describe their relation to the work of others (with references) to the topic. Do not repeat information of Results in this section. Make sure the limitations of the study are clearly stated.

f)Tables and Figures: These should not be more than six. Tables should be typed in triplicate on separate sheets and given serial Arabic numbers. Titles should be clearly place underneath Tables and above Fig- ures. Unnecessary and lengthy tables and figures are discouraged. Same results should not be presented in more than one form (choose either figure or table). Units should appear in parentheses in captions but not in the body of the table. Statistical procedures, if not in common use, should be detailed in the METH- ODS section or supported by references. Legends for figures should be typed on separate sheets, not stapled to the figures. Three dimensional histograms are discouraged. Recognizable photographs of patients should be disguised. Authors should submit editable soft versions of the tables and figures.

g)Acknowledgement: Appropriate recognition of contributors to the research, not included under Au- thors should be mentioned here; also add a note about source of the financial support or research funding, when applicable.

h)References:

∙ The titles of journals should be abbreviated according to the style used for MEDLINE (www.ncbi.nlm.nih.gov/nlmcatalog/journals).

∙ References should be numbered consecutively in the order in which they are first mentioned in the text and identify references in text, tables, and legends by Arabic numerals in parentheses.

∙ Type the References on a separate sheet, double spaced and keyed to the text.

∙ Personal communications should be placed NOT in the list of references but in the text in parentheses, giving name, date and place where the information was gathered or the work carried out (e.g. personal communication, Alasebu Berhanu, MD, 1984, Gondar College of Medical Sciences). Unpublished data should also be referred to in the text.

∙ References with six or less authors should all be listed. If more than six names, list the first three, followed by et al.

∙ Listing of a reference to a journal should be according to the guidelines of the International Committee of Medical Journal Editors ("Vancouver Style') and should include authors' name(s) and initial(s) sepa- rated by commas, full title of the article, correctly abbreviated name of the journal, year, volume number and first and last page numbers.

∙ Reference to a book should contain author's or authors’ name(s) and initials, title of chapter, names of editors, title or book, city and name of publisher, year, first and last page numbers.

The following examples demonstrate the acceptable reference styles.

Articles:

∙ Gilbert C, Foster A. Childhood blindness in the context of Vision 2020: the right to sight. Bull World Health Org 2001;79:227-32

∙ Teklu B. Disease patterns amongst civil servants in Addis Ababa: an analysis of outpatient visits to a Bank employee’s clinic. Ethiop Med J 1980;18:1-6

87

∙ Tsega E, Mengesha B, Nordenfelt E, Hansen B-G; Lindberg J. Serological survey of human immuno- deficiency virus infection in Ethiopia. Ethiop Med J 1988; 26(4): 179-84

∙ Laird M, Deen M, Brooks S, et al. Telemedicine diagnosis of diabetic retinopathy and glaucoma by direct ophthalmoscopy (Abstract). Invest Ophthalmol Vis Sci 1996; 37:104-5

Books and chapters from books:

∙ Henderson JW. Orbital Tumors, 3rd ed. Raven Press New York, 1994. Pp 125-136.

∙ Clipard JP. Dry Eye disorders. In Albert DM, Jakobiec FA (Eds). Principles and Practice of Ophthal- mology. W.B Saunders: Philadelphia, PA 1994 pp257-76.

Website:

∙ David K Lynch; laser History: Masers and lasers. http://home.achilles.net/jtalbot/history/massers.htmAccessed 19/04/2001

2.Brief Communication

Short versions of Research and Applications articles, often describing focused approaches to solve a health problem, or prelnary evaluation of a novel system or methodology

∙ Word count: up to 2000 words

∙ Abstract up to 200 words; excluding: Abstract, Title, Tables/Figures and References

∙ Tables and Figures up to 5

∙ References (vide supra – Original Article)

3.Case Series

Minimum of three and maximum of 20 cases

∙ Up to 1,000 words; excluding: Abstract, Title, Tables/Figures and References ∙ Abstract of up to 200 words; structured; (vide supra)

∙ Statistical statements here are expressed as 5/8 (62.5%)

∙ Tables and Figures: no more than three

∙ References: maximum of 20

4. Case Report

Report on a rare case or uncommon manifestation of a disease of academic or practical significance ∙ Up to 750 words; excluding: Abstract, Title, Tables/Figures and References

∙ Abstract of up to 100 words; unstructured; ∙ Tables and Figures: no more than three ∙ References: maximum of 10

5. Systematic review

Review of the literature on topics of broad scientific interest and relevant to EMJ readers ∙ Abstract structured with headings as for an Original Article (vide supra)

∙ Text should follow the same format as what is required of an Original Article

∙ Word count: up to 8,000 words, excluding abstract, tables/Figures and references ∙ Structured abstract up to 250 words

∙ Tables and Figures up to 8

6. Teaching Article

A comprehensive treatise of a specific topic/subject, considered as relevant to clinical medicine and public health targeting EMJ readers

∙ By invitation of the Editorial Board; but an outline of proposal can be submitted ∙ Word limit of 8,000; excluding abstract, tables/Figures and references

∙ Unstructured Abstract up to 250 words

7. Editorial

∙ By invitation of the Editorial Board, but an editorial topic can be proposed and submitted ∙ Word limit of 1,000 words: excluding references and title; no Abstract

∙ References up to 15.

8. Perspectives

88

∙ By invitation of the Editorial board, but a topic can be proposed and submitted ∙ Word limit of 1,500

∙ References up to six

9. Obituaries

∙ By invitation of the Editorial board, but readers are welcome to suggest individuals (members of the EMA) to be featured.

Preparation of manuscripts

∙ Manuscripts must be prepared in English, the official language of the Journal.

∙ On a single separate sheet, there must be the title of the paper, with key words for indexing if required, and each author's full name and professional degrees, department where work was done, present address of any author if different from that where work was done, the name and full mailing address of the cor- responding author, including email, and word count of the manuscript (excluding title page, abstract, references, figures and tables). Each table/figures/boxes or other illustrations, complete with title and footnotes, should be on a separate page.

∙ All pages should be numbered consecutively in the following order: Title page; Abstract and key- words page; main manuscript text pages; References pages; acknowledgment page; Figure-legends and Tables

∙ The Metric system of weights and measures must be used; temperature is indicated in degrees Centi- grade.

∙ Generic names should be used for drugs, followed by propriety brand name; the manufacturer name in parenthesis, e.g. diazepam (Valium, Roche UK)

∙ Statistical estimates e.g. mean, median proportions and percentages should be given to one decimal place; standard deviations, odds ratios or relative risks and confidence intervals to two decimal plac- es.

∙ Acronyms/Abbreviations should be used sparingly and must be given in full, at first mention in the text and at the head of Tables/foot of Figure, if used in tables/figures.eg. Blood Urea Nitrogen (BUN). Interstitial lung disease (ILD).

∙ Use the binomial nomenclature, reference to a bacterium must be given in full and underlined - under- lining in typescript becomes italics in print (e.g. Hemophilus influenzae), and later reference may show a capitalised initial for the genus (e.g. H. influenzae)

∙ In the text of an article, the first reference to any medical phrase must be given in full, with the initials following in parentheses, e.g., blood urea nitrogen (BUN); in later references, the initials may be used.

∙ Manuscripts for submission should be prepared in Microsoft Word document file format

Submission of manuscripts

∙ As part of the submission process, authors are required to check off their submission's compliance with journals requirements

∙ All manuscripts must be submitted to the Editor-in-Chief of the Journal with a statement signed by each author that the paper has not been published elsewhere in whole or in part and is not submitted elsewhere while offered to the Ethiopian Medical Journal. This does not refer to abstracts of oral com- munications at conferences/symposia or other proceedings.

∙ It is the author's responsibility to proof-read the typescript or off-print before submitting or re- submitting it to the Journal, and to ensure that the spelling and numerals in the text and tables are accu- rate.

∙ Authors should submit their work through the Ethiopian Medical Journal website; [email protected].

Conflict of interest

89

Authors should disclose at the time of submission of manuscripts any conflict of interest, which refers to situations in which financial or other personal considerations may compromise, or have the appearance of compromising their professional judgment in conducting or reporting the research results They should declare that there is no conflict of interest to declare if there is none,

Manuscripts review procedures

The procedures for manuscripts review include:

∙ Within one week of receipt of a manuscript, the Editorial Board will review it in reference to (i) conformity with the Journal's "guidelines to authors (revised version available in all issues starting January 2020)", (ii) relevance of the article to the objectives of the EMJ, (iii) clarity of presentation, and (iv) plagiarism by using appropriate software

∙ The Editorial Board has three options: accept manuscripts for external review, return it to author for revision, or reject it. A manuscript not accepted by a board member is blindly reviewed by another board member. If not accepted by both, the manuscript is rejected by the Editorial Board. Decision will be made by the sug- gestion of a third Editorial Board member if the decisions of first two do not concur.

∙ Once accepted for external review, the Editorial Board identifies one (for brief communication, case reports, and teaching articles) or two (for original articles) reviewers with appropriate expertise. The reviewers will be asked to review and return manuscripts with their comments online within two weeks of their receipt. Reviewers have four options; accept, accept with major revision, accept with minor revision, or reject.

∙ A Manuscript accepted subject revision as suggested by reviewers will be returned to the corresponding au- thor. Author(s) will be given four weeks to respond to reviewers' comments, make necessary changes, and return the manuscript to the Editorial Board. A Manuscript not returned within the specified time will be considered withdrawn by the author(s).

∙ Manuscripts with minor revisions will be cleared by the Editorial Board and accepted for publication. Those with major revisions will be returned to external reviewers and follow the procedures as outlined for the ini- tial review.

General information

The Editorial Board reserves the right for final acceptance, rejection or editorial correction of papers submitted. However, authors are encouraged to write an appeal to the Editor-in-Chief for reconsideration of rejected manu- scripts or any other complaints they might have.

Accepted papers are subject to Editorial revision as required and become the copy-right of the EMA Twenty- five reprints of published articles are supplied free to the first/corresponding author.

The Editorial Board welcomes comments on the guidelines from Journal readers.

Privacy statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

92

THE ETHIOPIAN MEDICAL JOURNAL

The Ethiopian Medical Journal, founded in 1962, appears four times a year and is available from the Secretary, EMA

House, Addis Ababa, or by mail P. O. Box 3472, Addis Ababa, Ethiopia. Request for previous issues is wel- comed. For this and any other information, please contact us through:

e-mail: [email protected] Tel. 251-1-158174 or 251-1-533742; Fax: 251-1-533742

The Journal contains original articles and research of special relevance to the broad issue of medicine in Ethiopia and in other developing countries. It is listed in the Index Medicus and Current Contents. Its ISSN number is ISSN 0014– 1755.

If you wish to subscribe to the Journal, please complete the section below and return it to the Secretary. The Subscrip- tion rates are:

Ethiopia: Eth. Birr 700.00 annually, postage included; World-wide: US$ 200, airmail postage included

………………………………………………………………………………………………………………………….

Request to: The Secretary, Ethiopian Medical Journal, P. O. Box 3472, Addis Ababa, Ethiopia. I wish to subscribe to the Ethiopian Medical Journal for the Year(s) …………. to …………….

Name .....................................................................................................................……..

Address ................................................................................................................………

I enclose my subscription fee of ...................................................................................

Signed ................................

Cheques should be made payable to the Ethiopian Medical Journal. If payment is made by Bank Transfer (A/C No. 1000000892932, Commercial Bank of Ethiopia, Addis Ababa Branch), please ensure that the Secretary of the Ethio- pian Medical Journal is notified of the transfer.

NOTICE TO MEMBERS OF THE ETHIOPIAN MEDICAL ASSOCIATION

If you are a paid–up member of EMA, and have not received your copy of EMJ, please notify the secretary, with the support of your ID card or letter from your hospital. Also, if you are transferred to a different hospital or institution, please return the following change of address form PROMPTLY.

NAME (in block) ...................................................................................................……...

FORMER ADDRESS: ............................................................................................……..

P. O. BOX

.................................. CITY/TOWN

NEW ADDRESS ................................................................................................…………

INSTITUTION ..........................................................................................................…….

P. O. BOX

....................... CITY/TOWN ..................................................................…..